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Résumé 
Au cours des dernières décennies, la fluoroscopie est devenue une technique d'imagerie à 
rayons X diagnostique et thérapeutique largement utilisée pour de nombreuses interventions 
médicales, grâce à sa capacité à visualiser des phénomènes dynamiques dans le corps 
humain en temps réel et à un caractère minimalement invasif. En raison de la présence 
obligatoire de personnel médical dans la proximité immédiate du patient, ces interventions 
posent un problème unique pour la radioprotection, impliquant que les radiologues et 
cardiologues interventionnels sont parmi les travailleurs professionnellement exposés aux 
rayonnements ionisants qui reçoivent les doses efficaces les plus élevées. En outre, de 
nombreuses autres spécialités médicales ont repris la fluoroscopie comme principal outil de 
travail. En conséquence, le manque de connaissances et d’une formation spécifique à 
l’utilisation des rayonnements ionisants est un défi qui peut être difficile à résoudre au niveau 
institutionnel. En outre, de nombreuses innovations technologiques ont été introduites afin de 
surveiller les doses délivrées aux patients (p. ex. des logiciels de collecte automatiques des 
doses), afficher l'exposition du personnel en temps réel, ou encore réduire la dose au patient 
en appliquant de fortes filtrations du faisceau primaire et en améliorant simultanément la 
« qualité d'image » en appliquant des traitements d’image en ligne, comme c'est le cas pour 
la reconstruction itérative des images en tomodensitométrie. Pour la qualité de l'image, il n'y 
a par conséquent plus de lien direct entre l'exposition du patient et la qualité de l'image – 
sans parler de l’absence-même de définition adéquate de la qualité d’image. Ainsi, les 
mesures physiques traditionnellement utilisées pour sa mesure, déjà peu appropriées pour 
une optimisation clinique pertinente, ne sont plus applicables. Durant cette recherche, nous 
avons testé plusieurs de ces innovations et tenté d’en déterminer les forces et faiblesses. 
Tout d'abord, nous avons effectué une revue de la littérature afin de résumer l'actuel état de 
l'art dans les procédures sous guidage fluoroscopique. Deuxièmement, nous avons décrit les 
moyens d'évaluer la dose au patient et le risque radiologique associé, ainsi que la façon de 
corriger les indicateurs dosimétriques en fonction de la corpulence du patient, et avons 
effectué une analyse spécifique de la prise en charge de la patiente enceinte. 
Troisièmement, nous avons décrit l'exposition et les risques du personnel médical, 
principalement en nous concentrant plus avant sur l’irradiation du cristallin et du cerveau 
(deux organes généralement pas protégés au cours de l’intervention, et pour lesquels 
plusieurs études récentes ont montré que le risque radiologique avait été sous-estimé), ainsi 
qu'une description précise de l'efficacité des lunettes plombées. Quatrièmement, nous avons 
proposé que la qualité d'image devienne la pierre angulaire de l'optimisation clinique. Pour 
cela, nous avons réalisé une étude de faisabilité de l'utilisation d'un modèle d’observateur 
mathématique dans des conditions d’acquisition statiques et dynamiques, visant à qualifier la 
qualité d'image sur la base d'une tâche de détection binaire pertinente d’un point de vue 
clinique. Enfin, notre conclusion souligne les limites actuelles de notre approche et propose 
une série de questions à développer, dont la résolution pourrait avoir un impact significatif 
sur la gestion globale de la dose et de la qualité de l'image.  
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Summary 
Over the last decades, fluoroscopy has become a widely-used diagnostic and therapeutic X-
ray imaging technique for numerous medical procedures thanks to its capability of displaying 
dynamic phenomena in the human body in real time and its minimally-invasive nature. Due to 
the customary presence of medical staff in the immediate vicinity of the patient, interventional 
procedures pose a unique radiation protection problem, implying that interventional 
radiologists and cardiologists are among the professionally-exposed to ionising radiation 
workers who receive the highest effective doses. In addition, many other medical specialties 
have taken up fluoroscopy as a central working tool. As a consequence, the lack of radiation 
awareness and specific training is a challenge that may be difficult to solve at the institutional 
level. Furthermore, many technical innovations have been introduced to either monitor 
patient doses (such as automatic dose-collection software solutions), display staff exposure 
in real time, or reduce patient dose by applying heavy beam filtrations and simultaneously 
enhancing “image quality” through on-line image post-processing, as is the case for iterative 
image reconstruction in computed tomography. For image quality, the consequence is that 
there is no straightforward link anymore between patient exposure and image quality – and 
not even a proper definition of image quality. Therefore, the physical metrics classically used 
for quality measurement, already flawed for pertinent clinical optimisation, are no longer 
applicable. For this research, we tested several of these innovations, and tried to pinpoint 
their strengths and weaknesses. First, we performed a literature review to summarise the 
current state-of-the-art in fluoroscopic procedure guidance. Secondly, we described the ways 
of assessing patient dose and radiological risk, as well as how to correct the dose indicators 
based on patient body habitus, and performed a dedicated analysis of the management of 
the pregnant patient. Thirdly, we described the exposure and risks of the medical staff during 
interventional procedures, mainly by concentrating more thoroughly on eye lens and brain 
dose (two organs that are usually not protected during interventional procedures, and for 
which several recent studies have shown that the risk had been previously underestimated), 
as well as a precise description of the efficiency of leaded glasses. Fourthly, we proposed 
that the image quality becomes the cornerstone of clinical optimisation. For this purpose, we 
performed a feasibility study of the use of a mathematical model observer in static and 
dynamic imaging conditions, aiming at grading image quality on the basis of a clinically 
relevant binary detection task. Finally, we concluded by pointing out the current limitations of 
our approach, and proposed a series of follow-up questions whose resolution may have a 
significant impact on the overall management of patient and staff dose and image quality. 
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Introduction 
Over the last years, fluoroscopy has become a preferred diagnostic and therapeutic imaging 
technique for numerous minimally-invasive medical procedures. It relies on the real-time 
visualisation of dynamic phenomena in the human body, such as blood flow restrictions due 
to an arterial lumen reduction, the position of a needle near a vertebra prior to a vertebral 
cementoplasty, or the embolisation of a cerebral aneurism, using planar X-ray imaging. 
Among its advantages are: reduced patient hospitalisation times (only several hours for 
percutaneous coronary interventions (PCI) against several days for open-heart surgery) and 
reduced associated costs for the local healthcare reimbursement system; reduced patient 
septic risk and blood loss; more efficient and flexible clinical workflow. Interventional 
fluoroscopy poses a unique radiation protection problem, in the sense that the customary 
presence of medical staff in the immediate vicinity of the patient implies an increased 
exposure of the operator(s) and mobile staff in angiography suites or operation theatres. 
For patients, fluoroscopically-guided interventions are among the medical procedures that 
yield the highest individual effective doses, and the typical patient exposure for a given 
medical indication is non predictable. Indeed, interventional radioscopy functions with an 
automatic exposure control (AEC) system, based on a desired image quality – and thus 
detector sensitivity. The AEC automatically adjusts the X-ray tube output based on the 
patient’s absorption properties (body size, tissue density, presence of any metallic objects in 
the patient’s body – a prosthesis, bone screws, etc.) and a target detector dose through pre-
calibrated voltage – current – exposure time curves, i.e. the imaging parameter space 
necessary for a pre-desired contrast-to-noise or signal-to-noise ratio, depending on the 
manufacturer. As such, even for a same diagnostic question, there is no possible way to 
predict patient dose accurately, and patient effective doses can therefore be consequent, 
depending on the case complexity. Furthermore, interventional fluoroscopy is a classically 
diagnostic means of imaging often used for therapeutic purposes. Indeed, the real-time 
dynamic imaging properties of fluoroscopy have quickly driven it from a pure diagnostic 
modality towards a tool allowing the guidance of numerous devices intended at curing health 
conditions previously only reachable by chemicals. For example, the fraction of ST Elevation 
Myocardial Infarction (STEMI) patients undergoing systemic drug-induced thrombolysis went 
from 51 % (male) and 39 % (female) in 1997 to less than 1 % for both genders in 2007. 
Meanwhile, the fraction of the same condition treated by percutaneous coronary intervention 
(PCI) rose from under 10 % for both genders to 80 % (male) and 70 % (female) in the same 
decade [Radovanovic 2012]. As a consequence, the exposure burden has the potential to 
induce severe immediate radiation injuries (mainly skin injuries), in addition to the cumulative 
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long-term mutagenesis effects such as radiation-induced cancer. Indeed, on the 634 
reported radiation-related accidents between 1980 and 2013 (including radiation therapy, 
industrial imaging, military purposes, orphan sources or other potential causes), 194 (31 %) 
were due to the use of fluoroscopy [Coeytaux 2015], among which the vast majority of events 
concerned local skin injuries. 
Regarding staff exposure, tissue effects are not to be expected, since only a small fraction of 
the patient’s dose will be scattered to the people positioned next to the patient, especially the 
main procedure operators. However, cumulative doses may be quite high over one’s career, 
and have become a growing concern over the last few years, since the International 
Commission on Radiological Protection (ICRP) has stated in 2011 that the threshold of 
radiation-induced cataract (currently estimated around 0.5 Gy) had been overestimated in 
the past (i.e. previously thought to be around 5 Gy), thus leading to an overall reduction of 
the annual eye lens dose limit in national and international regulations to a mere 20 mSv per 
year [Ciraj-Bjelac 2010, ICRP 2011]. As for the stochastic risk, some publications have 
recently reported several cases of cardiologists diagnosed with glioblastoma, with an 
apparent excess of the lesions occurring in the left hemisphere, where the X-ray tube is 
usually located [Roguin 2013a and b]. Although theses papers are no epidemiological 
studies but case reports, the mentioned results have brought concern among the 
interventional cardiology community. But, as a matter of fact, interventional radiologists and 
cardiologists are among the professionally-exposed to ionising radiation workers who receive 
the highest effective doses [FOPH 2016]. Classically, fluoroscopically-guided interventions 
were the “private ground” of radiologists and cardiologists, and the basics of clinical radiation 
protection and the management of image quality within the ALARA (as low as reasonably 
achievable) principle is usually taught to those specialists during their training and continuous 
education. However, many of other medical specialties, traditionally based on more invasive 
patient treatment techniques, have adopted fluoroscopy as a central working tool. These 
specialties include – but this list is not restricted to – orthopaedic surgeons, 
gastroenterologists, urologists, gynaecologists, anaesthesiologists, and vascular surgeons 
[ICRP 2010]. For example, a questionnaire-based study by S. J. Bordoli et al. showed that, 
among 311 vascular surgery trainees in the United States in 2012 (with a 14 % response 
rate), 45 % percent had not followed formal radiation safety training, 74 % did not know the 
radiation safety policy for pregnant vascular surgeons, 48 % were unable to bring up their 
radiation safety officer’s (RSO) contact information, and 43 % did not even know their yearly 
acceptable levels of radiation exposure [Bordoli 2014]. This poses a major challenge with 
respect to patient and staff radiological safety, as well as the technical and scientific 
knowledge regarding the optimal choice of image acquisition parameters. 
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Finally, image quality is – and has always been – a key element for an accurate diagnostic 
and therapeutic efficiency of fluoroscopy. Recent technological innovations have allowed for 
images to be acquired at much lower doses, thus reducing patient and staff radiation risk, by 
adapting the AEC systems to spare patient skin dose while aiming at keeping a satisfying 
image quality. However, this does not prevent potential high exposures, as X-ray tubes 
become more powerful and can sustain much longer procedure times. Furthermore, as is the 
case with iterative reconstruction in computed tomography (CT), the link between the 
classical physical image quality parameters (signal-to-noise ratio SNR, contrast-to-noise ratio 
CNR, modulation transfer function MTF, etc.) is no longer straightforward. Indeed, the 
underlying hypotheses for these metrics include noise stationarity and a linear behaviour with 
respect to detector entrance dose. However, many of these dose-reduction algorithms 
involve some strength of recursive noise damping, as well as on-line pixel-wise analysis of 
image content and its subsequent correction based on the statistical knowledge of image 
noise characteristics and the expected clinical information contained in the images. This 
implies highly non linear image properties, and thus calls for the need of more reliable – and 
clinically relevant – tools for assessing image quality, ideally qualifying it on the basis of the 
capacity of the system to deliver a given diagnostic information, i.e., task based imaging 
performance. Based on psychophysical formalism [Barrett 2004], the use of model observers 
can help circumvent the underlying limitations due to non linear image reconstruction 
algorithms by qualifying image quality based on a clinical task (e.g. signal detection) and the 
analysis of image background noise properties. 
In this work, we will describe our work on the three previously mentioned topics. Firstly, we 
will perform a short but thorough literature review to pinpoint the current state-of-the-art in 
fluoroscopic procedure guidance. Secondly, we will describe the ways of assessing patient 
dose and radiological risk, mainly with respect to skin injuries, as well as how to correct the 
dose indicators based on patient body habitus, and how the particular condition of the 
pregnant patient may influence the management of radiation dose. The question of the 
strengths and weaknesses of automatic patient dose collection software solutions will also be 
discussed. Thirdly, we will describe the exposure and risks of the medical staff during 
interventional procedures, as well as a precise description of the efficiency of leaded glasses 
aiming at reducing eye lens dose. Fourthly, we will describe the decreasing dependency 
between image dose and image quality, and try circumventing this non-linear behaviour by 
using a mathematical model observer in static and dynamic imaging conditions. Finally, we 
will stress out the current limitations of our approach, and propose a series of follow-up 
questions whose resolution may have a significant impact on the overall management of 
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patient and staff dose and image quality in a more intricate way as is being carried out 
currently.   
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Literature review 
This short literature review will summarise the key concepts used within this research. We 
will first focus on patient exposure and dose management. Next, we will analyse the current 
state of staff exposure and means of protection available. Then, we will stress out the main 
challenges of image quality assessment, especially for dynamic imaging tasks. And finally, 
we will present the main tasks presented to a medical physicist within an interventional 
radiology suite. 
Patient exposure 
The quantification of X-ray tube output vs. patient exposure is not straightforward. Ideally, 
patient dose should be monitored in situ at any moment during a fluoroscopically-guided 
intervention. The ideal dose measurement for patient deterministic risk assessment would be 
the peak skin dose (PSD) [Jones 2011], i.e., the highest dose absorbed anywhere by the 
patient’s skin, thus indicating the most likely location for subcutaneous skin injuries, as well 
as the potential severity of the radiation-induced lesions. A paper by S. Balter et al. [Balter 
2010] summarises the potential skin lesions with respect to dose absorbed by the patient’s 
skin, ranging from no early or late effects under 2 Gy, to early transient erythema requiring 
surgical interventions, and up to long-term telangiectasia or other persistent deeper lesions 
at doses above 15 Gy. More generally speaking, above 5 Gy, there is a risk for long-term 
skin affections, and the probability of skin lesion occurrence is close to 100 % at these levels 
– as a reminder, a dose threshold is defined as the dose necessary for 1 % of the population 
to develop these effects, with a rapid increase of that proportion with increasing dose. 
However, the task of accurately measuring patient skin dose, although theoretically feasible 
by placing adequate radio-transparent dosimeters across the patient’s anatomy, is practically 
impossible to perform on a routine basis. And organ doses – and the subsequent effective 
dose – cannot be measured directly. Furthermore, the overall absolute number of 
occurrences remains low, with a further tendency in decrease over the 2000 – 2009 decade 
[Coeytaux 2015], so risk monitoring should be steadily adapted. This is why the dosimetry 
evaluation of the patient prior to, during, or after the examination, will rely on pre-defined 
dose indicators. Indeed, in order to unify dose – as well as risk – management, several easy-
to-measure and intuitive patient dose indicators have been established for fluoroscopy by the 
International Commission on Radiation Units and Measurements (ICRU) [ICRU 2005], of 
which we will adopt the formalism for dose indicator nomenclature. In addition, a publication 
by M. S. Stecker et al. [Stecker 2009] summarises the current guidelines on patient radiation 
dose management, with respect to modern angiography units. We will describe the four most 
widely used dose indicators. 
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- Fluoroscopy time (T): The fluoroscopy time (T) is defined as the time during which the 
pedal is being pressed by the operator. Because of the usual pulsed frame 
acquisition – rather than continuous exposure – this value is far from being indicative 
of the actual beam-on time. Indeed, the typical pulse duration is on the order of 10ms. 
At 8 frames per second [fps], the actual patient exposure time will only be 8 % of the 
displayed fluoroscopy time. Furthermore, some manufacturers only calculate 
fluoroscopy time, thus not incrementing the chronometer when proceeding with 
diagnostic quality imaging. Indeed, there is usually a major distinction between the 
fluoroscopy and acquisition modes, as stated by the National Council on Radiation 
Protection and Measurements (NCRP) report 168 [NCRP 2010]: 
o Fluoroscopy: Usually low quality (high noise)/low dose images used for 
preparatory imaging (catheter positioning, tool guidance). These images are 
usually not automatically recorded, although some modern units are equipped 
with RAM allowing for the buffering of the last several seconds of imaging and 
manual saving if needed – e.g. if their content is sufficient for the diagnosis, 
o Acquisition: High quality/dose images, automatically stored for diagnostic 
purposes. Typical acquisition series include cineradiography, digital 
subtraction angiography (DSA) or single-frame digital radiography (DR). 
As a consequence, T is a good indicator of the procedure complexity but is not a 
reliable patient dose indicator. 
- Number of radiographic frames per intervention (N): Like T, N is an indication of the 
procedure complexity but does not provide an accurate estimation of patient PSD. 
Indeed, even if much information about the image-wise acquisition parameters (tube 
voltage and current, pulse duration, focus-to-detector distance, table height, etc.) is 
stored in their respective DICOM headers, the major part of images are, as 
mentioned previously, usually not saved, namely the low-quality fluoroscopy frames 
used solely for positioning or navigation purposes. Nevertheless, it can still serve to 
optimise image acquisition rate, as identical fluoroscopy times and similar patient 
body habitus distribution do not necessarily mean an identical number of recorded 
diagnostic frames. 
- Cumulative air kerma-area product (PKA): The cumulative air kerma-area product 
(PKA) is defined as the integral of the air kerma (𝐾𝑎) cumulated at a given location 
over the area exposed by the primary beam at that same location: 
𝑃𝐾𝐴 = � 𝐾𝑎(𝑥,𝑦)𝑑𝑥𝑑𝑦
𝑒𝑥𝑝𝑜𝑠𝑒𝑑 𝑠𝑢𝑟𝑓𝑎𝑐𝑒  
Conveniently, the PKA does not depend on where it is measured. Indeed, the air 
kerma rate decreases with the inverse square of the distance to the focal spot, 
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whereas the exposed area increases with the square of the distance to the focal spot. 
As a consequence, the product of both is an invariant with respect to the 
measurement point within the primary beam. A usual application of the PKA is a quick 
and straightforward – when knowing the beam quality in units of aluminium half-value 
layers – conversion to patient effective dose using conversion factors determined by 
extensive Monte-Carlo simulations [Struelens 2009]. Indeed, for a given medical 
purpose, the X-ray beam will usually be focused on a given anatomical region (head, 
chest, pelvis, etc.) using beam angles as defined by different medical requirements, 
and with acquisition parameters determined automatically by the system’s AEC. The 
organs in the primary beam field of view (FOV), along with those exposed by 
internally scattered X-rays, are thus more or less the same. The PKA is, de facto, an 
integral value of the number of X-ray photons delivered to the explored patient’s 
anatomy, and effective dose calculated by Monte-Carlo simulations can be 
normalised by the delivered PKA. 
- Cumulative air kerma at a reference point (Ka,r): Unlike PKA, Ka,r has to be expressed 
relative to at a given location. The International Electrotechnical Commission (IEC) 
defines the interventional reference point (IRP) as virtually lying at 15 cm from the 
device’s isocenter towards the X-ray tube, along the central beam axis [IEC 2010]. 
The IRP was designed to be representative of the entrance point of the X-ray beam in 
the patient, thus used as an estimator of possible patient skin injuries. The Food and 
Drug Administration (FDA) reference point differs from the IEC reference point by its 
definition: It is located at 30 cm from the entrance of the imaging device, 
independently of the focal spot-to-detector distance. According to A. K. Jones et al. 
[Jones 2011], the Ka,r is not equal to the PSD, but is the best dose indicator to 
perform a quite precise evaluation of PSD, providing the knowledge of beam angle(s), 
table height and primary beam filtration.  
Figure 1 summarises the two latter dose indicators and the location of the IRP. As we see, 
these indicators remain limited for patient risk assessment, and a solution for this problem 
could come from a new DICOM object, the Radiation Dose Structured Report (RDSR), 
recording many operational parameters for all exposure events. It is important to understand 
that an analogous dose indicator to Ka,r used in conventional planar radiography, the 
entrance surface air kerma (ESAK, measuring the entrance air kerma at the patient’s skin) 
does not imply the same radiological risk. Indeed, for conventional radiography, the usual 
acquisition parameters (FOV, patient position, beam angle) are quite similar between 
different radiology centres. As such, the ESAK can be used for patient effective dose 
estimation, providing a relevant conversion factor. But for fluoroscopy, the PKA is the 
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preferential choice of effective dose estimator, whereas the Ka,r (or ideally PSD), similar to 
the ESAK, will this time be an indicator of patient tissue effect risks. As we can see, the 
measurement referential is not the same even if the schematic imaging chain is almost the 
same between radiography and fluoroscopy. 
 
Figure 1: Schematic depiction of the relevant elements defining Ka,r and PKA.  a: focal spot - b: X-ray 
detector - c: X-ray primary beam - d: interventional reference point (IRP) - e: isocenter - f: exposed X-ray 
field at an arbitrary distance from the focal spot. 
The patient, by contrast with staff, is not subjected to any dose limitations, the risk of using 
ionising radiation being, for medical purposes, always considered inferior to the advantage it 
represents for the well-being of the patient. But the aforementioned dose indicators (T, N, PKA 
and Ka,r) are useful to optimise one’s practice using diagnostic reference levels (DRL), 
defined by the ICRP [ICRP 1990]. Usually, DRLs are defined as the third quartile of the 
distribution of a specific dose indicator (e.g. PKA) for a given medical examination (e.g. 
coronary angiography) within a single centre. For a whole country, the DRL is calculated as 
the third quartile of each centre’s median dose value. DRLs being defined for a standard 
patient body habitus, this value can of course be exceeded from time to time if the 
circumstances require it (large patient, complicated case, unexpected complication, etc.). But 
if a DRL is regularly exceeded, the operator should take active measures to reduce patient 
exposure. As we mentioned earlier, fluoroscopy doses being non predictable – and 
fluoroscopy being also used for therapeutic purposes – we will use the term of reference 
level (RL) rather than DRL. 
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Staff exposure 
As previously mentioned, staff involved in fluoroscopically-guided procedures is highly 
exposed to radiation emitted by the patient interacting with the primary beam, mainly by 
Compton scattering. This implies that the effective doses received by these professionals are 
among the highest for professionally-exposed radiation workers. For example, in 2015, 93 
753 workers were routinely monitored for their exposure to ionising radiation in Switzerland 
[FOPH 2016]. Out of this population, 68 270 (73 %) were active in medicine (Table 1). 
 
Dose range 2014 2015 
[mSv / year] Total Medicine Total Medicine 
0-2 89 702 65 888 92 855 68 145 
2-4 507 92 594 77 
4-6 138 35 203 35 
6-8 36 12 75 10 
8-10 8 3 21 1 
10-12 3 1 3 1 
12-14 1 0 1 0 
14-16 2 1 1 1 
Total 90 397 66 032 93 753 68 270 
Total >2 mSv 695 144 898 125 
Total person Sv 5.39 1.19 5.88 1.10 
Table 1: Number of professionally-exposed workers and subset of medical workers in Switzerland for 2014 
and 2015, with respect to their dose ranges. Adapted from [FOPH 2016]. 
 
The average dose per medical worker was at 16.1 µSv over the whole year 2015, but the 
distribution of individual doses was highly asymmetric. Indeed, only 125 (0.2 %) of medical 
workers had doses between 2 and 16 mSv over the whole year, out of the 898 professionally 
exposed workers in that same range, representing about 14 % of the workers with effective 
doses above 2 mSv. Interestingly though, this proportion was higher in 2014 (144 medical 
workers out of 695 with doses above 2 mSv – about 21 %), for an overall lower number of 
medical professionals (66 032) for the same year. It is not yet clear if this reduction is due to 
the technological advancements we will describe later on, or if there is perhaps a reduction in 
the discipline required to systematically wearing one’s dosimeter. Nevertheless, of these 
several tens of workers with non-zero doses, the majority were interventional radiologists and 
cardiologists. These doses may, in themselves, be quite low. But due to the high dose rates 
encountered in angiography suites, interventional staff is required to use high atomic number 
(Z) protective clothing and leaded means of protection such as glasses or mobile shielding. 
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The effective dose being measured under the apron, routine dose monitoring may severely 
underestimate dose scattered to parts of the body not protected by individual clothing. 
As mentioned in the literature review on patient dose – and as we will see in the next section 
on image quality – fluoroscopy units adapt the patient dose rate based on a pre-defined 
image quality, the patient’s body habitus, and the type of tissue that has to be imaged (lung, 
soft tissue, bone, etc.). It is therefore very difficult to predict an individual operator dose per 
procedure using routine dosimetry. Indeed, dosimeters used for routine dose monitoring, 
such as thermoluminescent dosimeters (TLD), are usually read every month, thus displaying 
an effective or skin dose over a whole month in one reading. Two solutions exist to assess 
individual procedure doses. The first solution consists of real-time dosimeters, recently 
brought unto the market, allowing for a real-time visualisation of individual staff dose rates 
and cumulative doses. The individual solutions, as well as their technical capabilities and 
limitations, have been thoroughly tested and discussed in the ORAMED report published by 
the EURADOS in 2012 [Vanhavere 2012]. However, these solutions, although 
straightforward to implement, are usually very costly, and cannot easily be deployed at a 
whole hospital level. These solutions are thus used punctually for specific dosimetry studies, 
or for teaching purposes, usually worn above the apron to assess one’s individual radiation 
protection behaviour. The second solution is the normalisation of cumulative doses by the 
dose delivered to the patient, usually the PKA. This mathematical tool, usually expressed in 
[µSv / (Gy cm2)], is called a scatter factor, and allows for a quick estimation of dose scattered 
around the patient after a specific examination [Schueler 2006]. It is usually expressed at a 
certain distance from the radiation field centre, or from a pre-defined point on the patient 
table, when multiple beam angles are used during an intervention. It may be either derived 
from Monte-Carlo simulations, or following an aforementioned dose assessment campaign 
using electronic dosimeters. Scatter factors are especially useful for assessing individual 
radiation protection discipline within a given angiography suite, as different operators may 
use the available means of protection with different degrees of accuracy. 
The risks encountered by medical staff have been recently described in a publication by J. R. 
Parikh et al. in the American Journal of Roentgenology [Parikh 2017]. The different risks 
described within this paper are summarised in Table 2. As we can see, the different 
described health conditions have a very low – yet probably existing – dependence on the 
long-term exposure to ionising radiation. Particularly brain tumours and radiation-induced 
cataracts are the recent reasons for concern. 
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Health condition Details Comments 
Skin cancer 
Basal cell and squamous cell 
carcinoma 
No influence on melanoma 
Observed in the pre-1950 era, 
when occupational doses were 
much higher 
Breast cancer Very low influence Especially for technologists employed before 1985  
Leukaemia No evidence since the 1970s - 
Thyroid cancer Very small risk Radiosensitivity decreases with age 
Brain cancer 
Case reports on 31 
interventional cardiologists 
deceased from brain tumours 
85 % of the malignancies in 
the left hemisphere 
Skin injuries Permanent depilation of the distal lower extremities 
Less frequent than in the past 
due to lower-hanging draping 
Radiation-induced 
cardiovascular disease 
Some strokes or myocardial 
infarction probably observed 
Overall mortality rate from 
circulatory disease may be in 
the same order as cancer-
induction risk 
Radiation-induced 
cataracts 
Tissue effects, threshold 
around 500 mGy, independent 
of dose rate (chronic or acute) 
ICRP proposed a reduction of 
the annual equivalent dose 
limit from 150 mSv to 20 mSv 
per year 
Table 2: Summary of the different health conditions that may be due to long-term exposure to ionising 
radiation, adapted from [Parikh 2017]. 
 
To protect themselves from ionising radiation scattered by the patient, healthcare 
professionals can use various protective devices in addition to the usually compulsory 
individual high-Z aprons, such as ceiling-suspended or floor-mounted leaded acrylic 
shielding, leaded glasses, or highly absorbing high-Z sterile draping to be placed on the 
patient. These means of protection, although highly efficient in test conditions (incident 
radiation normal to the protective device, static conditions), may quickly lose their protective 
efficiency when used with less caution. C. J. Martin analysed the theoretical and effective 
eye lens dose reduction efficiencies [Martin 2016], and these are synthesised in Table 3. 
Further means of reducing operator dose by increasing the distance to the patient may also 
be useful, such as contrast medium injection pumps, rather than the manual injection using a 
hand-held syringe. 
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Type of protective 
device 
Lead equivalent 
thickness 
[mm Pb] 
Dose reduction 
factor Comments 
Ceiling-suspended 
or floor-mounted 
shielding 
0.5 In theory: 4 – 33 In practice: 2 – 7  
Necessity of high working 
discipline for accurate 
device positioning 
Sterile patient 
draping 0.25 2 – 4.5  
To be positioned outside 
the primary X-ray field 
Leaded glasses 0.5 – 0.75 In theory: 5 – 7 In practice: 2.5 – 4.5   
Less efficient for the less 
exposed eye (generally 
right: 1.5 – 2.0)  
Integral facial mask 0.1 Unknown 
Geometric efficiency 
probably very high 
Potential brain dose 
reduction up to 81 % 
[Marshall 1992] 
Table 3: Summary of the theoretical and practical eye lens dose reduction factors of different means of staff 
protective devices, adapted from [Martin 2016]. 
 
Image exposure and quality 
In modern fluoroscopy devices, the X-ray output is automatically adjusted with respect to a 
pre-required detector entrance dose per acquired frame and a given need of image quality. It 
is thus highly dependent on patient body habitus and tissue type, as we already stated, but is 
also vendor-dependant. The current state-of-the-art summary of the different AEC systems 
has been described in the American Association of Physicists in Medicine (AAPM) task 
group 125 report, published in 2012 [AAPM 2012]. Twenty-two angiography units were 
investigated by the different members of the task group and, for each manufacturer (GE 
Healthcare, Philips Medical Systems, Shimadzu Medical USA, and Siemens Medical 
Systems – now “Siemens Healthineers”), a representative from the industry was included in 
the study. Traditional AEC systems are based on three parameters: Tube potential [kV], tube 
current [mA] and pulse width [ms]. Modern units usually work with two supplementary 
parameters: Primary X-ray beam filtration [mm Al or mm Cu], and focal spot size (two or 
three, depending on the manufacturer). These different AEC systems were assessed using 
PMMA slabs as surrogate for patient attenuation, leaving the respective systems change the 
exposure parameters. It would be cumbersome to summarise the different vendors, but 
several elements are quite common between all the systems: 
- For increasing patient thickness, the tube potential will steadily increase, while the 
beam filtration will decrease. This is intended at keeping image contrast as high as 
possible by adapting the beam effective energy to the patient’s body habitus, fine 
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tuning being performed by the respective power curves for the respective anatomical 
regions. 
- When switching from fluoroscopy to acquisition (diagnostic) series, for a same patient 
thickness and anatomical region, tube potential will be usually lowered – and tube 
current increased – while the beam filtration is reduced. This will imply a much lower 
beam effective energy, and thus a higher contrast. This is because fluoroscopy is 
usually used during much longer times – for e.g. catheter positioning prior to a 
diagnostic acquisition or DSA series. This implies that patient skin dose is spared by 
increasing the effective beam energy for the longer exposure times. 
However the current AEC systems are currently aimed at lowering patient skin dose, not all 
technological innovations have allowed a systematic patient dose reduction. Indeed, E. Vaño 
et al. [Vaño 2009] showed that, when switching from image intensifiers (II) to flat-panel 
detectors (FPD), the average patient dose rates for fluoroscopy, as well as the dose per DSA 
frame do not significantly vary when switching from an older technology (II) to a more 
modern technology (FPD) (Figure 2). This paradigm shift is similar to the transition from 
screen-film systems to computed radiography (CR) or digital X-ray imaging (DR): The 
dynamic range of the imaging systems was increased, thus allowing for much higher patient 
exposures without the detector saturating, but the payback was a higher flexibility in the 
acquisition parameters and subsequent possible image post-processing possibilities. 
 
Figure 2: Comparison between II and FPD. Centres 1 to 5 were equipped with II, while centres 6 to 10 were 
equipped with FPD. The shaded bars show patient dose rates for low, medium and high quality fluoroscopy, 
while the black squares show the average dose per DSA image. Image from [Vaño 2009]. 
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However, the use of FPD have opened the door to new on-line image post-processing 
techniques, aiming at reducing patient dose by increasing image quality using new 
mathematical algorithms for image information maximisation, just like is the case for iterative 
reconstruction in CT. Furthermore, current norms on fluoroscopic imaging have also required 
a limitation on patient skin dose rate, as was already the case for detector entrance dose 
[DIN 2013], as is shown in Figure 3. 
 
 
Figure 3: Patient skin dose rate limitations for different fluoroscopic imaging  purposes. Table from [DIN 
2013]. 
 
Image quality is a challenging topic to handle. First, one has to agree on the actual definition 
of image quality. In 1991, the diagnostic information in an image has been given 6 levels of 
accuracy [Fryback 1991].The lowest step is probably the easiest to measure, and the higher 
one aims at increasing the levels of accuracy, the more difficult it becomes to actually 
quantify the image quality, since it will apply not only on the sole pattern of gray levels in an 
image, but gradually involve the diagnostic accuracy (level 2), up to the societal efficacy 
(level 6), thus gradually involving more disciplines, such as psychology, sociology, and even 
economy. On the first level, image quality relies on well-defined metrics (image noise, CNR, 
spatial resolution, etc.). These metrics, on their own, have the advantage of being easily 
reproducible, and can serve to guarantee the technical accuracy of the imaging acquisition 
and rendering device (quality assurance (QA) of the imaging chain). But it has little to no 
significance for the end user, i.e., the physician, who has to take a decision on what follow-up 
to prescribe based on his/her knowledge of the patient’s medical status and history and the 
information extracted from an X-ray image of a possible disease. 
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The report on objective image quality by M. Tapiovaara [Tapiovaara 2003] describes the first 
steps of objective image quality assessment. It describes the precise definition of “image”, in 
this case, the acquired image data, without the actual rendering step; and the definition of 
“quality”, in this case, the detectability of phantom details that look like diseased structures in 
actual patients. It therefore concentrates on the second step of Fryback’s scale, and this 
work will equally concentrate on that same step. Further, it describes the basic (physical) 
factors of image quality, i.e., the modulation transfer function (MTF), image contrast and the 
noise power spectrum (NPS), as well as the characterisation of a detector, based on the 
signal-to-noise ratio (SNR), the noise equivalent quanta (NEQ) and detective quantum 
efficiency (DQE). Finally, it introduces and describes the tool we are currently working on, 
which is a mathematical model observer, that will us allow to grade image quality based on a 
clearly defined diagnostic task. 
A model observer is a mathematical concept based on statistical decision theory [Barrett 
1993 and 2004]. It allows to extract as much information from the imaging chain as possible 
(ideal linear observer) or to evaluate the entire imaging chain using a model with 
downgraded performance (anthropomorphic observer). It relies on four cornerstones: 
- The choice of a clinically relevant diagnostic task: 
o Classification tasks: 
 Lesion detection (i.e. “do I see what I am looking for?”), 
 Lesion location (i.e. “where is the lesion I am looking for?”),  
 Lesion shape assessment (i.e. “is it spherical or spiculated?”), 
o Estimation tasks: 
 Lesion size change assessment (i.e. “has the lesion grown since last 
time?”), 
- A statistically significant set of images to establish a response curve, 
- An observer (ideal or anthropomorphic), 
- A figure of merit (FOM) for image quality quantification. 
A publication from X. He and S. Park [He 2013] describes the basics of model observer 
implementation and use in medical imaging, and serves as a concise adaptation of [Barrett 
2004] for clinical imaging. Conceptually, model observers can be divided into two categories: 
- The ideal observer (IO): It extracts all available statistical information from the image, 
and is used for unit benchmarking. Ideal does not mean that it always performs right, 
but that it reflects the technical ability of the imaging unit to acquire and render 
diseased and healthy structures 
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- The anthropomorphic observer: Like humans, its performances are below ideal, and it 
is aimed at qualifying given image acquisition and reconstruction protocols, mimicking 
the performance and errors a human could do when submitted to a given diagnostic 
task. 
As such, model observers give an image quality grading with respect to a diagnostic task, 
and are probably the first step for bridging the gap between physics and healthcare. We will 
further on describe, in the chapter on our work on image quality, how the model was 
implemented and tested, as well as what is yet to come. 
Challenges for the medical physicist 
As such, patient and staff dose have become less of a concern, since technological evolution 
has allowed to drastically – or at least has the potential to – lower patient and therefore staff 
doses. Of course, long-term exposure to ionising radiation remains a threat for human health, 
and particular care should be brought to measuring individual doses, as well as offering 
efficient yet easy-to-use protective solutions. But the key problem resides within the disparity 
of the users of fluoroscopy devices. Indeed, interventional radiologists and cardiologists are 
usually pretty-well trained on the risks of ionising radiation and the optimisation of patient 
dose. But as mentioned by the ICRP [ICRP 2010], a large number of medical specialties 
outside the imaging department have taken up using fluoroscopy as a primary diagnostic 
and/or therapeutic tool. Thus, potentially lesser-trained professionals work with units, usually 
mobile, that are increasingly capable of performing highly irradiating procedures. 
Furthermore, as stated by that same report, in the absence of proper education or 
awareness, people might become overconfident – thus exposing themselves and other to 
increased doses – or, on the contrary, might overestimate the risks, thus potentially 
underexposing the patient and missing medically relevant lesions. 
A publication by M. M. Rehani [Rehani 2015] underlines the current and future challenges in 
radiation protection in medicine. The first challenge is keeping the current trend in dose 
lowering reasonably going, especially for paediatric imaging. An examination yielding several 
mSv of patient dose should not be a cause for over-alarming, and the accent should be put 
on minimising the risk of radiation-induced skin injuries. With respect to paediatric imaging, 
several publications are launching controversies on radiation effects in children undergoing 
CT scans. Indeed, large-cohort studies have potentially statistically shown the carcinogenic 
effect of low-dose ionising radiation, but these studies are often stained with matters of 
reversed causality. The risk is avoiding examinations based on hypothetical risks, and 
potentially creating more harm due to not diagnosing a potentially severe disease. 
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Furthermore, dose indicators should be refined in order to more precisely assess patient 
dose and subsequent radiation risk. The AAPM has already introduced a correction faction 
for CTDIvol based on patient geometry (the size-specific dose estimate or SSDE), and this 
should also be proposed for interventional fluoroscopy, in order to correct the relevant dose 
indicators based on patient body habitus. Finally, these procedures will have to be thoroughly 
documented, within the scope of the upcoming clinical audits, which will be mandatory by 
2018. It is also to mention that the big picture of dose optimisation should also not rely on the 
sole imaging part, but should also include other relevant – and perhaps trickier parameters – 
such as the volume of injected iodinated contrast media. Indeed, when lowering patient dose, 
the CNR could become so low that, without the possibility of reducing the image noise, the 
only solution that remains for the operator is to increase the imaged structure’s contrast by 
injecting more contrast medium, which poses an immediate renal toxicity problem. 
Our first publication tried to summarise this approach [Ryckx 2014]. Indeed, since 2008, the 
implication of medical physicists in medical imaging has been rendered compulsory for CT, 
interventional fluoroscopy and nuclear medicine in Switzerland. For fluoroscopy, it proposes 
an evaluation method for patient skin dose due to the AEC system. At that time, no image 
quality was performed, and the assumption was made that physicians using the devices 
routinely were judges of image quality suitable for their needs. We noticed a large 
discrepancy in patient exposure between different manufacturers, and the perspectives of 
the paper laid the first basis of model observers for objective clinically-relevant image quality 
optimisation.   
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Our contributions to the field 
Patient exposure 
Automatic dose collection and establishment of reference levels 
Within the scope of the ICRP recommendation on dose reference levels (RL) [ICRP 1990], 
implemented in the IAEA basic safety standards (BSS) and the Euratom 2013/59 on the 
“basic safety standards for protection against the dangers arising from exposure to ionising 
radiation”, the Swiss Federal Office of Public Health (FOPH) is in charge of setting up and 
updating RL for the different diagnostic procedures using ionising radiation. A call was made 
to 9 centres to participate in the survey with contribution with data from any interventional 
cardiology (IC) procedures, both vascular and electrophysiology procedures. Preference was 
given to centres with high volume of workload and to centres using automatic database 
generation such as CardioReport XP (CVX Medical, France). Data was collected for the 
period of 2010 – 2013. For each instance, the examination type and the year were required 
as general data. As dose metrics, the Ka,r, PKA, T, and the number of sequences (S) were 
required. As regards the patient, the weight, height, body mass index (BMI), age and 
catheter access route were requested. 
The vascular procedures were: Coronary angiography (CA, 24 261 procedures collected), 
percutaneous transluminal coronary angioplasty (PTCA, 1 099), CA+PTCA (18 797), shunt 
closure (SC, 622), transcatheter aortic valve implantation (TAVI, 221) and myocardial biopsy 
(73). The electrophysiology procedures were: diagnostic procedures (EFO, 210), defibrillator 
implantation (ICD, 281), pacemaker implantation (PM, 300), radio-frequency ablation (RFA, 
720) and alcohol septal ablation (7). The latter was discarded due to an insufficient number 
of procedures. This list of ten procedures has been an improvement with respect to the 
previous study, which showed RLs only for CA and PTCA procedures. 
Since RLs are established for standard patient body habitus, the collected data could 
undergo the following correction steps: 
- Weight banding, which is the simplest method and consists in the selection of 
patients within a desired weight range (65 – 75 kg or 60 - 80 kg usually). This method 
involves a significant loss of data and is therefore not useful for small populations. 
- Size correction, which is based on the application of a numerical correction to 
compensate the deviation in body habitus of those patients outside the mean size in 
order to compare radiation dose among populations. There are several methods to do 
so. In the present study we used a correction based on that the method described by 
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Chapple et al. [Chapple 1995] and Marshall et al. [Marshall 2000], which has been 
used by other authors, and was also used in the last Swiss survey. The method 
consists in dividing the PKA by a factor 𝑓𝑠𝑡𝑎𝑡 described below: 
𝑓𝑠𝑡𝑎𝑡 = 𝑃𝐾𝐴(𝑚𝑒𝑎𝑛 𝑝𝑎𝑡𝑖𝑒𝑛𝑡)𝑃𝐾𝐴(𝑟𝑒𝑎𝑙 𝑝𝑎𝑡𝑖𝑒𝑛𝑡) = 𝑒−𝜇(𝑑𝑚−𝑑𝑟) 
where 𝜇 is the mean attenuation coefficient, 𝑑𝑚 is the diameter of the median patient, 
and 𝑑𝑟 the diameter of the real patient. The original method makes use of a factor k, 
instead of 𝜇, determined experimentally, that reflects changes in dose for subjects of 
different sizes owing to changes in kV, mAs and filtration settings. In our method we 
might use 𝜇 instead, which accounts for the primary radiation attenuation. The patient 
diameters are calculated from the patient height (ℎ) and weight (𝑤), as follows: 
𝑑 = 2� 𝑤
𝜋ℎ𝜌
 
where 𝜌 is the volumetric mass of water (1000 kg m-3). In the last survey a value of 
0.3 cm-1 was considered for 𝜇. In the present survey we should also consider 0.2 cm-1 
to take into account the additional Cu filtration of the current machines. These values 
were calculated for the typical primary beam used in interventional cardiology (75 kVp 
and 4.5 mm Al with and without Cu filtration). The resulting RLs were calculated using 
the size correction algorithm and published in June 2016 by the Federal Office of 
Public Health (FOPH), with the introduction of the Ka,r in the FOPH directive, used for 
tissue reaction risk estimation, in addition to the PKA, T, and N values that were 
already in the previous revision of the Swiss RLs. 
- Linear or polynomial regression. Since the PKA and Ka,r correlate with the patient’s 
body-mass index (BMI) and/or weight, an empirical estimation of the aforementioned 
correction factors might be obtained on a large dataset using basic polynomial fitting. 
Since the Swiss study collected a large amount of data, the regression has been 
performed using this method and the applying it to diagnostic CA procedures (about 
25 000 examinations collected). 
A second order polynomial regression was performed using the R statistical library for the 
analysis of the PKA as a function of patient weight. This allowed calculating patient-specific 
RLs (yet to be published, expected to submit by September 2017), of which an excerpt can 
be seen in Table 4.  
As an example, for patients of 90 kg undergoing a percutaneous transluminal coronary 
angioplasty (PTCA), the specific PKA RL associated to this weight would be 183 Gy cm2 
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instead of 130 Gy cm2. The method yields a PKA RL of 29 Gy cm2 for patients of 50 kg who 
undergo a CA, instead of the published value of 50 Gy cm2. 
 
 Weight-dependent RL 
[Gy cm2] 
 CA PTCA CA+PTCA 
75 kg patient RL 50 130 110 
    
Patient weight (kg)    
5 2 5 4 
10 4 10 8 
20 9 22 19 
30 14 37 32 
40 21 55 47 
50 29 75 64 
60 38 98 83 
70 48 124 105 
80 58 152 128 
90 70 183 154 
100 83 216 183 
110 97 252 213 
120 112 290 246 
130 127 331 280 
140 144 375 317 
150 162 421 356 
160 181 470 398 
170 201 522 441 
180 221 576 487 
190 243 632 535 
200 266 692 585 
Table 4: Example of patient weight-corrected PKA using statistical analysis, for coronary angiography (CA), 
standalone percutaneous transluminal coronary angioplasty (PTCA), and the combined procedure 
(CA+PTCA). The top bold lines show the RLs as published by the FOPH. 
 
On the basis of that same eight-centre dose registry, a paper has been published in 
Radiation Protection Dosimetry (RPD) [Ryckx 2016] on selective practice optimisation clues 
based on a large-scale patient dose collection and the cross-comparison to national 
standards (such as RL) or other large datasets. For this purpose, an in-house software 
solution (Memoviz, Memoways, Geneva, Switzerland) was elaborated to visualise the data. 
For each procedure type, T, N, PKA and Ka,r could be displayed for each of the eight 
participating centres. For every dose indicator distribution, the software calculated the first, 
second and third quartiles of the respective distributions. According to the definition of the 
RLs, the third quartile was used as the main metric for dose indicator comparison. A 
visualisation tool could display the respective quartiles of each dose indicator for the ten 
aforementioned cardiac procedures, as can be seen in Figure 4. 
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Figure 4: Visualisation of the quartile comparison of PKA (Gy cm2) for CA + PTCA procedures and for all eight 
cardiology centres. Mouse hover-over allows for an immediate display of the actual quartile values and 
immediate comparison with the dose levels of the other centres. The numbers are part of the web interface 
and display the selected dataset. Figure from [Ryckx 2016]. 
As an example, the third quartiles for CA + PTCA dose indicators for centres B, F and 
Switzerland (CH) were the following: 
- Centre B RL: PKA 132 Gy cm2, Ka,r 2.2 Gy, T 17.9 min, N 1820 images, 
- Centre F RL: PKA 129 Gy cm2, Ka,r 1.2 Gy, T 20.5 min, N 2420 images, 
- CH RL: PKA 150 Gy cm2, Ka,r 2.0 Gy, T 18.1 min, N 1527 images. 
It could be seen that PKA was rather similar for centres B and F, but the Ka,r of centre B was 
roughly twice as high as that of centre F. This could indicate that centre F worked with 
imaging fields roughly twice as large as B, thus advising for a more thorough use of beam 
collimation. When comparing the values of centre F with the Swiss values, it could be seen 
that the number of images (N) at F was much higher for similar fluoroscopy times (T). This 
26  
could indicate a higher frame rate (e.g. 30 fps instead of 15 fps, which could still be 
diagnostically acceptable). 
The analysis of the respective distributions could give an indication on where to start the 
dose optimisation. Indeed, underlining that one single dose indicator out of the four was 
higher with respect to the other did not necessarily mean that one centre worked ‘better’ than 
another. The four dose indicators are, de facto, correlated one to another but are not linearly 
dependent. This kind of multivariate analysis, based on anonymous centre cross-
comparison, could give the respective centres ideas on what to optimise, rather than just 
telling the operators that their mean doses were higher than pre-existing RLs. 
Pregnant patients 
A subgroup of patients especially sensitive to ionizing radiation is pregnant patients. In 
particular, infants, neonates and foetuses are more sensitive to ionizing radiation due to their 
higher metabolism and rapidly dividing young body cells. However, the mean prevalence of 
coronary heart disease is only 0.6 % for patients between the ages of 20 and 39 years in the 
US [Bordoli 2014], making the theoretical and practical skills needed to properly handle these 
cases quite challenging due to the low volume of clinical opportunities. In this regard, a 
publication has been co-authored and submitted in the European Journal of Medical Physics 
(EJMP, Physica Medica), for an upcoming special issue on pregnant patient management. It 
acts as a literature review on the current status on the management of pregnant patients 
within cardiac angiography suites, and is currently under review [Kallinikou 2017]. It lists the 
typical foetal doses, as well as the foetal risks when exposed to alternative procedures, such 
as drug-induced thrombolysis. Risks due to ionising radiation were weighed against the 
natural occurrence of peripartum child morbidities. The overall conclusion was that, when 
care is being taken by the physician, no particular increase in child morbidity risk is to be 
expected, and the lives of both the mother and child will be preserved when treating acute 
coronary syndromes properly. 
A typical protection of the carrying mother that may be used is placing a lead apron around 
the lower abdomen to protect the uterus and child from ionising radiation. Although probably 
relevant before the 1950s and FDA regulations on leakage radiation limitation [FDA 2016], 
this solution may not be adequate anymore. Therefore, we submitted a paper on the 
efficiency of patient lead aprons in CT imaging in EJMP for the aforementioned special issue 
on the pregnant woman [Ryckx 2017], currently under review. First, we performed a literature 
review, during which we found 11 relevant articles, all of them reporting uterus exposure due 
to CT imaging performed for exclusion of pulmonary embolism, one of the leading causes of 
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peripartum deaths in western countries. Our findings of the literature review were that uterus 
doses – taken as a surrogate for foetal exposure in the early stages of pregnancy – ranged 
between 60 and 660 µGy per examination, and relative dose reductions to the uterus due to 
high-Z garments were between 20-56 %. The dose reduction efficiencies of these garments 
were compared to Monte-Carlo simulations of CT protocols, for which the overall scan length 
was reduced as a means of patient exposure optimisation (the equivalent way of reducing 
patient effective dose in fluoroscopy is the reduction of the primary X-ray beam field size by 
using the collimation system) using the ImPACT Monte-Carlo simulation spreadsheet. shows 
the ImPACT graphical user interface (GUI). In red are the initial (a) and reduced (b and c) 
scan lengths. 
 
Figure 5: Screenshot of the ImPACT GUI for chest CT. (a) acquisition volume before scan length reduction, (b) 
acquisition volume after reducing the scan length by 1 cm above the lung apex, (c) acquisition volume after 
reducing the scan length by 3 cm under the lung base. Figure from [Ryckx 2017] (under review). 
Again, uterine doses were taken as surrogate of the foetal doses. Simulations showed that 
reducing the scan length by one to three centimetres could potentially reduce uterus dose up 
to 24 % for chest imaging and even 47 % for upper abdominal imaging, thus in the order of 
the dose savings achieved by high-Z garments. However, using the latter may negatively 
influence the diagnostic image quality and even interfere with the AEC system. Our 
conclusions pointed out that efforts should be concentrated on positioning the patient 
correctly in the gantry and optimising protocol parameters, rather than using high-Z garments 
for out-of-plane uterus shielding. As no publication on foetal dose reduction in interventional 
fluoroscopy procedures using lead aprons was found during the preliminary literature review 
of the publication, we conclude that this practice has been abandoned for fluoroscopically-
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guided procedures. And since the apron efficiency in CT is only useful to block radiation 
back-scattered by the patient table, we assume that the efficiencies of lead garments in CT 
could be transposed to fluoroscopy.  
Staff exposure 
Estimation of radiological doses and risks 
The current problem with staff exposure is, in contrast to patient exposure, not acute but 
chronic cumulative doses, be they effective or to certain organs, such as the eye lens or the 
brain. The error bars of measuring staff dose during a single examination are already quite 
large, due to measurement uncertainties and variable scattered X-ray spectra around the 
patient, that degrade electronic or TLD measurement accuracy. As a corollary, the estimation 
of cumulative doses and risks over a whole career becomes cumbersome. Furthermore, as 
mentioned earlier, scatter factors are usually given at a specific distance from the patient, as 
well as for a specific measurement position on the operator, usually at chest level. This 
implies discrepancies between chest and eye or brain dose due to the distance between the 
measurement points, as well as the attenuation by the skull and protective devices used by 
the operator. 
To estimate staff risk over a whole career, a website (http://intercardiorisk.creal.cat/) was set 
up and validated through a publication in the Journal of Radiological Protection in 
collaboration with a team from the Centre for Research in Environmental Epidemiology 
(CREAL) in Barcelona [Moriña 2016]. It allows for a staff eye or brain dose and risk 
estimation based on the following inputs: 
- Career span between two dates, 
- Number of procedures per working year, 
- Operator birth date and gender, 
- Protective behaviour according to three working practices: 
o Typical working practice, 
o No radiation protection measure at all, 
o Protective equipment fully employed. 
- Operator profile: 
o Interventional cardiologist (vascular procedures), 
o Electrophysiologist. 
Doses and risks are displayed as probability distributions of respectively cumulative 
equivalent dose to the considered organ [mSv], relative risk (RR) for radiation-induced 
29  
cataracts and lifetime fractional risk (LFR) for central nervous system tumours. Radiation 
risks are estimated using the currently accepted linear non-threshold (LNT) model and large-
scale published epidemiological data. The eye and brain dose calculations are performed in 
two consecutive yet conceptually different steps. First, eye lens dose is calculated based on 
typical patient exposure scenarios and scatter fractions to the eye lens established during the 
ORAMED study [Vanhavere 2012]. In the second step, brain dose is calculated on the basis 
of experimentally-determined conversion factors between these two organ doses, which 
were the part of the study dedicated to our group. For this purpose, we performed phantom 
simulations of a clinically realistic patient and operator exposure scenario, irradiated in an 
interventional cardiology suite (Allura Xper FD10, Philips Healthcare) at our hospital. An 
anthropomorphic adult chest and head phantom (CIRS Inc., Norfolk, USA) representing the 
operator, was placed next to a stack of PMMA slabs representing the patient, 50 cm laterally 
from the isocenter and 50 cm at the right of the major patient (and table) axis, as can be 
seen in Figure 6. 
 
 
Figure 6: Geometry of the experimental setup aimed at simultaneously measuring eye lens and brain doses 
using TLDs. 
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The operator phantom was equipped with a lead apron, and a batch of 13 TLDs was 
simultaneously used for eye lens- and brain dose assessment, dispatched as following: 
- 11 TLDs were used for brain dosimetry, 
- 2 TLDs were used for eye dosimetry. 
The unit was used with standard clinical AEC settings for both fluoroscopy (low quality) and 
angiography (high quality). Beam angles were set to the most typical clinical positions, as 
displayed in Table 5. 
 
Orientation 
PA 
RAO 30° / CAUD 20° 
RAO 30° / CRAN 20° 
LAO 20° / CAUD 20° 
LAO 20° / CRAN 20° 
LAO 50° / CAUD 5° 
LLAT 
Table 5: Tube angles used for staff dose assessment. 
 
The detail of the individual measurements will not be described here; for each beam angle, 
the AEC system was allowed to deliver at least 20 Gy cm2 of PKA to the patient in order to 
obtain significant amounts of scattered radiation to the operator phantom. No mobile or 
ceiling-suspended leaded shielding was left in place to attenuate the scattered radiation. The 
ratios between each measured cumulative eye and a brain doses were then calculated for 
use as a conversion factor from eye dose to brain dose. The resulting conversion factors 
ranged from 3.4 (eye furthest from unit) and 8.1 (eye closest to unit). In order to account for 
uncertainties due to positioning of the interventional cardiologist, the conversion factor was 
defined as a uniform distribution between 3.4 and 8.1. This project was started in order to 
give a factual answer possibility to several healthcare professionals claiming to suffer from a 
radiation-induced cataract, and to show the limitations of current routine under-apron 
dosimetry. 
However, this evaluation may be biased by the underlying hypotheses of practice considered 
as identical between different interventional angiography suites. Indeed, some procedures 
are being performed using non-standard approaches (i.e. other than right femoral or right 
radial punction) like, for example, left radial approach, that forces operators to bend over the 
patient since they are standing on his/her right side. To assess the exposure differences 
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between those three approaches, we set up an experimental protocol for a five-manned 
senior operator team at a local hospital. During seven months, the coronary angiography 
(CA) and PTCA procedures were monitored using an electronic dosimetry system 
(DoseAware, Philips Healthcare, The Netherlands). Each procedure cumulative dose 
(measured above the operator apron) was normalised by patient PKA to evaluate operator 
exposure by the mean scatter factor per approach. As was expected, the average right 
femoral approach (RFA) scatter factor was lower than that of the right radial approach (RRA), 
i.e., 0.06 (0.01-0.18) vs. 0.51 (0.32-0.81) µSv / (Gy cm2) – values given in parentheses are 
the 25th and 75th percentile of the individual scatter factor distributions. Surprisingly, the left 
radial approach (LRA) showed an intermediate value of the scatter factor, i.e., 0.23 (0.10-
0.45) µSv / (Gy cm2). The distribution of the exposure factors are shown in Figure 7. 
 
Figure 7: Exposure factors (in the study's nomenclature cumulative dose (CD) divided by dose-area product 
(DAP) for the RFA, LRA and RRA procedures, shown as the respective quartile distributions, as published in 
[Kallinikou 2016]. 
A possible explanation for these findings was that, during RRA procedures, the leaded glass 
mobile panel is positioned further from the patient in comparison to LRA and RFA, in order to 
facilitate the right radial access. The gap created between the patient and the leaded 
shielding was likely to be more pronounced during RRA procedures, thus creating a higher 
source of radiation exposure to the operator by diminishing the shielding efficiency, as stated 
by C. J. Martin [Martin 2016]. Second, when using RRA, the operator is de facto positioned 
closer to the x-ray tube compared with both LRA and RFA procedures. The study’s results in 
terms of respective procedure difficulty (in terms of ﬂuoroscopy and procedural times) and 
radiation dose of the operator (absolute cumulative dose per procedure) and the patient PKA 
were in line with published data in the literature. As such, and although not randomised, the 
study reﬂected operator exposure in everyday clinical practice, despite a bias in the choice of 
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vascular access site by the respective operators. These results were subsequently published 
in the American Journal of Cardiology [Kallinikou 2016]. 
Efficiency of protective glasses 
Currently, effective dose to interventional physicians is not much of a concern, at least for the 
immense majority of medical radiation-exposed workers. However, as we saw previously, 
certain organs remain potentially highly exposed, namely the brain and the eye lens. To 
reduce eye lens dose, physicians may use one or several means of protection, as has been 
described by C. J. Martin [Martin 2016]. Among these, leaded glasses are a common choice 
of interventional professionals. As mentioned in the publication by C. J. Martin, the actual 
protective efficiency of these glasses can vary widely, but the factors influencing the 
efficiency are not well described. For this purpose, the following radiographer diploma work 
by C. Bolomey and G. Fasel, whom we followed during approximately one year, addressed 
this question. In order to determine the factors influencing the efficiency of leaded glasses, 
measurements were carried out by reproducing the clinical conditions in which these glasses 
are used. Four pairs of leaded glasses were selected to test the following parameters of 
influence: 
- Equivalent lead thickness: 0.5 or 0.75 mm Pb, 
- Surface of the protective glass: 18 or 21 cm2, 
- Presence or not of a lateral protective layer, 
- Orientation of the operator’s head, 
- Use of the frontal or lateral C-arm or both simultaneously. 
The orientation of the operator’s head is defined as the angle defined by two imaginary lines: 
the first crosses the centre of the X-ray field at patient level and the operator’s forehead; the 
second crosses the operator’s forehead and the diagnostic screens. Depending on the 
patient size (a child or an adult) or the approach (radial or femoral), the angle may vary 
between 45° and 90°, as depicted in Figure 8. 
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Figure 8: Schematic depiction of the 90° (left) or 45° (right) operator exposure geometry. Figure adapted from 
[Bolomey 2016]. 
 
The respective glasses models tested in this study are shown in Table 6. 
 
Glasses # Model 
Lead equivalent 
thickness 
[mm Pb] 
Lateral layer 
Surface 
[cm2 ] 
Image 
1 Sports 0.75 Yes 18 
 2 Sports 0.75 No 18 
3 Classical 0.5 No 21 
 4 Classical 0.75 No 21 
Table 6: Summary of the differences between the different models of glasses. Adapted from [Bolomey 2016]. 
 
The different exposure scenarii were simulated by using a solid-state detector (Unfors NED, 
RaySafe, Sweden) taped against the eye of an anthropomorphic head phantom. The 
exposure of an anthropomorphic patient head phantom for neuroradiological procedure 
simulation was performed on a biplane angiography suite (Philips Allura Xper FD20/10). The 
results of the protective efficiencies, defined as the differences between the scatter factors 
without and with glasses in front of the solid-state detector, are given in Table 7. 
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Attenuation of the scattered radiation to the eye lens 
as a function of operator’s head orientation 
Unit used Glasses # Mean attenuation [%] Standard deviation [%] 90° 45° 90° 45° 
Frontal 
1 8.5 11.8 0.8 0.4 
2 4.0 10.7 2.9 0.6 
3 39.8 23.7 0.2 1.9 
4 53.6 28.4 0.7 1.2 
Lateral 
1 43.4 61.8 0.1 0.2 
2 31.9 52.1 0.5 0.1 
3 69.0 66.9 0.1 0.3 
4 74.9 67.4 0.1 0.1 
Biplane 
1 23.5 34.6 0.2 0.6 
2 13.9 23.4 0.9 0.3 
3 52.2 44.8 0.5 0.5 
4 63.1 43.6 0.1 0.6 
Table 7: Summary of the measurement results from [Bolomey 2016]. 
 
As expected, an increased lead thickness brings a higher attenuation, and is more 
pronounced for the 90° than the 45° scenario. A larger glass surface also brings a higher 
protection against scattered radiation, and again this effect is more marked for the 90° 
scenario. The presence of a 0.5 mm Pb protective layer on the frame side allowed for an 
increase of the protection efficiency, with no particular difference between 90° and 45°. In 
summary, the highest protection efficiency is reached by highly covering glasses (large glass 
area and side protection), the main factor being the glass surface. This may also explain the 
high reported efficiency for brain dose reduction of leaded acrylic full-face masks of 0.1 mm 
Pb protective thickness, as has been stated in [Marshall 1992]. Results of this study have 
been published in Radioprotection [Bolomey 2016]. 
Image quality: A feasibility study 
The ALARA principle states that a diagnostic image – or image series – should be acquired 
at a dose sufficient for the diagnosis but not more, implying the need of “good” rather than 
“nice” images. Until recently, image quality relied mainly on the DQE of a detector, thus 
mainly on the capacity of a detector to detect the maximal amount of impinging photons 
without adding any further noise, so as to display an image with the maximal amount of 
statistically significant data, i.e., the lowest possible noise level. Nowadays, detector 
technology is sufficiently efficient – or does not evolve as quickly as previously – so image 
reconstruction shifts from a physical – or engineering problem – to a mathematical problem, 
where acquired data is post-processed in order to enhance image quality by means of step-
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wise optimisation processes, as is the case in nuclear medicine or CT, where iterative image 
reconstruction has been introduced to artificially reduce image noise. Furthermore, a medical 
physicist usually has no access to the detector raw data, as may be the case for 
mammography or radiography QA, but only to the unit’s user mode. For this purpose, he/she 
has to propose optimisation possibilities in accordance to the way the fluoroscopy units are 
used by the physicians. 
When these units are upgraded, two alternatives are offered to the users: 
- Acquire images at the same dose level as for older reconstruction processes, and 
using new image reconstruction algorithms to enhance subsequent image quality, 
namely in terms of image noise, 
- Acquire images at lower dose levels, but adapt image quality to reach subjective 
image quality levels the users’ eye is accustomed to. 
Both of these paradigms are possible, but only the second one is in phase with the ALARA 
principle. The most speaking example of such a paradigm shift is the use of iterative image 
reconstruction in CT. When first and second generation iterative algorithms have been 
introduced in the past years, the commercial promise of such improvements were in the 
order of 25 – 40 % dose reduction for first-generation algorithms (mainly based on sinogram 
de-noising by applying smoothing filters on the data – since CT noise lies mainly in the high 
frequencies), or even 80 – 90 % dose reduction for model-based algorithms [Image Wisely 
2016]. However, due to the reasons we will mention further on, these algorithms were 
deemed unfit, since the noise texture was too drastically changed for the reader’s comfort, 
and a compromise has been set up by the vendors between the first and second generation, 
implying 50 – 60 % of potential dose reductions while claiming to maintain a similar image 
quality when compared to classical filtered back-projection [FBP]. However, the downside of 
these new image reconstruction algorithms is the fact that they allow dose reductions without 
assessing the larger picture of clinical tasks whose performances may or may not be 
deteriorated by this reduction. For example, a recent study by J. Solomon et al. [Solomon 
2017] has compared classical FBP to a commercially available state-of-the-art iterative 
image reconstruction algorithm. They assessed the low contrast detectability (LCD) of subtle 
hypoattenuating liver lesions using a visual grading analysis (VGA) performed by 16 readers 
(6 radiologists and 10 medical physicists) grading the diagnostic images. The results showed 
that, for LCD (one of the most difficult imaging tasks), the dose reduction potential while 
maintaining the same LCD capacity was merely close to 16 %. On the other hand, a study by 
B. Pauchard et al. showed that the mean oncologic follow-up CT imaging dose could be 
reduced by a factor 5 for young patients, using a model-based iterative image reconstruction 
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technique [Pauchard 2017]. We see that the dose reduction potential is highly dependent on 
the underlying clinical task. For fluoroscopic imaging, some image post-processing methods 
have also allowed a potential dose reduction without reducing image quality, as claimed by 
the respective manufacturers. The potential of these technological improvements could be 
much different with respect to a clinical task. For example, neuroradiology procedures deal 
with usually non-moving structures, whereas interventional cardiology procedures have to 
take into account the rapid motion of the coronary arteries, and the dose reduction 
possibilities could be different between both specialties, even if they use the same imaging 
unit. 
One of these solutions was evaluated using a similar method as the study by J. Solomon et 
al. in the following study: Before upgrading the four angiography rooms with a technical and 
software upgrade (Allura Clarity, Philips Healthcare, The Netherlands), our hospital 
management asked for an evaluation of the efficiency of this solution. For this purpose, a 
patient of varying body thickness was simulated using PMMA slabs of 20 by 20 by 5 cm, 
piled up to obtain thicknesses of 5, 10, 15 and 20 cm, to take into account the behaviour of 
the AEC system. Entrance air kerma rates were measured using a 6-cc ionisation chamber 
(RadCal Corp., Monrovia, USA), placed at the entrance of the phantom to asses patient skin 
dose (and not Ka,r per se). At all times, the focus-to-detector distance was kept constant at 
110 cm, while the focus-to-ionisation chamber was kept constant at 75 cm, as mentioned in 
[Ryckx 2014]. For image quality assessment, a standard IQ phantom (TOR CDR, Leeds Test 
Objects, UK) was placed on top of the first PMMA slab, with additional PMMA slabs 
subsequently piled on top of the phantom, so as to simulate inner body lesions for different 
patient morphologies. The 17 low-contrast discs of varying contrast and fixed diameter of 11 
mm contained in the phantom were used for LCD assessment, and the phantom’s resolution 
test pattern with 30 line groups of increasing spatial frequency was used to assess perceived 
spatial resolution. Two units – one upgraded and one before upgrade – were measured 
using the same experimental setup. The acquired images were displayed on a DICOM 3.14 
compliant diagnostic monitor, on which a single observer subjectively assessed image quality 
of LCD and perceived spatial resolution by noting the disc with lowest detectable contrast – 
taken as the LCD performance – and line group with highest perceptible frequency as spatial 
resolution perception. 
For fluoroscopy settings, the air kerma rates were systematically lower for the upgraded 
radiology unit than the reference unit. The average air kerma rate reduction over all PMMA 
thicknesses was 25.5 % for low fluoroscopy quality, 43.5 % for medium-quality and 34.5 % 
for high-quality fluoroscopy mode. For DSA, the air kerma per frame reduction was in 
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average 69.7 % for abdominal angiography and even 84.4 % for lower limb angiography. 
Subjective static image quality showed no significant decrease for both LCD and perceived 
spatial resolution. After implementation of this upgrade on our angiography units, a 
retrospective patient PKA and Ka,r assessment for selective neuroangioplasty procedures 
showed a statistically significant decrease of patient dose by a factor of 3 – 4, with no 
significant change in fluoroscopy times (T), taken as an indicator of mean case difficulty. 
These results have been published in RPD [Ryckx 2015]. However, the interventional 
cardiologists did not find the image quality sufficient, and patient exposure had to be 
increased after the initial four-fold drop of the aforementioned dose indicators. 
Mathematical model observers 
Schematically, these new algorithms are based on pixel-wise or neural network image 
analysis by “black box” hardware and software implementations, and are highly non linear 
and non stationary, and may see their performances therefore altered for different diagnostic 
tasks than those the solution was implemented for. Indeed, while interventional 
neuroradiologists did not perceive any difference in subjective image quality after the units’ 
upgrade, interventional cardiologists complained of worsened image quality. The main 
difference between both medical specialties is that neuroradiology concentrates on static 
structures (the vasculature of the brain), while interventional cardiologists have to follow 
structures in motion (coronary arteries). 
More generally, the necessary hypotheses for the validity of classical image quality metrics 
based on noise properties (SNR, CNR, NPS) are no longer adequate, as has been re-stated 
by Verdun et al. in a 2015 review paper [Verdun 2015]. Furthermore, although theses metrics 
are still useful tools for detector efficiency measurement, clinically relevant image quality and 
dose optimisation has become very difficult since they are of little use to the end users, who 
use these images to accomplish certain clinical tasks, as summarised in the present 
literature review. 
In order to circumvent these limitations, the use of mathematical model observers has 
become of interest to perform clinically relevant image quality assessment. Indeed, state-of-
the-art clinical – not technical – image quality assessment is usually performed by defining 
image quality as how much the desired information can be extracted from an image or a set 
of images. As performed by J. Solomon et al., VGA studies, based on the response of 
several observers grading many images (phantom or patient) acquired with precisely known 
acquisition and reconstruction parameters, allow for a reliable evaluation of clinical image 
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quality. However, these studies are usually time-consuming, and prone to inter- and intra-
observer variability, whatever the sample size. 
Studies have shown that using mathematical model observers, such as the channelized 
Hotelling observer (CHO) [X. He and S. Park], can serve as a surrogate of the human visual 
system for simple binary tasks, such as signal detection in a given background. However, as 
will be shown later on, the complete image content analysis using these methods 
necessitates a tremendous amount of images in order to completely assess the imaging 
chain, and some preliminary steps will be necessary before grading image quality. We will 
now describe the overall functioning of model observers, describe the particular case of 
channelized model observers, and finally describe our proposed solution for fluoroscopic 
image quality assessment based on a clinical task, i.e., the detection of a high-contrast linear 
object (a coronary guidewire). 
Model observer formalism 
Let us summarise the model observer formalism by repeating the four cornerstones of an 
observer study: 
- The choice of a clinically relevant diagnostic task, 
- A statistically significant set of images to establish a response curve, 
- An observer (human or model), 
- A figure of merit (FOM) for image quality quantification. 
Mathematical model observers are matrices with dimensions matching the images’, as well 
as matching number of pixels along each dimension. Let us assume that our dataset consists 
of two-dimensional 𝑛 × 𝑚 images (defining 𝑁 = 𝑛 ∙ 𝑚), designated by 𝒈(𝑥,𝑦) as following: 
𝒈 = 𝒈(𝑥,𝑦) = �𝑔1,1 ⋯ 𝑔1,𝑚⋮ ⋱ ⋮
𝑔𝑛,1 ⋯ 𝑔𝑛,𝑚� 
The model observer is defined as a matrix called template, designated by 𝒘, with matching 
dimensions: 
𝒘 = 𝒘(𝑥,𝑦) = �𝑤1,1 ⋯ 𝑤1,𝑚⋮ ⋱ ⋮
𝑤𝑛,1 ⋯ 𝑤𝑛,𝑚� 
For the sake of mathematical simplicity, both the images and the template are vectorised, 
i.e., all components are aligned column by column in a single vector form: 
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⎥
⎥
⎤
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⋮
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⎥
⎤
 
Formally, the operation of observing the i-th image 𝒈𝑖 corresponds to the multiplication of 
said image 𝒈 with the transposed observer template 𝒘: 
λ𝑖 = 𝒘𝑇𝒈𝑖 
The subsequent i-th λ𝑖 is called a decision variable and is analogous to an in-vivo observer 
grading his/her certainty of perceiving a signal on the image background. Images may either 
contain a signal (signal-present) or no signal at all (only noise – signal-absent). 
The observer template 𝒘 of the Hotelling observer (HO) is the optimum linear discriminator 
and is mathematically defined as: 
𝒘𝑜𝑝𝑡 𝑙𝑖𝑛 = 𝑲𝒈−1∆𝒈� 
where 𝑲𝒈 is the image covariance matrix of the signal-absent images: 
𝑲𝒈 = �𝜎1,12 ⋯ 𝜎1,𝑚2⋮ ⋱ ⋮
𝜎𝑛,12 ⋯ 𝜎𝑛,𝑚2 � 
with each 𝜎𝑖,𝑗2  being the variance of pixels i and j. As such, the covariance matrix is the 
generalisation of the variance to an arbitrary number of dimensions. The application of the 
covariance matrix allows for noise de-correlation (or whitening). 
∆𝒈� is defined as the mean difference between the signal-present and signal-absent images 
(i.e. 〈𝒈𝑠 − 𝒈𝑛〉), thus representative of the theoretical signal that is being looked after in a 
given image set. 
Channelized model observers 
As such, the HO is computationally very expensive, and needs a number of images that is 
often too large to be acquired within feasible times. Indeed, for an image 𝒈 with 𝑀 pixels, the 
size of the covariance matrix is 𝑀 × 𝑀. Since the application of the HO implies the inversion 
of the covariance matrix, this means that, in order to obtain an invertible matrix, we will need 
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at least 𝑀2  images. For example, for a 256 × 256  image, we will need at least 65 536 
images, which is usually impossible to obtain on an imaging system. 
To reduce the problem dimensionality, the images and the template can be filtered by a 
given set of J channels 𝑼, with J significantly lower than N: 
𝑼 = �𝒖1,𝒖2,𝒖3, … ,𝒖𝐽� 
Each channel 𝒖𝑖 has the same dimension of the images. As a consequence, the channel 
matrix 𝑼 is a 𝑁 × 𝐽 matrix where each column is an individual channel. The channelization 
mechanism of an image consists of multiplying the image 𝒈𝑖  by the transposed channel 
matrix 𝑼, to obtain the channelized image 𝒗𝑖: 
𝒗𝑖 = �𝑣1𝑣2⋮
𝑣𝐽
� = 𝑼𝑇𝒈𝑖 
The channels act as a compression mechanism, which selects a certain content of the image 
information. The channels are chosen depending on the necessary information to be 
extracted from the images, while eliminating the unnecessary information. As a result, the 
native images 𝒈𝑖  become channelized images 𝒗𝑖  of dimension 𝐽 × 1 , of which each 
component is the results of the j-th transposed channel 𝒖𝑗 multiplying the image: 
𝑣𝑗 = (𝒖𝑗)𝑇𝒈𝑖 
The resulting channelized Hotelling observer (CHO) template 𝒘𝐶𝐻𝑂 becomes: 
𝒘𝐶𝐻𝑂 = (𝑲𝑣/𝑛)−1〈𝒗𝑠 − 𝒗𝑛〉 
where 𝑲𝑣/𝑛 = 𝑼𝑇𝑲𝑔𝑼  is the channelized covariance matrix and 〈𝒗𝑠 − 𝒗𝑛〉  is the mean 
difference between the channelized signal-present (subscript s for signal) and signal-absent 
(subscript n for noise) images. As a consequence, 𝑲𝑣/𝑛 is a 𝐽 × 𝐽 matrix. As the current ideal 
number of channels 𝐽 is around 10, the resulting channelized covariance matrix is much 
easier to invert. 
The channelized decision variable for the i-th channelized image thus becomes: 
λ𝐶𝐻𝑂,𝑖 = 𝒘𝐶𝐻𝑂𝒗𝑖 
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The set of images used to set up the template is called the training set and the images used 
for image quality assessment is called the testing set. 
Model observer analysis workflow 
For a set of signal-present and signal-absent images acquired in a given condition, the 
workflow of image quality grading goes as following: 
1. The appropriate set of channels 𝑼 is created, 
2. The CHO template is set up: 
a. The covariance matrix is calculated on the basis of the signal-absent (i.e. 
noise only) images, channelized using the aforementioned channel matrix, 
and inverted to achieve the (𝑲𝑣/𝑛)−1 matrix. 
b. The signal-absent and signal-present images are channelized, and their mean 
difference 〈𝒗𝑠 − 𝒗𝑛〉 is calculated, to complete the CHO template 𝒘𝐶𝐻𝑂, 
3. For each channelized image (signal-absent or signal-present) 𝒗𝑖, a decision variable 
λ𝑖 is calculated by applying the CHO template on each individual image, 
4. Two distributions are created, as can be seen in Figure 9: 
a. All decision variables corresponding to the signal-present images (red), 
b. All decision variables corresponding to the signal-absent images (blue). 
 
Figure 9: Example of the distributions of signal-present (red) and signal-absent (blue) decision variables for a 
set of channelized images. 
From these distributions, the image quality can be graded using different FOM: 
1. The certainty of making the difference between signal-absent and signal-present 
images is dependent on how much both distribution means lie apart from each other 
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(difference between both mean values) and how much they overlap (function of the 
mean difference and both standard deviations). Consequently, a first FOM is known 
as the signal to noise ratio 𝑆𝑁𝑅λ, defined as: 
𝑆𝑁𝑅λ = |𝜇𝑠 − 𝜇𝑛|
�12 (𝜎𝑠2 − 𝜎𝑛2) 
where 𝜇𝑠  and 𝜇𝑛  are the respective mean values of the signal-present and signal-
absent decision variable distributions, and 𝜎𝑠  and 𝜎𝑛  their respective standard 
deviations. Per definition, the signal to noise ratio varies between 0 (for the worse 
possible system) and ∞ (for the best possible system). Caution must be used with 
this FOM, especially for non-Gaussian distributions with long tails. 
2. When an observer has to make a decision on whether an image is apparently 
containing evidence of pathology, each individual applies a decision threshold to the 
decision variable distributions, above which the test is deemed positive, and under 
which it is deemed negative. Based on this assumption, a full description of the 
system can be performed by establishing a receiver operating characteristic (ROC) 
curve. For this, an arbitrary decision threshold is “swept” across the entire distribution 
of both signal-absent and signal-present decision variables. For each position of the 
threshold, one can extract the true positive fraction (TPF, also called the sensitivity), 
as well as the true negative fraction (TNF, also called the specificity). For each 
threshold position, each (1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦, 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦) couple is drawn on a plot, on 
which both axes are graduated from 0 to 1, as can be seen in Figure 10 (right). 
 
Figure 10: Schematic illustration of the calculation of a ROC curve for a binary observation strategy by 
"sweeping" a decision threshold across the decision variable space. 
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The second FOM that can be derived from this result is the area under the ROC 
curve (AUC). By construction of the sensitivity and specificity, the worst system is not 
better than randomly assigning a “lesion present” or “lesion absent” decision to each 
image, so every point of the ROC curve will be on the first diagonal (intersecting the 
origin). The consecutive AUC has a value of 0.5. On the contrary, the perfect system 
will have an AUC of 1.0. 
3. When both signal-present and signal-absent distributions are Gaussian with equal 
variance, the ROC curve becomes symmetric with respect to the second diagonal. A 
third FOM may be derived from this particular distribution, and is called the 
detectability index 𝑑′ = 𝑆𝑁𝑅λ . By definition, 𝑑′  will have a value of 0 for the worst 
system and a value of ∞ for the perfect system. 
Detectability of a coronary guidewire 
The choice of the clinical task and specific channel matrix depends on the underlying 
diagnosis. For example, focal liver lesion detection in CT imaging relies on the capability of 
detecting low-contrast lesions, as has been described in [Racine 2016a], [Racine 2016b] and 
[Ott 2016]. For these studies, the diagnostic task was the detection of a low-contrast sphere 
in a homogenous background; the set of images consisted of at least 40 signals of the same 
size and contrast for each acquisition and reconstruction protocol; the observer was the CHO 
with dense difference of Gaussian channels (D-DOG); and the FOM was the AUC under the 
ROC curve. 
For this work, we decided to develop the following model: 
- Clinical task: The detectability of a high contrast thin linear object with a periodic 
motion, i.e. a coronary guidewire; 
- Image set: A series of images of a home-made phantom, which we will describe later 
on; 
- Observer: CHO with Gabor channels; 
- FOM: The 𝑆𝑁𝑅λ. 
Gabor channels 𝐺 are described using the following formula: 
𝐺(𝑥,𝑦) = 𝑒𝑥𝑝�− (𝑥 − 𝑥0)2 + (𝑦 − 𝑦0)22𝜎2 � ∙ cos �2𝜋𝑓 ∙ �(𝑥 − 𝑥0) ∙ cos(𝜃) + (𝑦 − 𝑦0) ∙ sin(𝜃) + 𝛽�� 
where 𝑥 and 𝑦 are the spatial coordinates, 𝑥0 and 𝑦0 the centre of the specific channel, 𝜃 the 
channel orientation, 𝛽  the phase of the channel, 𝑓  the selected spatial frequency and 
𝜎 = 0.56/𝑓, as described in [Favazza 2015]. 
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When analysing the expression of a Gabor channel, we see two components: The first is the 
definition of a two-dimensional Gaussian curve of variance 𝜎2  and means 𝑥0  and 𝑦0 ; the 
second is a cosine function with frequency 𝑓, orientation 𝜃, and phase 𝛽. This indicates that 
Gabor channels are selective to the spatial orientation and the size of the signal, making 
them appropriate for linear signal selection. An example of a Gabor channel is given in 
Figure 11. 
 
Figure 11: Example of a Gabor channel profile (100x amplified for better visualisation), with frequency 1.1 
mm-1, phase 0 rad and orientation 3π/4 rad. 
The experimental setup consists of a 3 mm thick PMMA plate (lateral dimensions 25 x 25 
cm), engraved with a 1 mm deep and 1 mm wide grove with 45° edges along one of the 
diagonals. The grove is intended at receiving a 0.014” coronary guidewire. This metallic 
thread is designed to allow coronary angioplasty material (such as balloons and stents) to be 
guided, as though they were on a rail, to the lesion to be dilated. Symmetrically to the plate’s 
centre, two 3 mm diameter lead cylinders of 3 mm thickness, 10 cm apart from each other, 
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serve as imaging fiducials, marking the position of the guidewire with absolute certainty. 
These fiducials will serve as a non-ambiguous target for the extraction of the regions of 
interest (ROI) required by the program. 
The plate is placed parallel to the patient table, and the guidewire is positioned at the 
isocenter by tethering two magnets on both sides of the plate on its geometric middle, 
allowing the gantry to fully rotate around the plate, and setting the table position until the 
visualisation of the magnets remains in the middle of the field of view, thus indicating that the 
guidewire centre is at the unit’s isocenter. 
2.5 and 5.0 cm PMMA slabs (lateral dimensions of 30 x 30 cm) are placed above and under 
the guidewire holder plate, to ensure that the signal we want to acquire is in the middle of our 
surrogate PMMA patient. PMMA thicknesses (without the 3 mm wire holder) range from 5 to 
20 cm, by steps of 5 cm. A set of LEGO blocks allow to separate the plates, so the wire 
holder can freely move between the PMMA slabs. The 3 mm wire holder plate is suspended 
to a little lever, itself attached to an electrical motor allowing the wire holder to move parallel 
to the table with pre-selected motion profiles (QRM-Sim2D, QRM, Germany). A photograph 
of the experimental setup can be seen in Figure 12. 
 
Figure 12: Photography of the experimental setup. 
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Using the previously described experimental setup, two series of images are acquired for 
each PMMA thickness and AEC setting (fluoroscopy or image acquisition): 
- One series with the motor switched off: This first series will allow us to create the 
model template. Indeed, as mentioned previously, the AEC system adapts the dose 
rates by changing up to five parameters at the same time, including the focal spot 
size. This last parameter will have an influence on the spatial resolution of the 
images, thus influencing the apparent size of the signal. For this reason, the training 
set consists of static images, and we will hypothesise that the noise characteristics 
are identical between the training and the testing set; 
- One series with the motor switched on: When switching on the QRM-Sim2D engine, 
the lever follows a back-and-forth motion based on a pre-implemented profile. We 
used the 75 bpm pre-recorded motion, as the writing rights on the engine did not 
allow us to implement a motion with both steps of one stroke defined as a uniformly 
rectilinear motion with known velocity. 
The recorded images look like the one represented in Figure 13. 
 
Figure 13: Example of a fluoroscopy image (20 cm PMMA, medium quality AEC setting). Note the trail left by 
the lead fiducials. 
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The first set of channels consists of four frequencies (the same as [Favazza 2015]) and two 
orientations (𝜋 4�  and 3𝜋 4� ). The phase was left at zero. 
At first, the AUC was chosen as the FOM. However, it turned out that, even for the most 
difficult conditions (20 cm PMMA, low quality fluoroscopy), the AUC was close to 1.0, with 
little variation between the different conditions, as can be seen in Table 8. Furthermore, for a 
purely static image (no cardiac motion), the detection assessment is trivial, as a motionless 
high contrast target is very easy to detect, whatever the viewing conditions. The assessment 
of dynamic image quality is less trivial, although the system we tested our model on (Philips 
Allura Xper FD10 with AlluraClarity) performs well even for the theoretically most difficult 
conditions, because angiography units are dedicated to detecting these kinds of rectilinear 
signals in moving conditions. 
 
Fluoroscopy 
setting Static conditions Dynamic conditions 
FOM 𝑆𝑁𝑅λ 𝐴𝑈𝐶 𝑆𝑁𝑅λ 𝐴𝑈𝐶 
Low quality 5.40 0.99997 3.45 0.9931 
Medium quality 6.95 1.0 4.12 0.99914 
High quality 11.32 1.0 4.90 0.99919 
Table 8: AUC and SNR results for static (left) and dynamic (right) acquisition conditions. We see that the AUC 
rapidly "saturates", rendering it useless as a FOM. But the SNR being not limited, it serves as a more pertinent 
FOM. 
 
Since the AUC is no longer a pertinent FOM, we decided to use the 𝑆𝑁𝑅λ as the FOM. The 
aim of the present model will thus be to serve as an objective quality indicator when fine-
tuning the AEC system or other dose-reduction solutions, such as recursive filters, that may 
blur even high-contrast objects.   
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Conclusion 
Throughout this research project, we have discussed the three main aspects of 
fluoroscopically-guided procedures: Patient exposure, staff exposure, and image quality.  
For patient exposure optimisation for IC procedures, the data we collected in eight 
interventional cardiology centres using CardioReport has been analysed using the R 
software, and the results have allowed to establish a set of corrective factors for the PKA and 
Ka,r, allowing a physician to compare a specific procedure – on a patient of arbitrary body 
habitus – to the dose that would have been delivered to a standard body-sized patient. The 
corresponding paper is still in the writing process, and we expect to have it submitted to a 
peer-review journal by the end of the third trimester. Furthermore, a literature review on the 
exposure of the pregnant woman during IC procedures, as well as on the current low 
pertinence of patient high-Z protective garments, have been performed and are currently 
under review for a special issue on the management of the pregnant patient in radiology in 
EJMP. 
For staff dose, the last epidemiological studies have shown that the risks for radiation-
exposed medical staff have been underestimated, especially for eye lens and brain 
exposure, and that there is a need for a good quantification of the exposure of these organs, 
that are not protected by lead aprons. Throughout this research, we have gained a better 
knowledge of their exposure, and the efficiencies of the protective devices that can be used 
to reduce scattered dose. We have seen that, nowadays, staff effective dose is no longer a 
concern, since technological advances have allowed or a drastic reduction for patient and 
subsequent staff effective doses. However, routine dosimeters should always be worn to 
continuously monitor medical radiation workers, as this working category remains a special 
topic in the management of professional health questions. The main concern now comes 
from eye lens and brain dose, as cumulative doses to both these organs can grow quite high 
over a whole career, and their radiosensitivity has been underestimated [ICRP 2011]. 
Finally, and this was probably the most innovative part of this research, for image quality, we 
have seen that there is a need for clinically-relevant image quality assessment. This may be 
either performed by VGA studies by several human observers, but this method is time-
consuming and prone to inter- and intra-observer variability. Also, the non linearity of current 
image reconstruction processes has rendered previously used physical metrics (such as 
CNR or MTF) non applicable for objective image quality assessment. For this purpose, the 
use of mathematical model observers could be a solution for clinically relevant objective 
image quality qualification. These models are based on statistical decision theory, and can 
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be either used to assess a detector performance by extracting all available information from 
a dataset (i.e. the ideal observer), or its performance could be degraded to match that of 
humans (i.e. an anthropomorphic observer) to assess local acquisition and reconstruction 
protocols. Model observers necessitate the clear definition of four cornerstones: 
- A clinical task, 
- A statistically relevant set of images, 
- An observer (ideal or anthropomorphic), 
- A figure of merit (FOM). 
For this purpose, we decided to qualify the detectability (binary detection task) of high-
contrast thin linear objects (i.e. a coronary guidewire) in moving imaging conditions using an 
anthropomorphic channelized Hotelling observer (CHO). The test object we designed is a 
thin PMMA wire support plate, set in motion by a dedicated electrical motor applying a 
motion pattern similar to the heart strokes in a patient. The acquired images consist of a set 
of regions of interest (ROI) of the guidewire (signal-present images) and ROI of only noise in 
a homogenous background (signal-absent images). The application of the HO consists of 
multiplying the acquired images by a template, that consists of the average difference 
between both signal-present and signal-absent images and the covariance matrix of the 
signal-absent images for noise de-correlation. Since the calculation of the covariance 
necessitates a very large amount of images, and the inversion of large matrices being 
computationally expensive, we applied a set of Gabor channels to the template and the 
images, so as to extract the useful image information and to reduce the problem’s 
dimensionality. Gabor channels are fit for this imaging purpose, as they are sensitive to the 
orientation and size of the signal. A fine tuning of the number and parameters of the 
channels remains to be done in order to make the model more anthropomorphic, but we 
have already seen that the relative responses for different image qualities (low, medium and 
high fluoroscopy) and static vs. dynamic imaging conditions show the right trend. The FOM 
we decided to use is the signal-to-noise ration 𝑆𝑁𝑅λ of the decision variables’ distributions, 
as the area under the ROC curve (AUC) quickly reaches its maximal value of 1.0 without 
bringing any extra information on image quality.    
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Perspectives 
As we have seen, all three aspects we covered (patient dose, staff exposure, and image 
quality) are all intrinsically linked, as is schematically depicted in Figure 14. Indeed, changing 
one of the three summits of the represented schematic triangle often impacts the two 
remaining aspects. For example, reducing staff dose by increasing the detector sensitivity 
may alter the subsequent image quality, increasing the risk of under-diagnosing or missing a 
lesion. To continue the optimisation steps opened by this research, we propose several 
research themes in the field of fluoroscopically-guided procedures. But first, we would like to 
propose a paradigm shift. Indeed, until now, dose optimisation relied on the collection and 
analysis of patient doses, and practice optimisation using trial and error, with the physician’s 
opinion as FOM for image quality assessment. However, we propose to place image quality 
as the beginning step of clinical practice optimisation, and adapt patient exposure – and 
subsequent staff exposure – in adequacy to a precisely defined clinical task. The first step of 
this process will consist on the actual definition of the respective tasks for the different 
medical specialties. 
 
Figure 14: Schematic representation of the three-pronged problematic of fluoroscopic imaging. 
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By the end of 2013, automatic dose collection software (DoseWatch, GE Healthcare) was 
installed at our hospital, as in many other centres. It performs a direct query on the devices 
linked to the system, and extracts many technical and clinical parameters from the Radiation 
Dose Structured Report (RDSR), an object recently introduced in the DICOM standard, that 
records all technical parameters for every irradiation sequence. The software was configured 
to collect all dose indicators for the five CT and seven angiography units from CHUV. Of 
these seven angiography units, three are dedicated to interventional cardiology (one single-
plane and one dual-plane room), three to interventional radiology (same configuration), and 
one is used in the operation theatre, mainly for vascular surgery procedures. Although 
convenient, these software solutions usually perform their statistical classification based on 
the local protocol name, and our local solution is unfortunately highly sensitive to the actual 
spelling of the protocol name. For CT imaging, this implies that the current number of 
“different” protocols listed in our database is equal to 148, although a multi-disciplinary task 
force, consisting of radiologists, technologists and physicists decided on a 46 entry list for 
protocol nomenclature. As such, much valuable information is potentially diluted in useless 
entries. 
For interventional radiology and cardiology, the problem is more subtle. Indeed, although it 
would be difficult, the task of converging to a similar protocol description nomenclature is 
theoretically feasible. However, many examinations starting as a diagnostic procedure (e.g. a 
CA) may be immediately followed by a therapeutic procedure (e.g. a PTCA, when a coronary 
stenosis has been diagnosed). Since standalone therapeutic procedures are quite rare, 
many therapeutic procedures will thus be recorded as diagnostic procedures, with which they 
usually start. This may be problematic for establishing RLs, as the information on the actual 
procedure is lost. Overall, software aiming at only collecting patient doses rather than the 
whole procedural informational contents is at high risk of losing valuable information. In 
opposition to this, a dedicated global structured reporting and billing solution such as 
CardioReport is much less prone to miss-classification of procedures. One research 
perspective could consist on finding a better procedure classification algorithm, based not 
only on the entries on the respective radiological units, but also procedural data such as the 
treatment used or a special diagnostic tool that was used for a specific medical indication. 
The establishment of IC RLs for the FOPH was possible since the habit in the field of IC is a 
thorough open reporting of the procedures performed in Switzerland. An illustrative example 
of this paradigm is the AMIS Plus initiative, which is a national registry of acute myocardial 
infarction in Switzerland (http://www.amis-plus.ch/). Other fields using fluoroscopy as a 
diagnostic and therapeutic tool, such as interventional radiology or vascular surgery, could 
benefit from a more pragmatic and structured practice reporting. Only a correct classification 
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of the procedures will allow for a pertinent setup of the respective imaging tasks that will 
serve as the starting point for practice optimisation. 
On the subject of patient dose and risk estimation, the PKA, although derived from air kerma, 
does not benefit from a primary metrology standard, and is therefore subject to large error 
margins. For example, in Swiss law, the tolerated error margin for the measurement of PKA is 
of ±30 %. This implies that two examinations performed on two separate units, although 
physically delivering the same dose to two patients, may display doses showing up to 60 % 
difference. For this purpose, the AAPM task group 190 has issued a report on the accuracy 
of PKA and Ka,r evaluation, precisely describing a measurement methodology to verify the 
accuracy of both dose indicators [AAPM 2015]. For Ka,r measurement, this method relies on 
the punctual measurement of air kerma at the isocenter, and correcting it by the inverse 
square of the distance for the IRP. It also discusses the sources and estimation methods for 
the uncertainties. As for the PKA, the measured Ka,r is multiplied by the exposed surface, 
measured using an object of known dimensions at the same location, such as a metallic grid 
or a radio-opaque ruler. However straightforward, this method does not take into account the 
correction for beam filtration – especially when using solid-state chambers – or the heel 
effect of the anode, since the kerma is only measured at the field centre. Some large 
ionisation chambers, or arrays of diodes (like the electronic portal imaging device (EPID) for 
megavolt (MV) imaging in radiotherapy gantries) do exist for direct PKA measurement, but 
they do not benefit from a metrological attachment, at least not in Switzerland. We are 
convinced that, if PKA measurements were traceable back to the French Bureau International 
des Poids et Mesures (BIPM), both patient stochastic and deterministic risks could be better 
estimated on the basis of the values measured and displayed by the fluoroscopy units. 
For staff exposure, as routine effective dose monitoring has shown to be efficient, the 
physical measurement of eye lens dose, rather than the correction of the usual dosimetry 
worn at the chest level, would probably be the best solution to assess the risk of developing 
radiation-induced cataract. This dosimeter could also be used, provided good correction 
factors, to estimate brain dose. However, no dose indicator is yet sufficiently well-defined for 
the measurement of eye lens dose. Indeed, routine chest dosimeters are usually calibrated 
on the basis of depth dose (i.e. the absorbed dose under 10 mm of soft tissue – Hp(10)) 
surface dose (i.e. the absorbed dose under 0.07 mm of soft tissue – Hp(0.07)). A proposed 
intermediate calibration (Hp(3)) is probably the best compromise, and is currently being 
tested by the French IRSN (Dosiris). 
To sum up, perhaps the most challenging task for the medical physicist is the understanding 
of the needs of the different fluoroscopy units’ users (in terms of diagnostic quality and 
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availability of protective devices), while assuring and maintaining a proper education of the 
workers involved in interventional procedures. For this purpose, the combined use of 
electronic dosimetry during actual clinical procedures, along with the fine-tuning of image 
quality using clinically relevant model observers, will benefit the entire medical team. It would 
allow the physicians to express and define their respective diagnostic needs and how to 
quantify their outcome on a diagnostic image, as well as to optimise staff exposure by 
actively defining the proper radiation protection measures to be implemented at a local or 
institutional level, with respect to the needed image quality – and subsequent exposure. 
Furthermore, as patient dose benefits from a legal framework (local or national RLs), so may 
image quality, if an objective measurement standard were introduced along the average 
patient exposure for a given procedure. The final aim is to set up a metrological attachment 
of the model observer measurement method, as is the case for most of the dose 
measurements, be it routine monitoring or device dose indicators. The centre of gravity of 
practice optimisation will have to be shifted from dose optimisation to objective image quality 
assessment. 
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Since January 2008—de facto 2012—medical physics experts (MPEs) are, by law, to be involved in the optimisation process of
radiological diagnostic procedures in Switzerland. Computed tomography, fluoroscopy and nuclear medicine imaging units have
been assessed for patient exposure and image quality. Large spreads in clinical practice have been observed. For example, the
number of scans per abdominal CT examination went from 1 to 9. Fluoroscopy units showed, for the same device settings, dose
rate variations up to a factor of 3 to 7. Quantitative image quality for positron emission tomography (PET)/CT examinations
varied significantly depending on the local image reconstruction algorithms. Future work will be focused on promoting team co-
operation between MPEs, radiologists and radiographers and on implementing task-oriented objective image quality indicators.
In 1997, the European Council Directive 97/43/
EURATOM introduced the implication of medical
physics experts (MPEs) in the optimisation process of
radiological diagnostic procedures. That recommenda-
tion has been translated into the Swiss Radiological
Protection Ordinance (RO(1)) and applied officially in
2008, de facto in 2012. This contribution summarises
the application methodology, as well as the results, after
1 y of experience. (NB: The Radiological Protection
Ordinance is usually abbreviated using RPO, but RO
will be used in this text to avoid any confusion with
‘Radiation Protection Officer’.)
INTRODUCTION
In Switzerland, the Federal Office of Public Health
(FOPH) legally authorises the manufacturer for per-
forming quality control tests of their radiological
devices. The minimal frequency, as well as the con-
tents of those periodical controls, is set by the FOPH.
The manufacturer ensures that the device runs in
accordance with the norms and criteria established by
the International Electrotechnical Commission (IEC)
standards. As a consequence, until now, the tasks of
the manufacturer were completely separated from
those of the users (physicians and radiographers).
In addition to these tests, the FOPH audits the differ-
ent radiological centres on a regular basis, in order to
ensure compliance with the national and international
safety and quality standards.
Until now, no MPE was involved in the optimisation
process in diagnostic and therapeutic radiological pro-
cedures. As such, the manufacturer is judge and jury of
the implemented clinical protocols. The authors’ aim is
to provide objective image quality assessment tools in
order to use the devices to their full potential in dose
optimisation while remaining clinically relevant. As
such:
† The manufacturer will continue to maintain the
technical integrity of the device, ensuring the link
between detector dose and image quality.
† The radiation protection expert is in charge of the
operational safety of the staff using the device.
† The MPE, in close collaboration with the physi-
cians and radiographers, will make sure that the
device is being properly used on patients, ensuring
the link between patient dose and image quality
(or, more specifically, diagnostic quality).
In opposition to several countries where MPEs are
already in place, a lot had to be done to rethink the
role of the MPE. The MPEs’ work had to yield added
value to the clinical practice without substituting the
manufacturer for the periodical technical controls.
The major part of the authors’ effort was put in the
field of computed tomography (CT), since it is the
most common diagnostic device in the vast majority of
private and public radiology practices. Furthermore,
the radiation protection requirements in interventional
radiology and nuclear medicine (NM) being more
obvious, the involvement of an MPE was much easier
in these fields.
OBJECTIVES AND METHODOLOGY
The authors will now describe the approach used for the
implementation of Article 74, Paragraph 7, of the RO.
The description, as well as the rest of this contribution,
will be separated into three imaging fields: CT, fluor-
oscopy and NM.
A common objective for those three fields was to
make an inventory of the different devices and
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technologies used by the centres in the authors’ data-
base, as well as gaining acceptance within the differ-
ent radiology institutes.
Computed tomography
The approach used for CT was focused on three axes:
† verification of the main dose indicators, since they
are used as the primary tools for protocol opti-
misation,
† benchmarking of the institutions’ image quality
using a pre-defined acquisition and reconstruction
protocol on a QA phantom,
† dosimetry assessment of the clinical use of the
devices.
Machine output
First: control of the main output parameters of the
device itself:
† volumetric computed tomography dose index
(CTDIvol), using a standard IEC 16-cm-diameter
head phantom and a 100-mm pencil ion chamber
(Radcal Corporation, Monrovia, California),
† beam collimation and penumbra, using self-
developing Gafchromic XR-CT strips,
† Hounsfield unit (HU) calibration in water at the
available X-ray tube voltages,
† laser alignment using a Catphanw 600 aligned on
the lasers, later on compared with the projection
image (topogram).
Local abdomen protocol qualification and unit
benchmarking for a given CTDIvol condition
Second: qualification of the local abdomen acquisition
and image reconstruction protocols using a standard
QA phantom (Catphanw 600, The Phantom Laboratory,
Salem, New York). Furthermore, a standard acquisi-
tion and reconstruction protocol was elaborated in
order to enable device benchmarking. Standard test
parameters were as follows:
† CTDIvol of 15 mGy, corresponding to the Swiss
diagnostic reference level (DRL) for an abdomin-
al examination,
† gantry rotation time of 1 s,
† reconstructed slice thickness of 2.5 mm (or 2 mm,
depending on the CT manufacturer and/or soft-
ware version), with contiguous slices,
† standard (soft tissue) reconstruction kernel,
† filtered back-projection, no iterative reconstruc-
tion,
† field of view (FOV) of 220 mm.
As body examinations yield the largest effective
doses(2) with the largest spread in clinical practice(3),
one of the critical aspects in diagnosis is the low-con-
trast detectability (LCD). This depends strongly on
the used dose, the reconstruction convolution kernel,
the slice thickness and the detector performance. The
three first parameters being equal, the latter could be
benchmarked. For this purpose, three observers have
looked at the images on a diagnostic screen and esti-
mated subjectively the diameter of the smallest rod
they could distinguish for a given contrast.
Clinical use of the device
Third: dosimetry analysis of a sample of clinical exami-
nations sent by the different institutions. The requested
examinations concerned standard head, chest, abdomen,
paediatric, upper- and lower-limb and cardiac acqui-
sitions. The analysed parameters were as follows:
† CTDIvol per scan,
† cumulated dose–length product (DLP), as well as
DLP per scan,
† examination effective dose E(2),
† number of scans per examination,
† measurement of the antero–posterior and lateral
(LAT) patient dimensions, to calculate the size-
specific dose estimate(4),
† used slice thicknesses,
† noise in a homogeneous zone for a given slice
thickness,
† assessment of the use of the automatic exposure
control system,
† positioning of the patient in the gantry,
† visibility check of a given list of organs by review
of the diagnostic images by an experienced radi-
ographer.
Fluoroscopy
Fluoroscopy units were characterised using the locally
implemented clinical parameters. The characterisation
was done using PMMA slabs of different thicknesses,
thus simulating patients of different sizes (Figure 1).
Dose rates measured in different sites and units were
collected and compared.
Since the dose rates of different units can differ sig-
nificantly(5), the aim was to provide the users of the unit
with a framework that showed the orders of magnitude
of their patients’ exposure by their most commonly
used clinical protocols.
No image quality measurements were performed.
However, clinical image quality requirements were ap-
parently satisfied for all systems since physicians use
those units without any preference.
Nuclear medicine
Quantitative imaging is of prime importance in NM.
Indeed, the estimation of the volumetric activity in a
lesion will yield precious information about its metab-
olism and will influence the subsequent clinical deci-
sions. This is why these aspects have to be assessed
correctly.
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Single photon emission computed tomography
For single photon emission computed tomography
(SPECT), the use of the Jaszczak (Deluxe) phantom for
overall system performance assessment is recommended
by the European Association of Nuclear Medicine
(EANM)(6), but also by the American Association of
Physicists in Medicine (AAPM) and the American
College of Radiology.
In this protocol, the phantom was filled with 400
MBq of 99mTc. Uniformity of the reconstructed
slices, cold sphere contrast and spatial resolu-
tion based on the visualisation of cold rods were
evaluated. The presence of macroscopic artefacts
was also checked by visual inspection of the recon-
structed images.
Positron emission tomography
For quantitative PET performance assessment, the
EANM promoted EARL protocol (http://earl.eanm.
org/cms/website.php?id=/en/projects/fdg_pet_ct_
accreditation.htm) was adopted as a reference. This
protocol is based on a PET/CT acquisition of the
NEMA-IEC body phantom filled with an 18F-FDG
activity concentration ratio of 10 : 1 between the hot
spheres and the background, respectively. However,
differently from the EARL protocol, the two largest
Figure 1. Schematic figure of the fluoroscopy characterisation geometry: PMMA in the primary beam, ion chamber at the
entrance point of the beam. Source-to-imaging device distance (SID): 110 cm, source-to-detector distance (SDD): 75 cm.
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spheres were filled with plain water (no activity) to
test cold contrast and, indirectly, the performance of
scatter and attenuation corrections.
CTuse in NM and feedback
Since there are currently no DRLs for the CT units
used in SPECT/CT and PET/CT, the use of CT has
to be evaluated in the scope of the different imaging
purposes. Indeed, the dose requirements are not the
same for a diagnostic scan than for the creation of a
correction attenuation map. Furthermore, the technol-
ogy employed in NM can differ from state of the art
radiologic CT (e.g. cone-beam CT or a pseudo-CT
with common gantry with the cameras). Therefore, CT
imaging in NM examinations has to be correctly assessed
based on the specific tasks to be accomplished.
For both imaging modalities (SPECT/CT and
PET/CT), the local acquisition protocols were tested,
results were discussed and a specific advice was given
in order to optimise the image acquisition and/or
reconstruction protocols to improve both qualitative
and quantitative outcomes.
Continuous education
The collected data were summarised and shared with
the users during continuous education (CE) sessions.
The aim was to update the users0 knowledge in radiation
protection, optimise the clinical use of the devices, as
well as to promote a team collaboration spirit.
RESULTS
Computed tomography
Forty-five CT units were tested in 2013 (18 % of all
CTunits in the country). Several elements were noticed.
Machine output
Four devices evidenced patient positioning laser align-
ment off by as much as 10 mm, possibly resulting in an
increase in patient dose of 6 %(7).
Nine of 45 CT units (20 %) presented a beam colli-
mation that was widely different from the value stated
by the device, e.g. 4 mm measured for 1 mm nominal.
These units took this parameter into account into their
beam efficiency calculation. For example, for a 1-mm
single-slice acquisition protocol (e.g. examination of the
posterior fossa or the petrous bone), one unit displayed
an efficiency of 14 %, thus resulting in a CTDIvol of 299
mGy, whereas a same-generation CT unit with a beam
collimation of 1.25 mm with the exact same parameters
displayed a CTDIvol of 41.5 mGy for a beam efficiency
of 55 %. Radiographers were not aware of the import-
ance of their choice of collimator settings.
Twenty-one of 45 CT units had HU in water that
were not within the legal tolerance (0 + 4 HU) for
tube voltages different from 120 or 140 kV. This was
mainly due to a lack of calibration because the ten-
sions were not used in routine. Surprisingly, even
then, an acquisition at a non-calibrated tension was
still available in user mode, thus potentially leading to
a completely erroneous examination if, for example, a
newly engaged radiologist were to perform an exam-
ination at a lower tube voltage.
Abdomen protocol qualification
The subjective estimation of the LCD performance
yielded some interesting results. For 2-mm slices, 4 of
16 CT units showed a lower detection performance,
whereas for the 2.5-mm slices, 3 of 27 CT units showed
LCD performance under the mean value. The mean
values are given in Table 1. Without clearly setting one
manufacturer apart from the others, it reminded the
users that, for the same acquisition parameters, an in-
crease in the slice thickness could lead to an increased
LCD.
However, one of the main limitations of the authors’
approach was that this was subjectively assessed, without
taking into account the spatial frequency of the noise.
Clinical use of the device
The clinical use of the devices showed a large variabil-
ity, especially for the abdominal examinations. Tables 2
and 3 and Figure 2 give an overview of this dispersion.
For example, the ratio of the 75th and 25th percentile
of the mean CTDIvol was 1.9, whereas the effective
dose showed a dispersion factor of 3.0. This shows that
the number of scans per examination is not uniform.
In 2008, the FOPH estimated the mean effective dose
for abdominal examinations at 9 mSv. The current
analysis shows a value of 18.7 + 12.7 mSv, more than
twice the last value (Figure 2 and Table 2). Reasons for
this could be a miscalculation of the 2008 value, a quick
increase in the number of scans per examination during
this period or a biased selection of the examinations.
One critical aspect is that, among CT users—and
MPEs—the concept of DRL is not clear, especially
since the number of scans is not standardised. The
current approach allowed for a clarification of the
Table 1. LCD performance for the unit benchmarking
protocol.
Slice thickness
[mm]
LCD@0.5 %
[mm]
LCD@0.3 %
[mm]
2 9.6+2.8 14.5+1.7
2.5 8.0+0.6 14.0+2.3
LCD performance is given in terms of the average smallest
low-contrast insert detected, for a given native contrast (0.5
or 0.3 %).
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actual patient exposure, thus triggering discussions
among radiologists in order to limit the dispersion of
the practice.
A further limitation was the collection of clinical cases
on the basis of anatomical regions. Thus, a bias was
introduced by comparing examinations for obviously
different clinical demands. An effort will be placed
upon analysing clinical practice with respect to
demand in the coming years.
Fluoroscopy
For approximately the same clinical settings, the dose
rates showed large variations. For example, when
putting 20 cm of PMMA in the primary beam, acqui-
sitions at 15 frames per second (typical for interven-
tional cardiology procedures) had differences up to a
factor 3 (Figure 3). Measurements made with diag-
nostic settings (cineradiography or digital subtraction
angiography) even yielded differences up to a factor 7.
Nuclear medicine
The analysis of early results obtained from a few tested
devices showed heterogeneous PET performance. The
main factor for differences was the availability or not of
time-of-flight and point spread function corrections
that strongly impact both overall image noise and
activity recovery in small-sized lesions.
Furthermore, although the radiographers practis-
ing SPECT/CT and/or PET/CT examinations were
fairly aware of the principles of radiation protection
when manipulating radioactive sources, they were not
comfortable with the interpretation of the CT dose
indicators, as there are still no existing DRLs specific-
ally for transmission imaging in NM.
Continuous education
Approximately 150 radiographers have participated
into 7 CE sessions organised throughout the year. The
lecture’s themes were a description of the methodology
Table 3. Dispersion of the clinical use in terms of the percentile of abdomen dose indicators.
Percentile Mean CTDIvol [mGy] Mean DLP [mGy cm] Cumulated DLP [mGy cm] No. of phases E [mSv]
25th 8.0 320 550 1 8.4
75th 14.8 665 1655 3 25.4
75th/25th 1.9 2.1 3.0 3 3.0
The dispersion of the practice is given by the ratio between the 75th percentile and the 25th percentile of the distribution, thus
ignoring the extreme values.
Table 2. Mean values of the main dose indicators for clinical use of CT units, along with the measured ranges.
Protocol Mean CTDIvol [mGy] Mean DLP [mGy cm] No. of phases E [mSv]
Head 51.2+13.9
22.1–84.2
905+275
286–1812
1.7+0.7
1–4
3.2+1.3
1.0–6.6
Chest 8.5+5.5
2.6–31.8
310+165
96–816
1.4+0.5
1–3
6.2+3.5
1.4–20.3
Abdomen 12.2+7.0
2.6–48.8
535+320
96–2085
2.4+1.3
1–9
18.7+12.7
2.0–112.0
Mean CTDIvol and DLP are given per scan, whereas the effective dose and number of scans are given per examination.
Figure 2. Dispersion of the clinical use of CT for abdominal
examinations in terms of effective dose per examination. The
2008 value from the FOPH dose estimation is given as a
comparison.
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used in CT qualification within the new legal frame-
work and a reminder of the dose indicators as well as
the metrics of image quality with respect to dose. One
important aspect was the gain of confidence between
the radiographers and the MPE.
PERSPECTIVES
For CT, the future tasks are divided into two subsets.
First, there is a strong need for an objective qualifica-
tion of LCD, so the user is aware of the potential loss
in LCD performance when using low-dose protocols
along with iterative image reconstruction algorithms.
Second, the sampling of examinations is to become
task-oriented rather than relative to a given anatomical
region. The ultimate goal would be to have one (or
several) objective image quality indicator(s) for a given
clinical demand. For example, the search of kidney
stones (high contrast) does not need the same dose
level than a suspected liver carcinoma. For this, the im-
plementation of model observers on anthropomorphic
systems is a promising tool towards this solution.
For fluoroscopy, a great deal of effort has been put
into the establishment of new reference levels in inter-
ventional cardiology. For this purpose, automated
dose collection software will become of prime import-
ance. Nonetheless, a crucial point that has yet not been
investigated thoroughly is the reliability of the dose
indicators of the devices, such as cumulative dose or
cumulative dose–area product. Indeed, the former is
defined at two different locations in the beam (FDA or
IEC reference points); the latter, especially since diag-
nostic beams are heavily filtered using copper, is, based
on preliminary measurements, potentially off by a
factor of 2. A new investigation protocol to address this
problem is currently being set up by the AAPM task
group 190, and their final report is due in December
2014. As a consequence, the traceability of the testing
instruments will be even more important, and the toler-
ance on dose indicators will have to be lowered.
Furthermore, the nomenclature of the specific diagnos-
tic and/or therapeutic interventions is not unified, thus
making a proper large-scale dose collection tedious.
Interventional cardiology, for which soon-to-be
published DRL have been established (as cited previ-
ously), could serve as a role model for this task. An
effort will also be taken on the establishment of a
database of objective image quality indicators for
parameters deemed acceptable by physicians after
optimisation.
Finally, for NM, two aspects seem to emerge from
the first results. First, a great deal of effort has to be put
into the calibration of the individual activity meters of
the different institutions, by using a solid 68Ga/68Ge
phantom for PET and the Jaszczak phantom for
SPECT. Second, the use of CT for attenuation correc-
tion will, as for conventional CT, benefit of the model
observer routines to tackle objective image quality.
The CE sessions have allowed the MPE to gain
knowledge of the devices across the country and confi-
dence with respect to their clinical applications. The next
step will be to establish partnerships with radiologists.
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Fluoroscopically guided procedures might be highly irradiating for patients, possibly leading to skin injuries. In such a context,
every effort should be done to lower patient exposure as much as possible. Moreover, patient dose reduction does not only benefit
to the patient but also allows reducing staff exposure. In this framework, Philips Healthcare recently introduced a system
upgrade for their angiography units, called ‘AlluraClarity’. The authors performed air kerma rate measurements for all available
fluoroscopy modes and air kerma per frame measurements for the digital subtraction angiography protocols, along with subject-
ive spatial resolution and low-contrast detectability assessments using a standard QA phantom. Air kerma reductions ranging
from 25.5 to 84.4 % were found, with no significant change in image quality when switching from a standard operating mode to
an upgraded version. These results are confirmed by the comparison of actual patient exposures for similar procedures.
INTRODUCTION
Fluoroscopically guided interventions are among the
most highly irradiating diagnostic and/or therapeutic
procedures, both for the patient and the operating
staff. Therefore, according to the as low as reasonably
achievable principle, all available measures should be
taken to optimise the use of ionising radiation.
One way to proceed is the use of technological
improvements. In this scope, Philips Healthcare (Best,
The Netherlands) has issued an upgrade for their
Allura angiography units called AlluraClarity. This
technology makes use of both particular X-ray tube
and filter settings [especially additional Cu-filtration
and smaller focal spot(1)] and image processing that
are, unfortunately, not fully described in the literature.
The final result is an overall reduction in the image
noise level, allowing for a subsequent patient dose re-
duction, up to 75 % according to the literature(1).
This drastic dose reduction is associated with the
production of images that remain fully satisfying for
the users as mentioned by So¨derman et al.(1,2)
The authors’ aim is to assess the variability of air
kerma reduction and image quality (IQ) preserva-
tion using controlled exposure conditions and an IQ
phantom when going from the standard Philips Allura
system to the AlluraClarity upgraded system.
MATERIALS AND METHODS
The patient was simulated using PMMA slabs of 20
by 20 by 5 cm, piled up to obtain thicknesses of 5, 10,
15 and 20 cm, in order to study the behaviour of the
automatic exposure control system. The air kerma
rates were measured using a 6-cc ionisation chamber
(10`  5–6, RadCal Corp., Monrovia, CA, USA) and
a readout unit/power supply (9015, RadCal Corp.).
All measurements are traceable to the Swiss Federal
Office of Metrology (METAS).
Two sets of measurements were taken in two slightly
different geometric set-ups, one for the air kerma
rate measurements and one for the IQ. At all times,
the focus-to-detector distance was kept constant at
110 cm, while the focus-to-ionisation chamber was
kept constant at 75 cm. This geometry has been
chosen to reproduce typical clinical acquisition
geometry(3).
The set-up used for dosimetry consisted in placing
the ionisation chamber in the middle of the entrance
surface of the X-ray field, close to the phantom
(Figure 1). It is worth mentioning that the ionisation
chamber was not localised at the interventional refer-
ence point since the choice made was to be as close as
possible to clinical conditions.
Concerning the set-up used for the IQ measure-
ments, and as previously mentioned, the focus-to-
detector and focus-to-PMMA have been kept con-
stant. A standard IQ phantom (TOR CDR, Leeds
Test Objects, Boroughbridge, UK) was placed on top
of the first PMMA slab (Figure 2). The additional
PMMA slabs were subsequently piled on top of the
phantom, so as to simulate inner body lesions for dif-
ferent patient morphologies, following a standard
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internal procedure. The total patient thickness was
of 5-, 10- and 15-cm PMMA þ the extra 1 cm of the
phantom.
The phantom consists of a solid polymer disc em-
bedded with four groups of test objects:
† 17 high-contrast discs of varying contrast and
fixed diameter of 0.5 mm,
† 10 discs, fixed diameter of 5.6 mm, used for grey-
scale calibration,
† 17 low-contrast discs of varying contrast and
fixed diameter of 11 mm,
† A resolution test pattern with 30 line groups of in-
creasing spatial frequency.
Figure 1. Schematic figure of the dosimetry set-up
geometry: PMMA in the primary beam, ion chamber at the
entrance point of the beam. The additional 5-cm PMMA
slabs are represented in grey.
Figure 2. Schematic figure of the IQ set-up geometry:
PMMA in the primary beam, TOR CDR IQ phantom on
top of the first PMMA slab. The additional 5-cm PMMA
slabs, piled up on the IQ phantom, are represented in grey.
Table 2. Air kerma rates for fluoroscopy setting I (low
quality) and III (high quality).
PMMA
[cm]
FOV
[cm]
Air kerma rate
[mGy min21]
Difference
[%]
Upgraded Reference
10 42 1.40 1.80 222.2
3.30 5.20 236.5
27 1.95 2.35 217.0
4.40 6.55 232.8
15 2.55 2.89 211.8
6.30 8.90 229.2
20 42 6.7 10.1 233.7
21.0 31.2 232.7
27 8.7 13.0 233.1
27.5 40.5 232.1
15 11.5 17.5 234.3
36.0 50.5 228.7
PMMA thicknesses are of 10 and 20 cm, whereas the FOV
are 42, 27 and 15 cm, respectively.
Table 1. Air kerma rates for fluoroscopy setting II (medium
quality).
PMMA
[cm]
FOV
[cm]
Air kerma rate
[mGy min21]
Difference
[%]
Upgraded Reference
5 42 0.650 1.305 250.2
27 0.920 1.640 243.9
15 1.255 2.200 243.0
10 42 2.00 3.67 245.5
27 2.80 4.63 239.5
15 3.70 6.20 240.3
15 42 4.75 9.00 247.2
27 6.55 11.50 243.0
15 9.00 16.00 243.8
20 42 11.5 20.0 242.5
27 14.5 24.0 239.6
15 19.5 34.5 243.5
PMMA thickness ranges from 5 through 20 cm, whereas the
FOV are 42, 27 and 15 cm, respectively.
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The two latter elements were used for IQ assessment in
terms of, respectively, low-contrast detectability (LCD)
and spatial resolution. The acquired images were
displayed on a DICOM 3.14 compliant diagnostic
monitor (RadiForce MX 210, Eizo Nanao Corp.,
Hakusan, Japan). An observer subjectively assessed IQ
by noting the disc with lowest detectable contrast (thus
defining LCD performance, see Table 4) and the line
Table 3. Air kerma per image for lower limb DSA (PMMA thickness of 5 and 10 cm) and abdominal DSA (PMMA thickness
of 15 and 20 cm).
PMMA [cm] FOV [cm] Air kerma per image [mGy] Difference [%]
Upgraded Reference
Lower limb DSA 5 42 0.032 0.160 280.0
27 0.032 0.219 285.4
15 0.047 0.320 285.2
10 42 0.076 0.538 285.9
27 0.106 0.749 285.8
15 0.159 1.109 285.7
Abdominal DSA 15 42 0.288 1.046 272.5
27 0.414 1.521 272.8
15 0.648 1.918 266.2
20 42 0.827 3.061 273.0
27 1.229 4.286 271.3
15 1.889 4.573 258.7
The FOV are 42, 27 and 15 cm, respectively, for both anatomical regions.
Table 4. Subjective IQ assessment, in terms of spatial resolution and LCD.
PMMA [cm] FOV [cm] Mode Resolution [lp mm21] LCD [%]
Upgraded Reference Upgraded Reference
5 42 DR 2.24 2.24 1.3 1.3
DSA 2.24 2.24 1.3 1.3
Sc. II 2.00 1.60 1.7 2.2
31 DR 2.80 2.80 1.3 1.3
DSA 2.80 2.50 1.3 1.5
Sc. II 2.50 2.24 1.7 2.2
10 42 DR 2.24 2.24 2.2 2.2
DSA 2.24 2.24 1.5 2.2
Sc. II 1.80 1.80 2.7 2.7
31 DR 2.80 2.80 1.5 1.5
DSA 2.80 2.50 1.5 1.5
Sc. II 2.24 2.24 1.7 2.7
15 42 DR 2.24 2.24 2.2 2.2
DSA 2.24 2.24 2.2 2.2
Sc. I 1.60 1.60 3.2 3.2
Sc. II 1.60 1.60 2.7 2.7
Sc. III 1.60 1.60 2.7 2.2
31 DR 2.50 2.80 2.2 1.7
DSA 2.50 2.80 1.7 1.5
Sc. I 2.24 2.00 2.7 2.2
Sc. II 2.24 2.24 2.7 2.2
Sc. III 2.24 2.24 2.7 2.2
PMMA thickness ranges from 5 through 15 cm, whereas the FOV are 42 and 31 cm, respectively. Imaging modes were
fluoroscopy (Sc.) of medium (II) quality, single exposure (DR) and abdominal DSA. For 15 cm of PMMA, the results are also
given for low (I)- and high (III)-quality fluoroscopy. The LCD percentage is the native contrast of the perceived disc as defined
by the manufacturer (70 kVp tube voltage and 1-mm additional copper on the X-Ray tube, ranging from 0.2 to 7.5 %).
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group with highest distinguishable spatial frequency.
Measurements were performed on the same day, in the
same viewing conditions, by the same person (N. R.).
The same measurements were done for two separated
angiography units in two different hospitals, both used
mainly for pelvic and lower limb percutaneous blood
vessel interventions. Both rooms were equipped with an
Allura Xper FD20 flat-panel detector fluoroscopy unit,
one equipped with the AlluraClarity upgrade, the other
not. From this point on, they will be respectively desig-
nated as ‘upgraded’ and ‘reference’.
For the dosimetry assessment, the following proto-
cols were used:
† Fluoroscopy (used for positioning, images not
recorded, only last image hold recorded), with
three quality settings (I, II and III), 15 fps, all
available fields of view (FOV),
† Abdomen digital subtraction angiography (DSA),
varying frame rate, 3 FOV (15, 27 and 42 cm),
† Lower limb DSA, varying frame rate, 3 FOV
(idem).
For the fluoroscopy settings, the frame rate was high
enough in order to measure an air kerma rate at all
quality settings, all FOVs and all PMMA thicknesses.
For the DSA runs, since the frame rate varied
during the acquisition process and was quite low (3
fps), the dosemeter was switched to ‘air kerma inte-
gration’ mode and the cumulated air kerma was
divided by the resulting number of acquired frames.
The authors thus obtained an average air kerma per
frame, as is customary for DSA(4).
For the IQ assessment, the following protocols
were used:
† Fluoroscopy, with three quality settings (I, II and
III), 15 fps,
† Abdomen DSA, varying frame rate, raw images
displayed (no subtraction of the mask),
† Single exposure (DR).
Finally, a statistical analysis of actual patient expo-
sures before and after the upgrade of a further unit
was performed using dose-collection software
(DoseWatch, GE Healthcare, Little Chalfont, UK).
RESULTS
Dosimetry
Tables 1–3 show examples of the effect of the upgrade
on air kerma and air kerma per image, respectively.
For fluoroscopy settings, the air kerma rates were sys-
tematically lower for the upgraded radiology unit than
the reference unit. The average air kerma rate reduction
over all PMMA thicknesses was 25.5 % for low-
quality, 43.5 % for medium-quality and 34.5 % for
high-quality fluoroscopy mode. The reduction was
higher for larger FOV (e.g. lesser magnification).
For DSA, the air kerma reduction was in average
69.7 % for abdominal angiography and even 84.4 %
for lower limb angiography. Again, the effect was
more prominent for larger FOV, and no clear effect is
shown with respect to the PMMA thickness.
Image quality
Table 4 shows the results of the IQ assessment. Only
two FOV (31 and 42 cm) were studied, since the 15-
cm FOV did not allow for the low-contrast targets to
remain into the primary beam. Overall, there was no
significant change in IQ. The mean spatial resolution
Figure 3. Images of the IQ phantom taken in the same
acquisition and viewing conditions [i.e. same grey window
width (300) and level (400)]: 10-cm PMMA, FOV 31 cm,
single exposure (DR) for the (a) reference unit and (b) the
upgraded.
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performance showed a slight but non-significant in-
crease for the upgraded system (two-sample t-test,
p-value 0.55). The same could be said for the mean
LCD ( p-value 0.15).
Figure 3 shows an example of two images taken
exactly in the same conditions [10-cm PMMA, single
exposure (DR), FOV 31 cm, grey window width of
300 and level of 400]. The topmost (a) was made on
the reference angiography unit, whereas the second
(b) was taken on the upgraded unit. Respective stand-
ard deviations (noise) measured in an 18` 18 mm
square region of interest were 19.5 and 10.0, showing
a noise reduction of a factor 2 for the present condi-
tions when using the upgraded unit.
Clinical dosimetry
A preliminary data collection (Figure 4) was per-
formed by N. R. for a further unit recently upgraded,
using automated dose-collection software.
Data consisted of neurological angiography and
angioplasty procedures, 388 performed with the refer-
ence unit and 22 with the upgraded unit. Statistical
analysis showed a significant decrease in the mean
dose–area product (DAP) and cumulated air kerma
(AK) of respectively 63 and 72 % ( p-values ,0.01).
The mean fluoroscopy time (FT) showed a slight but
non-significant increase of 5 % ( p-value 0.96). Those
values are comparable to the results of phantom
measurements presented in this study, showing a re-
duction in patient air kerma rate between 25.5 % for
low-quality fluoroscopy and 84.4 % for lower limb DSA.
DISCUSSION AND PERSPECTIVES
The AlluraClarity upgrade for Allura angiography
units allows for a significant reduction in patient dose.
Although this has not been measured here, the conse-
quence is also a reduction in staff dose.
Figure 4. Box plots showing the DAP (a), AK (b) and FT (c) distributions. The bold bar shows the median, the filled point
the mean, box hinges show the first and third quartiles, whereas the whisker ends extend to the 5th and 95th percentiles. The
topmost rings show the outliers. Results are systematically shown for the reference (left) and upgraded (right) systems.
ALLURACLARITY UPGRADE: SKIN DOSE AND IMAGE QUALITY
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One major drawback in these measurements is the
subjectivity of the assessment, since the performance
characterisation was carried out by a single human ob-
server, prone to intra-subject variability. At the time of
the measurements, the observer was the only familiar
with the actual procedure and present at the place where
the measurements were performed. Furthermore, the
measurements were carried out solely in static imaging
conditions, whereas these units are used to visualise
dynamic phenomena, such as contrast medium wash
through or coronary angiography.
A solution for both these problems would be to use
model observers, such as the channelised Hotelling
observer, as proposed by Favazza et al.(5), or to use
several experienced radiologists to grade the phantom
images.
Finally, the thickness of 15 cm of PMMA for IQ
assessment, although compliant with the internal pro-
cedure used, is not representative of patient with a
larger body habitus. This peculiar aspect will have to
be modified so as to correspond to the evolution of
the morphologies in Western countries.
CONCLUSION
A set of measurements carried out in controlled con-
ditions showed that the AlluraClarity for Allura angi-
ography rooms is able to significantly reduce patient
dose with no significant change in IQ. However,
several limitations, such as a single human observer,
as well as conditions that do not include larger patient
habitus, will have to be taken into account for further
investigations. The use of model observers seems to
be a good solution to reduce inter- and/or intra-ob-
server variability, as well as to take into account the
assessment of dynamic phenomena.
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As the number and complexity of fluoroscopically guided interventions increase, a serious effort has to be put on the optimisation
of the X-ray dose delivered to the patient. In order to set up this optimisation process, the clinical practice for a given cardiology
centre has to be analysed with relevant statistical power and compared with the data at local or national level. Data from 8 Swiss
cardiology centres for 10 different vascular and heart rhythm procedures have been collected. The collected dose indicators were,
when available, cumulated air kerma, cumulated dose-area product, fluoroscopy time and the number of images per procedure.
Data analysis was performed using an in-house software solution in terms of the first, second and third quartiles. This kind of
large-scale analysis could yield some onsets towards local practice optimisation based on anonymous dose indicator cross-com-
parison. Further effort should nevertheless be made in order to proceed towards an operator-based data analysis, thus allowing
for an individual practice optimisation.
INTRODUCTION
Interventional cardiology (IC) procedures are among
the most dose-intensive for patients. Nevertheless,
they are performed in increasing numbers because of
their minimally invasive nature, which reduces septic
risks and patient hospitalisation time. In Switzerland,
the frequency of fluoroscopically guided diagnostic
and therapeutic procedures accounts for 0.8 % of all
X-ray examinations, whereas their dose contribution
is 20.7 % of the collective dose from X-rays to the
Swiss population(1).
The European Council Directive 2013/59/
EURATOM(2) underlines the importance of a regular
review of patient dose levels in order to optimise medical
practice. A major problem in dose optimisation for
fluoroscopically guided interventions is the non-predict-
ability of the four main dose indicators, which are fluor-
oscopy time, the number of frames, cumulated dose-area
product and cumulated air kerma. For example, for
a computed tomography (CT) examination, the volume
CT dose index (CTDIvol) and dose length product
(DLP) are known after performing the scanogram, used
for automatic X-ray tube current modulation and ana-
tomic volume planning, thus before the actual proced-
ure. In fluoroscopy, the resulting dose levels depend on
numerous factors, many of which are not known before
performing the examination: patient body habitus,
lesion complexity, operator experience, image acquisi-
tion pre-settings, beam collimation and filtration, etc.
Unfortunately, some of those parameters are the
ones an operator will have to monitor in order to
lower the value of a given dose indicator. Since the
main dose indicators used in fluoroscopy are strongly
correlated one to another, the optimisation process
has to start after a statistical analysis of a substantial
number of procedures, for which the dose indicators
have been collected, analysed and cross-compared.
The aim of this study was to show the main cues on
patient dose optimisation based on a statistical ana-
lysis of a large number of procedures.
MATERIALS AND METHODS
In the framework of updating the Swiss national diag-
nostic reference levels (DRLs) for IC, eight cardiology
centres reported their data, mainly through the use of
an automatic dose collection software (CardioReport,
CVX Medical, Croissy-Beaubourg, France). A total
number of 46 591 interventions have been collected for
the following 10 procedures:
† Coronary angiography (CA),
† Percutaneous transluminal coronary angioplasty
(PTCA),
† CA þ PTCA,
† Shunt closure,
† Transcatheter aortic valve implantation (TAVI),
† Myocardial biopsy,
† Diagnostic electrophysiology procedures (EFO),
† Defibrillator implantation (ICD),
† Pacemaker implantation (PM),
† Radio-frequency ablation (RFA).
Table 1 shows the respective numbers for each inter-
vention.
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An in-house software solution (Memoviz, Memoways,
Geneva, Switzerland) was elaborated to visualise the
data. For each procedure type, the following dose indica-
tors could be displayed:
† Fluoroscopy time (FT),
† Number of acquired images (N ),
† Cumulative dose-area product (PKA),
† Cumulative reference air kerma (Ka,r).
Up to eight sets of data, i.e. all eight centres or seven
centres and the Swiss mean values, could be displayed
alongside. This allowed for an immediate cross-com-
parison of the dose values of a given centre with the
Swiss values or between different centres. All data
have been displayed anonymously, all centres being
designated with a character between A and H.
For each dose indicator distribution, the software
calculated the first, second and third quartiles (Q1, Q2
and Q3). According to the definition of the DRLs, Q3
was used as the main metric for dose indicator com-
parison. The data analysis has been performed for the
10 types of IC interventions.
RESULTS
Figure 1 shows, as an example, the quartiles of PKA
for CA þ PTCA procedures. Hovering over a given
bar displays the numeric values of the respective
centres, thus permitting an immediate comparison of
the selected dose indicator.
Tables 2–5 show the results for, respectively, CA,
CA þ PTCA, TAVI and myocardial biopsy, as pro-
duced by the software. The analysis of the tables
could give an indication on where to start the dose op-
timisation. Indeed, underlining that one single dose
indicator out of the four was higher with respect to
the other does not necessarily mean that one centre
worked ‘better’ than another. The four dose indicators
are correlated one to another but are not linearly
dependent.
Table 1. Distribution of the data collected in the eight
participating cardiology centres.
Intervention Number recorded
CA 24 261
Coronary angioplasty (PTCA) 1099
CA þ PTCA 18 797
TAVI 221
Shunt closure 622
Myocardial biopsy 73
Diagnostic electrophysiology (EFO) 210
ICD 281
PM 300
RFA 720
Alcohol septal ablation 7a
aData discarded due to a too low number of cases.
Figure 1. Quartile comparison of PKA (Gy cm
2) for CA þ
PTCA procedures and for all eight cardiology centres. Mouse
hover-over allows for an immediate display of the actual
quartile values and immediate comparison with the dose levels
of the other centres. The numbers are part of the web interface
and display the selected dataset.
Table 2. Third quartiles (Q3) for CA for all eight cardiology
centres and all dose indicators.
CA: Third quartile (Q3)
Centre PKA (Gy cm
2) Ka,r (mGy) FT (min) N
A 72 960 6.6 749
B 60 812 8.9 1006
C 51 752 6.0 850
D 65 857 12.3 N/A
E 81 N/A 8.3 887
F 50 329 8.9 1070
G 66 N/A 7.7 N/A
H 90 1146 9.6 1389
Switzerland 69 841 8.9 877
Centres E and G did not record Ka,r, and Centres D and G
did not record N.
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As an example, the third quartiles (Q3) for CA þ
PTCA (Table 3) for Centres B, F and Switzerland
(CH) are the following:
† Centre B: 132 Gy cm2, 2.2 Gy, 17.9 min, 1820
images,
† Centre F: 129 Gy cm2, 1.2 Gy, 20.5 min, 2420
images,
† CH: 150 Gy cm2, 2.0 Gy, 18.1 min, 1527 images.
It can be seen that PKA was rather similar for Centres
B and F, but the Ka,r of Centre B was roughly twice as
high as the Ka,r of Centre F. This could indicate that
Centre F worked with imaging fields roughly twice as
large as B, thus advising for a more thorough use of
beam collimation. When comparing the values of
Centre F with the Swiss values, it can be seen that the
number of images at F was much higher for similar
fluoroscopy times. This could indicate a higher frame
rate (e.g. 30 fps instead of 15 fps, which could still be
diagnostically acceptable).
For the sake of clarity, another example, also
related to CA þ PTCA, is taken to illustrate the use
of data cross-comparison, in the same table, but this
time Q3 values for Centres A and B:
† Centre A: 150 Gy cm2, 2.3 Gy, 13.5 min, 1170
images,
† Centre B: 132 Gy cm2, 2.2 Gy, 17.9 min, 1820
images,
† CH: 150 Gy cm2, 2.0 Gy, 18.1 min, 1527 images.
It can be seen that the PKA and the Ka,r were rather
similar but that Centre B had longer times and a
higher N. This could mean that Centre Aworked with
a higher image quality, since a lower N resulted in the
‘same’ patient dose. Thus, Centre A could potentially
lower their image quality (e.g. by increasing the image
noise), thus reducing the dose per frame and the
resulting patient dose.
DISCUSSION AND PERSPECTIVES
This kind of multivariate analysis, based on anonym-
ous centre cross-comparison, could give the respective
centres ideas on what to optimise, rather than just
telling the operators that their mean doses are higher.
However, several limitations arise for this study.
Firstly, the heart rhythm procedures (EFO, RFA,
PM and ICD) were given only for one centre. Cross-
comparison was thus not possible. The values for this
centre might also underestimate the mean exposure,
since that centre is equipped with an electroanatomic
mapping system—based on the position of markers
on a catheter in a local magnetic field—designed to
enhance the 3D representation of the heart chambers
and main vessels, thus reducing the radiation burden.
Secondly, the quartile analysis was done for individual
centres. Since the dose values are very much operator
dependant, a finer analysis per centre and per operator
would yield a more detailed set of recommendations for
patient dose optimisation. Unfortunately, some proce-
dures, especially the ones with a heavier physiological
Table 4. Third quartiles (Q3) for TAVI for all seven
cardiology centres (Centre H did not perform any TAVI) and
all dose indicators.
TAVI: Third quartile (Q3)
Centre PKA (Gy cm
2) Ka,r (mGy) FT (min) N
A 114 934 12.1 625
B 128 1337 23.8 1216
C 73 933 8.7 1714
D 153 N/A 29.9 N/A
E 198 N/A 24.0 N/A
F 201 N/A 32.8 N/A
G 153 N/A 15.5 N/A
Switzerland 141 1189 28.4 1011
Centres D through G did not record Ka,r and N.
Table 3. Third quartiles (Q3) for CA 1 PTCA for all eight
cardiology centres and all dose indicators.
CA þ PTCA: Third quartile (Q3)
Centre PKA (Gy cm
2) Ka,r (mGy) FT (min) N
A 150 2300 13.5 1170
B 132 2170 17.9 1820
C 99 1660 12.3 1390
D 113 N/A 23.4 N/A
E 184 N/A 19.3 1930
F 129 1230 20.5 2420
G 148 N/A 16.3 N/A
H 213 N/A 20.8 3530
Switzerland 150 2014 18.1 1527
Centres D, E, G and H did not record Ka,r, and Centres D
and G did not record N.
Table 5. Third quartiles (Q3) for myocardial biopsies for four
cardiology centres (B, D, Fand H).
Myocardial biopsy: Third quartile (Q3)
Centre PKA (Gy cm
2) Ka,r (mGy) FT (min) N
B 13 146 5.2 81
D 9 N/A 5.5 N/A
F 12 106 20.5 6
H 9 N/A 3.4 N/A
Switzerland 12 146 5.9 81
Centres D and H did not record Ka,r nor N.
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burden, such as TAVI, were much less than the vascu-
lar interventions. As a consequence, splitting a lower
number into a higher number of fractions will strongly
reduce the statistical power of the analysis.
Finally, extra care has to be taken on the reliability
of the respective dose indicators, thus implying extra
efforts by medical physicists in the characterisation of
the dose monitors of the respective imaging units.
An interesting solution for the sometimes low number
of interventions might come from local dose collection
software, such as DoseWatch (GE Healthcare, Little
Chalfont, UK), Radimetrics (Bayer Healthcare,
Berlin, Germany) or even open-source software such
as OpenREM (Ed McDonagh, UK). Indeed, this
software allows an all-time full access to the dose in-
formation and a per-operator dose analysis. Although
still expensive, these systems tend to be more and
more used in healthcare facilities.
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Current CT technical have rendered the need for high Z garments obsolete. 
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Abstract 
When performing CT examinations on pregnant patients, great effort should be dedicated 
towards optimising the exposure of the mother and the conceptus. For this purpose, many 
radiology departments use high-Z garments to be wrapped around the patient's lower 
abdomen for out-of-plane organ shielding to protect the foetus. To assess their current 
protection efficiency, we performed a literature review and compared the efficiencies 
mentioned in the literature to Monte-Carlo simulations of CT protocols, for which the overall 
scan length was reduced. We found 11 relevant articles, all of them reporting uterus 
exposure due to CT imaging performed for exclusion of pulmonary embolism, one of the 
leading causes of peripartum deaths in western countries. Uterus doses ranged between 60 
and 660 µGy per examination, and relative dose reductions to the uterus due to high-Z 
garments were between 20-56%. Simulations showed that reducing the scan length by one 
to three centimetres could potentially reduce uterus dose up to 24 % for chest imaging and 
even 47 % for upper abdominal imaging. These dose reductions were in the order of those 
achieved by high-Z garments. However, using the latter may negatively influence the 
diagnostic image quality and even interfere with the automatic exposure control system thus 
*Manuscript
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increasing patient dose if positioned in the primary beam, for example in the overranging 
length in helical acquisition. We conclude that efforts should be concentrated on positioning 
the patient correctly in the gantry and optimising protocol parameters, rather than using high-
Z garments for out-of-plane uterus shielding. 
1. Introduction 
Over the 20th century, X-ray imaging has become an extremely useful diagnostic tool in 
medicine. Since its introduction in the 1970s, computed tomography (CT) has become an 
indispensable imaging tool within numerous clinical facilities. Recently, due to several 
technical and software innovations, the use of CT imaging has increased to represent a non-
negligible proportion of diagnostic examinations using ionising radiation. For example, in 
2013, it represented roughly 10% of all X-ray examinations, for a mean collective dose 
contribution of 70% due to X-ray medical imaging in Switzerland [1]. 
For any X-ray imaging modality, apart from the primary beam, several other sources of 
radiation can expose the patient: tube leakage and patient-induced scattered radiation (see 
Error! Reference source not found.). However, the tube leakage is limited by the International 
Electro-technical Commission (IEC) to a maximum dose rate of 0.1 mGy/h at 1 m from the 
patient, and will be substantially lower than the patient scatter [2]. Several lead and non-lead 
(high Z) based protective garments have been proposed to reduce scattered radiation: 
aprons, skirts and wrap-around drapes. The latter is the most commonly used within 
radiology suites. Currently, high Z garments used on patients for organ shielding outside the 
primary field are often proposed to provide some protection from radiation scattered by the 
table. Indeed, a study by Weber et al., decomposing the different components of scattered 
radiation in CT, found out that the main component of scatter irradiating the patient is 
internally-produced scatter, and that high Z garments are only efficient against radiation 
back-scattered from the table [3]. This implies that the proper use of these drapes is not to 
wrap it around the patient but merely to place it between the table and the patient, although 
many practitioners prefer wrapping the drape around the patient’s lower abdomen. 
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Infants are highly sensitive to ionising radiation [4]. It is therefore of current practice to 
perform the imaging of pregnant women with more consideration. However, the use of out-of-
plane high Z garments in the clinical routine gives rise to many questions within the radiology 
practice, and its application is quite heterogeneous. For example, the mean European usage 
rate of high Z garments for pregnant patients was 46.3%, whereas it rose to 94.5% in North 
America [5]. Furthermore, 25% of practitioners handling high Z garments complained about 
the weight of these garments, with approximately 20% experiencing occupationally-related 
back pain [5]. Within the current legal framework of all European countries, it is of interest to 
wonder whether these protection tools are still of any interest, or if they ought to be safely 
discarded with respect to alternative technical patient protection methods. 
The two purposes of this paper were the following: First, we sought to establish a literature 
review of high Z out-of-plane patient shielding efficiency for uterus dose reduction in CT. 
Then, we compared the respective efficiencies of the shielding items to simple examination 
optimisation techniques using a dedicated Monte-Carlo simulation. We will not discuss in-
plane garments, as these impair the diagnostic quality, as well as the functioning of the AEC 
system, as we will detail further on. 
2. Materials and methods 
2.1. Literature review 
We performed a literature search using the PubMed search engine. Search words were: 
shielding, radiology, computed tomography, uterus, and pregnant patient. Papers published 
before 2006 (older than 10 years) were discarded, to take into account the recent evolution 
of CT imaging, mainly automatic tube current modulation and iterative image reconstruction. 
Papers not citing uterus dose were rejected. 
2.2. Monte-Carlo simulations 
We performed Monte-Carlo simulations to compare the efficiency of dose reduction when 
using high Z garments from data gathered from the literature to the dose sparing to the 
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uterus when optimising the CT examinations by reducing the acquired scan length. We used 
the ImPACT dose calculation spreadsheet [6], version 1.0 (28.08.2009), to simulate standard 
single-phase CT examinations of the upper abdomen (Error! Reference source not found.) and 
the chest (Error! Reference source not found.). Since image quality at a given location is 
intrinsically linked to CTDIvol [7], to optimize the dose while keeping the image quality 
constant we reduced the respective scan lengths by several cm in steps of one cm, while 
maintaining the coverage of the organs of interest. The subsequent absorbed uterus doses 
for each protocol was calculated. The CTDIvol was set to correspond to approximately 10 
mGy, which is the diagnostic reference level (DRL) for a standard chest CT in Switzerland 
[8].  
3. Results 
3.1. Literature review 
We found 11 relevant articles, listed in Error! Reference source not found. [3, 9-18]. All of them 
reported uterus exposure due to CT imaging performed for exclusion of pulmonary embolism 
(PE). Indeed, the risk of venous thromboembolism (VTE) is increased by the haemodynamic 
changes during pregnancy, with a rate of 1.72 per 1000 deliveries [19], and is the sixth 
leading cause of maternal mortality in the US, with 20 to 30% of peripartum deaths due to PE 
[20]. It is thus the main indication of chest CT for pregnant women. Uterus doses, taken as a 
surrogate for foetal exposure, ranged between 60 and 660 µGy per examination. High Z 
garments, wrapped around the waist of the woman, allowed for a relative absorbed dose 
reduction between 20 and 56% to the uterus. 
3.2. Monte-Carlo simulations 
Error! Reference source not found. and Error! Reference source not found. show the results 
obtained by our Monte Carlo simulations for the dose sparing to the uterus for upper 
abdomen and chest CT respectively. Reducing the scan length by one to three centimetres 
can potentially reduce uterus dose up to 24 % for chest imaging and even 47 % for upper 
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abdomen imaging. These dose sparings are in the order of those achieved by high Z 
garments wrapped around the patient (between 20% and 56% dose sparing). Reducing the 
scan length by 1, 2 or 3 cm allows for an absolute uterus dose reduction of respectively 400, 
700 and 900 µGy for upper abdomen CT imaging, while a 3 cm length reduction in a chest 
examination will reduce the uterus dose by about 17 µGy (Error! Reference source not found. 
and Error! Reference source not found.). 
4. Discussion 
The efficiency of high Z garments to protect the uterus of pregnant patients is highly sensitive 
to its actual positioning. According to the extensive modelling study by G. Iball et al. [10], 
there seems to be a linear relationship between the uterus-to-garment edge distance and the 
uterine dose. As such, when the garment edge is placed at the same position as the uterus 
along the main patient axis, the dose reduction is about 10%, whereas it linearly increases 
when sliding the garment closer to the scanned volume (60% decrease with garment edge 
22.5 cm above the uterus), with a uterus dose of 63.3 µGy without any high Z garment. This 
seems to be in correspondence to a further measurement in that same study, where it is 
shown that the uterine dose increases exponentially with scan edge being moved closer to 
the edge of the garment, kept constant at 15 cm above the uterus with respect to the main 
patient axis. 
However, both experiments resulted in a partial irradiation of the anatomy covered by the 
garment. This presents several negative consequences. First, as is shown in a study by 
Dauer et al. [21], a high Z garment (in the present case a male gonadal shield in the primary 
beam) leads to massive photon starvation artefact, that render the images generated at 
those locations hardly useful for any diagnosis. Furthermore, the vast majority of adult CT 
protocols are based on automatic exposure control (AEC). Schematically, the information 
obtained by the scanned projection radiography (SPR) performed before the data acquisition 
is used for the scanned volume planning. It uses the information of patient’s attenuation 
along the main table axis and/or in both postero-anterior and lateral directions, and plans the 
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X-ray tube current accordingly to achieve a pre-defined noise level across the subsequently 
reconstructed images, independently of tissue absorption [22]. This implies that such high Z 
garments, when used, have to be kept outside the primary field, to guarantee images of good 
diagnostic quality, but also avoid a steep increase in patient dose rate when the highly 
absorbing garment is found to be in the primary field. Finally, even if the garment is left 
outside the scanned volume, scan lengths (in helical acquisition) are extended on both ends 
due to over-ranging, a side effect of data interpolation for image reconstruction in helical 
acquisition, which is the case for practically all scans nowadays [23]. This implies that organs 
right next to the planned acquisition volume might be irradiated by the primary beam, even if 
this exposure will not lead to any reconstructed images. This holds true if the protective 
garment is placed right next to the planned volume. Unfortunately, some CT manufacturers 
have recently introduced, a top of SPR-based AEC, ‘on-the-fly’ dose rate correction based on 
the actual dose rates measured directly on the CT detectors during the acquisition [24]. Due 
to this added feature, the dose rate might be unknowingly increased locally, thus increasing 
scattered radiation inside the patient and annihilating the desired effect of the garment. 
Additionally, the efficiency of increasing high Z thickness seems to quickly ‘saturate’. Indeed, 
as described by Iball et al. [10], efficiency rapidly increases between 0 and 3.5 mmPb, and 
seems to remain constant above these values. As such, too heavy garments may be 
detrimental to patient comfort and operator back constraints [16, 18], with no significant gain 
in dose reduction efficiency. 
Furthermore, the increase in the hypothetic lifetime risk of cancer or leukaemia induction in 
the child is in the order of 1 in 170 after a 100 mGy exposure (which is between two and 
three orders of magnitude above the mentioned dose sparing), whereas the overall risk of 
contracting cancer during a lifetime is about 1 in 3, 1 in 5 being the risk for a fatal malignancy 
[25]. Caution may be taken when reducing the scan length for a suspicion of PE, as sudden 
onset of lower chest pain may also be caused, although rarely, by adrenal haemorrhage, 
which can even become life-threatening [26]. As adrenal spontaneous haemorrhage has 
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been recorded as a complication during pregnancy, which can mimic PE symptoms, the 
spearing of few centimetres in the scanned volume could be dangerous. 
Finally, since the demand in CT examinations is steadily increasing, there is a growing 
pressure on medical staff to optimise the time the patient spends within the radiology 
department. In opposition to MRI imaging, the acquisition time of a single – or multiple – CT 
phase(s) is a mere matter of seconds [27]. As such, there is often limited time dedicated per 
CT procedure, implying a pertinent choice among the means of optimisation at the disposal 
of the medical staff. Thus, a proper positioning of the high Z garments for an efficient 
protection will consume time that could be spent to guarantee the overall patient care. 
One limitation of our study is not addressing the topic of in-plane bismuth protections. But, as 
for iterative reconstruction, organ-based modulation is sufficiently widespread in current CT 
imaging that those devices, prone to inducing photon starvation artefacts, are no longer 
deemed relevant for the protection of in-plane anatomy [28, 29]. 
 5. Conclusion 
The expected dose savings from the use of high Z garments may be counterbalanced by the 
optimisation of scan lengths, a parameter immediately accessible by the operator of the unit. 
Although dose savings from high Z garments might seem high (up to 56%), the absolute 
uterine doses delivered outside the primary field are already quite low (a few hundred µGy) 
per examination. In comparison, the efficiency in terms of dose reduction by correctly 
selecting the scan length is similar to the exposure reduction due to high Z garments, without 
the potential adverse effects, especially when using on-line dose rate adjustment. 
To summarise, a thorough justification of the examination [30], optimal patient positioning to 
fully take advantage of the bow tie filter and AEC, the choice of an appropriate clinically 
relevant image quality level and the strict limitation of the scan range will yield uterine dose 
sparing in the order of those expected for well-placed high Z garments, without the latter’s 
downsides. Patient exposure savings by means of optimising the examination length and 
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dose are probably much less time- and energy-consuming. The current main optimisation 
paradigm is adapting the acquisition parameters to the actual clinical demand and clinical 
task [7], that allows for an objective quantification of image quality gain (or loss) with respect 
to patient exposure, especially when using low-dose protocols. Dose sparing by high Z 
garments, albeit coming ‘free of charge’, is only to be expected if no other relevant technical 
or clinical parameter might be optimised, and if no garment is ever placed in the primary field 
of view, including the over-ranging in CT imaging. The current status of CT technology allows 
for drastic dose reductions by correctly using the AEC systems and/or increasing the level of 
iterative reconstruction. For the latter, one should take care as to not finally lose any 
diagnostic information, especially for low contrast detectability [7]. High Z garments may be 
used for psychological protection, even if their absolute efficiencies are quite low [31]. 
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Authors Year 
Type of 
examination 
Type of study 
Type of 
dosimeter 
Comments Reference uterus/foetal dose Efficiency 
Hurwitz et al. 2006 
PA, appendicitis, 
renal stones 
Anthropomorphic 
phantom 
TLD + 
MOSFET 
Uterus dose, no use of 
garments 
Between 240 and 660 µGy N/A 
Iball et al. 2007 PA 
Anthropomorphic 
phantom 
Ionisation 
chamber 
Systematic testing of 
acquisition parameters 
(kV, mA, scan length, 
garment position) 
Between 60 and 500 µGy 
Average: -39.7% 
kVp: [-33% -47%] (0.7 mmPb) 
Pitch: [-41% -45%] (0.7 mmPb) 
Garment posterior: -20% 
Garment around: -40% 
mAs: linear dose variation 
Rotation time: no sign. change 
Collimation: no sign. change 
Iball et al. 2008 PA 
Anthropomorphic 
phantom 
Ionisation 
chamber 
Testing of different 
garment materials, 
proposal of a predictive 
irradiation model 
Between 30 and 190 µGy Between -40% and -55% 
Palmer 2008 PA 
Anthropomorphic 
phantom 
TLD MSc thesis ~210 µGy -56% (0.7 mmPb) 
Doshi et al. 2008 PA 
Anthropomorphic 
phantom 
unknown - Between 60 and 230 µGy 
mA modulation: -10% 
High Z garment: -35% 
5cm shorter scan length: -56% 
Niemann et al. 2010 PA Literature review N/A 
Uterus dose due to CT 
and nuclear medicine for 
pulmonary embolism 
Between 13 and 26 µGy (early pregnancy) 
Between 60 and 100 µGy (late pregnancy) 
N/A 
Danova et al. 2010 Chest CT 
Anthropomorphic 
phantom 
TLD - ~65 µGy 
High Z garment posterior: -26% 
High Z garment around: -34% 
Iball et al. 2010 CT Worldwide survey N/A 
Questionnaire for 
radiographers 
N/A N/A 
Iball et al. 2011 Chest CT 
Anthropomorphic 
phantom 
TLD 
Estimated dose savings 
for multiple organs 
N/A -35% 
Iball et al. 2011 Chest CT Local survey N/A 
Radiographers 
alternatively playing the 
role of the patient 
N/A N/A 
Weber et al. 2015 CT CTDI phantom TLD 
Decomposition of the 
scatter components 
N/A N/A 
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Dose reduction 
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literature due to high Z 
garment 
CTDIvol: 10.4 mGy 
Tension: 120 kV 
Current: 200 mA 
Pitch: 1.375 
Rotation: 0.75 s 
Collimation: 40 mm 
 
32 39 - 
Between -20% and -56% 31 (top) 39 0 % 
29 (bottom) 22 -24 % 
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Table 1: Papers published in the literature, addressing the potential uterine doses and dose 
reductions due to CT examinations. 
 
Table 2: Technical parameters simulated for the chest CT examination. 
 
Table 3: Technical parameters simulated for the upper abdomen CT examination. 
 
Figure 1: Schematic depiction of the components of scatter for a chest CT examination using 
a high Z garment wrapped around the patient's waist. a) External scatter/leakage radiation, 
b) backscatter from the x-ray table, c) internal scatter. 
 
Figure 2: Screenshot of the ImPACT GUI for upper abdomen CT. (a) acquisition volume 
before scan length reduction, (b) acquisition volume after reducing the scan length by 3 cm 
under the liver. 
 
Figure 3: Screenshot of the ImPACT GUI for chest CT. (a) acquisition volume before scan 
length reduction, (b) acquisition volume after reducing the scan length by 1 cm above the 
lung apex, (c) acquisition volume after reducing the scan length by 3 cm under the lung base. 
Table and figure captions
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Résumé – Précédemment fixée à 150 mSv an−1, la CIPR recommande dorénavant de limiter la dose équivalente au
cristallin à 20 mSv an−1. En neuroradiologie interventionnelle pédiatrique, l’irradiation du cristallin de l’opérateur
peut être majorée par l’utilisation d’un système de radioscopie biplan et par la plus grande proximité du médecin avec
le patient. En pratique, l’eﬃcacité des lunettes plombées dépend de nombreux facteurs. La présente étude traite ces
deux aspects. Premièrement, la dose au cristallin d’un neuroradiologue a été mesurée, durant 12 interventions, à l’aide
de 36 TLD placés sur son bonnet chirurgical. Dans un deuxième temps, en vue de déterminer l’eﬃcacité des lunettes
plombées, des mesures ont été eﬀectuées en reproduisant les conditions cliniques. Un détecteur a été placé sur l’œil
gauche d’un fantôme représentant l’opérateur. Quatre paires de lunettes plombées ont été sélectionnées en vue de tester
diﬀérents paramètres. Pour les 12 interventions, un équivalent de dose individuel Hp(0,07) de 457 μSv pour le cristallin
côté tube a été obtenu. Cette étude démontre un ratio dose au cristallin / PDS 5 fois plus élevé que lors d’interventions
réalisées chez des patients adultes. La dose au cristallin peut être réduite d’environ un facteur 3 avec l’utilisation de
lunettes plombées adaptées. Le modèle de lunettes le plus couvrant atténue jusqu’à 50 % de plus qu’un modèle moins
couvrant. L’ajout d’une protection latérale permet d’augmenter l’atténuation jusqu’à 13 % comparé au même modèle
sans protection latérale.
Abstract – Staﬀ exposure in pediatric interventional neuroradiology: focus on the operator’s eye
lens. Previously at 150 mSv year−1, the ICRP now recommends limiting the equivalent dose to the eye lens to
20 mSv year−1. For pediatric interventional neuroradiology, the exposure of the operator’s eye lens may be increased by
the use of a biplane fluoroscopy system and by the proximity of the physician to the patient. In practice, the eﬃciency
of leaded glasses depends on many factors. This study addresses both aspects. First, the eye lens dose of a neuroradi-
ologist was measured during 12 procedures using 36 TLDs placed on his surgical cap. Secondly, in order to determine
the eﬃciency of leaded glasses, measurements were carried out by reproducing the clinical conditions. A detector was
placed on the left eye of a phantom representing the operator. Four pairs of leaded glasses were selected to test various
parameters. During the 12 procedures, an individual dose equivalent Hp(0.07) of 457 μSv was obtained for the eye lens
closest to the tube. This study shows an eye lens dose to DAP ratio 5 times higher than for procedures performed on
adult patients. The eye lens dose might be reduced by a factor of approximately 3 with the use of appropriate leaded
glasses. The eyewear model with the most coverage reduces the dose by up to 50% more than the model with the least
coverage. The addition of lateral protection increases the attenuation by up to 13% compared with the same model
without side protection.
Keywords: radiation protection / leaded glasses / radioscopy / eye lens dose / neuroradiology / pediatrics
1 Introduction
Anciennement de 150 mSv an−1, la Commission in-
ternationale de protection radiologique (CIPR) recommande
dorénavant de limiter la dose équivalente au cristallin à
 regis.lecoultre@hesav.ch
20 mSv an−1. Cette modification conduit à de nombreuses pré-
occupations concernant l’irradiation du cristallin du personnel
médical. Alors que leur eﬃcacité est clairement démontrée, le
port de lunettes plombées n’est pourtant pas suﬃsamment ap-
pliqué en routine. L’étude ORAMED met ainsi en évidence
que 24 % des opérateurs considérés sont susceptibles de dé-
passer la nouvelle limite de 20 mSv an−1. De plus, seuls 31 %
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des opérateurs en radiologie interventionnelle portent systéma-
tiquement des lunettes de protection (Vanhavere et al., 2012).
En radiologie interventionnelle pédiatrique, l’exposition
de l’opérateur peut être d’autant plus conséquente du fait de
l’utilisation fréquente d’un système de radioscopie biplan et
de la plus grande proximité du médecin avec le patient (Vaño
et al., 2009).
En radioprotection, l’eﬃcacité des diﬀérents moyens de
protection dépend de nombreux paramètres. Pour l’exposition
du cristallin, le choix du modèle de lunettes plombées utilisées
influence grandement sa protection et devrait être eﬀectué de
manière éclairée.
Cette étude porte sur ces deux thématiques intrinsèque-
ment liées. Tout d’abord, la dose au cristallin d’un neuroradio-
logue exerçant en pédiatrie a été mesurée au moyen de dosi-
mètres thermoluminescents (TLD) placés à diﬀérents endroits
sur un bonnet chirurgical, mesurant ainsi l’exposition du cris-
tallin en l’absence de lunettes de protection. Ce praticien uti-
lisant systématiquement des lunettes plombées, il a également
été choisi de se pencher sur l’eﬃcacité de ces dernières ainsi
que les diﬀérents paramètres d’influence. Pour ce faire, quatre
paires diﬀérentes ont été évaluées en reproduisant les condi-
tions cliniques observées durant la première partie de l’étude.
L’apport aux travaux existants de cette étude est l’articu-
lation dans un contexte clinque bien délimité de la probléma-
tique de l’évaluation de la dose au cristallin conjuguée avec
la problématique de l’eﬃcacité des lunettes plombée portées
en pratique. Les résultats présentés ne remettent nullement
en cause les connaissances amenées par les travaux existants,
mais vise à apporter un éclairage du terrain, une étude de cas,
de la complexité inhérente aux situations de travail rencontrées
en radiologie interventionnelle.
2 Matériel et méthode
2.1 Mesure de la dose au cristallin
Pour ces mesures, 36 détecteurs thermo-luminescentes
(TLD) de type LiF :Mg,Cu,P (MCP-N, TLD Poland, Pologne,
http://www.tld.com.pl/tld/mcpns.html) ont été répartis sur un
bonnet chirurgical. Ils ont été placés à raison de 12 dosi-
mètres positionnés respectivement au niveau de l’œil gauche,
au centre et au niveau de l’œil droit de l’opérateur (Figure 1).
Ce dernier a porté le bonnet muni des détecteurs pendant 12
interventions de neuroradiologie pédiatrique.
Sur les 12 interventions, 10 ont été réalisées sur un sys-
tème biplan et 2 sur un système monoplan. Le produit dose-
surface (PDS) de chaque intervention a été relevé directement
sur l’installation de radioscopie. L’installation a été utilisée se-
lon les réglages standards utilisés en neuroradiologie interven-
tionnelle pédiatrique dans l’institution. La modulation automa-
tique de dose (AEC, automatic exposure control) contrôlait le
débit au patient – et ainsi le PDS – tout au long de la procé-
dure. Les PDS ont été relevés tels qu’indiqué par l’installation
de radioscopie. L’étalonnage du système de mesure du PDS de
l’installation a été eﬀectué conformément à la législation en
vigueur.
Les TLD nécessitant d’être lus relativement rapidement
après la première irradiation, les 12 interventions ont été frac-
tionnées en 3 mesures, comprenant chacune 4 interventions.
Les dosimètres ont été utilisés sur une période maximale de
6 semaines entre l’étalonnage et la lecture. La lecture des do-
simètres par l’Institut de Radiophysique de Lausanne sur un
lecteur Harshaw s’est eﬀectuée au moins 24 h après la der-
nière irradiation, mais dans le mois qui l’a suivie, permettant
ainsi à la réponse de se stabiliser ainsi qu’il est d’usage pour
la dosimétrie TLD. Il faut noter qu’il est également important
de procéder à une lecture rapide des TLD MCP suite à leur
« mise à zéro » afin d’éviter que les faibles doses mesurées ne
soient cachées par l’incertitude sur le bruit de fond. L’étalon-
nage de la chaîne de lecture des TLD est traçable à un éta-
lon primaire selon la législation suisse en vigueur. La réponse
des TLD est exprimée en termes de Hp(0,07), leur étalonnage
initial eﬀectué au Co-60 étant corrigé par un facteur corres-
pondant à un champ de rayonnement X d’énergie moyenne
inférieure à 100 keV. Un étalonnage en termes de Hp(3) plu-
tôt que Hp(0,07) aurait probablement été plus adéquat, mais
l’institut en question n’oﬀre pour l’heure pas encore cette pos-
sibilité. L’utilisation du Hp(0,07) à la place du Hp(3) reste tou-
tefois acceptable dans les conditions de mesure de la radiolo-
gie interventionnelle comme démontré dans l’étude ORAMED
(Vanhavere et al., 2012).
Dans la suite de l’article, la dénomination suivante est uti-
lisée : mesure 1 = interventions 1–4 ; mesure 2 = interventions
5–8 ; mesure 3 = interventions 9–12.
2.2 Efficacité des lunettes plombées
Les mesures d’eﬃcacité des lunettes plombées ont été réa-
lisées en reproduisant les conditions cliniques observées du-
rant la mesure de la dose au cristallin. À partir de données
relevées durant les interventions, la position et l’angulation
des tubes, la hauteur de la table d’examen ainsi que les dif-
férents paramètres d’acquisitions ont alors été déterminés. Un
dosimètre électronique (Unfors NED, http://www.rosalina.in/
Unfors/ned_sensorchar.pdf) étalonné en termes de Hp(0,07),
deux fantômes anthropomorphes adultes représentant respec-
tivement le patient et l’opérateur ainsi que quatre diﬀérentes
paires de lunettes plombées ont été utilisés. Afin d’être conser-
vatif, c’est donc un fantôme de tête anthropomorphe adulte qui
a été utilisé pour simuler le diﬀusé généré par un patient pé-
diatrique, le crâne atteignant assez rapidement son diamètre de
l’âge adulte. Le dosimètre Unfors NED n’était, lui, pas ratta-
ché à une chaîne métrologique conformément à la législation
en vigueur. Néanmoins, un étalonnage en conditions contrô-
lées par le même institut ayant fourni les TLD a permis de
vérifier la stabilité ainsi que la reproductibilité des mesures.
Les résultats étant indiqués en valeurs relatives, les facteurs
d’étalonnage se simplifient dans les équations.
Les lunettes ont été choisies afin de tester diﬀérents para-
mètres pouvant influencer leur eﬃcacité. Il a été montré que la
surface couverte par les lunettes plombées jouait un rôle im-
portant dans la protection du cristallin. De même, l’eﬃcacité
des lunettes plombées est fortement influencée par l’orienta-
tion de la tête de l’opérateur par rapport à la source de rayon-
nement diﬀusé. En eﬀet, l’angle entre l’opérateur et la source
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Figure 1. Répartition et disposition des diﬀérents dosimètres.
Distribution and position of diﬀerent dosimeters.
 
Figure 2. Orientation de l’opérateur par rapport à la source de rayonnement diﬀusé.
Operator orientation with respect to the source of scattered radiation.
de rayonnement diﬀusé peut varier de 45◦ à 90◦ en fonction du
type d’intervention ou de la taille du patient (Figure 2). À 90◦,
le modèle le moins couvrant présente un facteur d’atténuation
du rayonnement diﬀusé de 1,4 par rapport aux deux autres mo-
dèles testés, qui présentent respectivement des facteurs de 2,6
et 3,9 selon les paires de lunettes (Sturchio et al., 2013).
L’Agence Internationale de l’Énergie Atomique mentionne
également que la surface couverte par les lunettes plombées est
un facteur important et que les conditions d’irradiation, ainsi
que l’orientation par rapport à l’opérateur, doivent être prises
en compte dans le choix des lunettes de protection (IAEA,
2013).
À partir de ces données, il a été choisi de comparer un mo-
dèle standard avec un modèle plus couvrant afin de mettre en
évidence la contribution de la surface des verres dans la pro-
tection du cristallin.
Afin de connaître l’apport réel d’une protection latérale,
deux lunettes d’un même modèle ont été testées, équipées ou
non d’une protection latérale de 0,5 mm d’équivalent de plomb
(mmEqPb).
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Tableau 1. Caractéristiques des lunettes sélectionnées.
Characteristics of the selected glasses.
Lunettes n◦ Modèle Épaisseur Protection Surface max. du Image
EqPb [mmEqPb] latérale verre [cm2]
1 Sport 0,75 Oui (05 mmPb) 18
2 Sport 0,75 Non 18
3 Classique 0,5 Non 21
4 Classique 0,75 Non 21
Tableau 2. PDS et Kerma air cumulé des 12 interventions.
DAP and cumulative air Kerma of 12 procedures.
Intervention PDS cumulé Kerma air cumulé Kerma air cumulé Kerma air cumulé
[mGy cm2] tube frontal [mGy] tube latéral [mGy] [mGy] Système monoplan
1 27 964 331,7
2 21 787 258,3 71,7
3 22 288 236,6 98,2
4 18 367 250,2 78,5
5 50 641 482,8
6 15 673 191,3 76,8
7 52 290 351,2 151,8
8 42 675 477,8 125,3
9 70 122 512,7 261,6
10 26 282 222,8 114,0
11 26 805 101,7 111,4
12 24 987 222,7 134,3
En eﬀet, l’épaisseur d’équivalent de plomb n’est pas un pa-
ramètre fiable à des fins d’estimation d’eﬃcacité des lunettes
plombées, notamment à cause de l’importante contribution du
rétrodiﬀusé ainsi que des potentiels rayons non atténués arri-
vant par le côté participant à l’irradiation du cristallin (Sturchio
et al., 2013). De ce fait, il a été décidé de tester ce paramètre
en utilisant deux paires de lunettes similaires, mais présentant
une fois 0,5 mmEqPb et une fois 0,75 mmEqPb. Le choix des
lunettes s’est donc eﬀectué selon plusieurs critères distincts :
l’influence de la surface protectrice, la contribution d’une pro-
tection latérale et l’influence de l’épaisseur d’équivalent de
plomb des verres.
Les 4 paires de lunettes choisies ont été fournies par la
société Scanflex-SIRAD :
– 2 paires de lunettes du modèle « spor » Ultralite 9941 (Pro-
tech, USA) avec et sans protection latérale. La protection
latérale est composée ’une petite plaque ’une épaisseur de
0,5 mmEqPb.
– 2 autres paires de lunettes du modèle « classiqu » Sx-0.5 et
Sx-0.75 (APX, France) avec 0,5 et 0,75 mmEqPb.
Le Tableau 1 liste les diﬀérentes paires lunettes utilisées pour
cette étude, les numéros par lesquelles elles sont identifiées
dans la suite du document ainsi que leurs caractéristiques.
Pour commencer, la paire de lunettes n◦ 1 a été placée sur
le fantôme anthropomorphe représentant l’opérateur. Le pa-
tient simulé a été irradié, en mode graphie, jusqu’à obtenir
450 μSv au niveau de l’œil gauche de l’opérateur. Le temps
d’exposition nécessaire a été relevé, puis l’opération a été répé-
tée avec les 3 autres paires de lunettes, en utilisant strictement
les mêmes conditions d’irradiation. C’est le temps d’irradia-
tion qui a servi de référence.
L’eﬃcacité des lunettes plombées a été testée pour des ac-
quisitions avec le tube frontal et latéral séparément, ainsi que
pour une acquisition réalisée en biplan. Chaque mesure a été
réalisée pour les deux orientations de la tête de l’opérateur, à
45◦ et 90◦ par rapport à la source.
Chaque mesure a été réalisée deux fois et l’atténuation des
lunettes plombées a été calculée par le rapport des doses avec
et sans protection plombée. Le résultat final a été déterminé par
les valeurs obtenues moyennées sur les deux mesures. L’expo-
sition du cristallin est exprimée en normalisant la dose cumu-
lée par le PDS du patient et exprimé en μSv/(Gy cm2), un rap-
port utilisé de manière standard en radiologie interventionnelle
et nommé facteur d’exposition (Schueler et al., 2006).
3 Résultats
3.1 Mesure de la dose au cristallin
La moyenne des résultats des trois diﬀérentes mesures a
premièrement été eﬀectuée. Le PDS cumulé des diﬀérentes in-
terventions est résumé dans le Tableau 2. Le Tableau 3 présente
les moyennes des équivalents de dose individuelle Hp(0,07)
des diﬀérentes mesures des yeux en fonction de leur locali-
sation ainsi que les facteurs d’exposition obtenus en divisant
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Tableau 3. Moyenne des équivalents de dose individuel Hp(0,07) au niveau des yeux en fonction de la localisation des TLD, ainsi que les
facteurs d’exposition du cristallin obtenus en divisant le cumul de dose TLD par le cumul de PDS des trois groupes d’interventions tels que
listés dans le Tableau 2. L’incertitude élargie (k = 2) liée au TLD s’élève à 11 %.
Average individual dose equivalents Hp(0.07) of the eyes as a function of the location of the TLDs, and the eye lens exposure factors obtained
by dividing the cumulative TLD doses by the respective cumulative DAP of the three groups of procedures, as listed in Table 2. The expanded
uncertainty (k = 2) related to the TLD is 11%.
Emplacement Mesure n◦ Moyenne Hp(0,07) Facteur d’exposition
des TLD [µSv] (CI 95 %) [µSv/(Gy cm2)]
Gauche
1 141 ± 7 (136, 146) 12
2 134 ± 8 (129, 139) 12
3 218 ± 10 (212, 224) 19
1 127 ± 7 (123, 131) 0,8
Centre 2 115 ± 9 (109, 121) 0,7
3 178 ± 12 (171, 185) 11
Droite
1 51 ± 16 (41, 61) 0,3
2 28 ± 9 (22, 34) 0,2
3 37 ± 8 (32, 42) 0,2
Moy. gauche 457 ± 27 12
Moy. droite 268 ± 30 0,6
le cumul de Hp(0,07) des trois groupes d’interventions par le
cumul des PDS des interventions résumées dans le Tableau 2.
En vue d’estimer la dose reçue par le cristallin de l’œil
gauche, une moyenne des valeurs des TLD placés sur la gauche
avec ceux placés au centre a été eﬀectuée. Pour le cristallin de
l’œil droit, c’est la moyenne des TLD placés à droite avec ceux
du centre qui a été eﬀectuée.
La dose totale au cristallin a ensuite été déterminée par la
somme des moyennes des trois mesures. L’équivalent de dose
individuelle Hp(0,07) obtenu est de 457 ± 27 μSv pour l’œil
gauche et de 268 ± 30 μSv pour l’œil droit.
3.2 Efficacité des lunettes plombées
Afin de pallier une exposition du cristallin potentielle-
ment élevée au cours d’une carrière, la protection oﬀerte par
des lunettes plombées est un atout non négligeable en neuro-
radiologie interventionnelle. Ainsi, les résultats des mesures
concernant l’évaluation de l’eﬃcacité des diﬀérentes paires
de lunettes plombées sont indiqués dans le Tableau 4 selon
l’orientation de la tête de l’opérateur, pour chaque paire de lu-
nettes ainsi que vous chaque tube utilisé (tube frontal, latéral
et biplan).
4 Discussion
4.1 Mesure de la dose au cristallin
4.1.1 Dose par intervention et « spécificité »
des interventions pédiatriques
Il a été obtenu respectivement 38 ± 2 μSv par procé-
dure pour l’œil côté tube et 22 ± 3 μSv par procédure
pour l’œil opposé. Ces valeurs représentent une irradiation
du cristallin sans lunettes plombées mais avec l’utilisation de
moyens de protection structurels (écran mobile 0,5 mmEqPb,
tablier0,5 mmEqPb et protège thyroïde 0,5 mmEqPb). Sur un
total de 104 procédures pédiatriques eﬀectuées en 2014 sur
cette installation, cela équivaudrait à un total théorique de
4,0 mSv an−1 pour l’œil côté tube et 2,3 mSv an−1 pour l’œil
opposé pour la seule neuroradiologie pédiatrique.
Les interventions pédiatriques peuvent être considérées
comme étant plus irradiantes que les interventions chez les
adultes, notamment à cause de l’utilisation d’une installation
de radioscopie biplan et de la proximité de l’opérateur vis-à-
vis de la source, la moyenne d’âge des patients étant de 3 ans
pour cette étude (i.e. le patient). Cependant, la procédure étu-
diée requérait une durée d’irradiation relativement faible, s’ex-
pliquant par le fait qu’elle est réalisée fréquemment dans cet
établissement hospitalier et que les patients ne présentent pas,
en règle générale, de comorbidité associée.
Pour une procédure pédiatrique fréquente, l’opérateur re-
çoit 38 μSv à son œil situé du côté tube, ce qui correspond aux
résultats délivrés dans l’étude ORAMED, réalisée chez des pa-
tients adultes (40 μSv pour des procédures de type angiogra-
phie cérébrale).
Le PDS de chaque intervention a été relevé durant la ré-
colte de données. Une comparaison entre le PDS moyen des
interventions pédiatriques avec les valeurs publiées dans le
rapport ORAMED montre que la dose au cristallin côté tube
est similaire alors que le PDS des interventions pédiatriques
est 5 fois plus faible. En eﬀet, pour les angiographies céré-
brales, le PDS moyen mesuré durant l’étude ORAMED est
de 126 Gy cm2 (Vanhavere et al., 2012) alors que, dans cette
étude, le PDS moyen de l’ensemble des interventions pédia-
triques d’une année s’élève à 29 Gy cm2 par procédure.
4.1.2 Différence entre les deux yeux
Dans cette situation, qui est similaire à ce qui peut se re-
trouver dans la littérature, les tubes RX se trouvent sur la
gauche de l’opérateur. Une diﬀérence importante est consta-
tée entre la dose mesurée à l’œil côté tube (œil gauche) par
rapport à l’autre œil.
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Tableau 4. Atténuation des lunettes plombées en fonction de l’orientation de l’opérateur et du tube utilisé.
Attenuation of the leaded glasses as a function of the operator’s orientation and the tube used.
Atténuation en fonction de l’orientation de la tête de l’opérateur
Tube utilisé Lunettes n◦ Moyenne [%] Écart type [%]90◦ 45◦ 90◦ 45◦
Frontal
1 85 118 0,8 0,4
2 4,0 107 29 0,6
3 398 237 0,2 19
4 536 284 0,7 12
1 434 618 0,1 0,2
Latéral 2 319 521 0,5 0,1
3 69,0 669 0,1 0,3
4 749 674 0,1 0,1
Biplan
1 235 346 0,2 0,6
2 139 234 0,9 0,3
3 522 448 0,5 0,5
4 631 436 0,1 0,6
Selon Chong et al. (2000), la raison d’une telle diﬀérence
réside dans l’orientation de la tête de l’opérateur selon la dis-
position des écrans de visualisations.
Il est intéressant de noter que la diﬀérence entre les deux
yeux mériterait d’être prise en compte dans l’estimation de la
dose reçue par le cristallin. Il serait alors conservatif de consi-
dérer prioritairement l’œil côté tube.
4.1.3 Facteurs d’exposition Hp(0,07)/PDS
Le calcul des facteurs d’exposition (rapport entre Hp(0,07)
mesurée au niveau du cristallin [μSv] et le PDS de l’interven-
tion [Gy cm2], Schueler et al., 2006) met également en évi-
dence une diﬀérence entre l’œil côté tube (gauche) et l’œil
opposé, qui est due à la diﬀérence de dose mesurée au ni-
veau des deux yeux. Le facteur pour l’œil gauche s’élève à
1,2 μSv/(Gy cm2) contre 0,7 μSv/(Gy cm2) pour l’œil droit.
Rappelons que ces facteurs d’exposition sont représentatifs
d’une situation dans laquelle l’opérateur ne porte pas de lu-
nettes plombées mais utilise un écran de protection latéral.
En multipliant ces facteurs d’exposition par le PDS moyen
de 29 Gy cm2 par intervention pour les 104 interventions
pédiatriques en 2014, nous obtenons respectivement 3,6 et
1,8 mSv an−1 pour l’œil gauche et droite, donc à peu près les
mêmes résultats qu’à la Section 4.1.1.
Ces résultats sont corroborés par ceux utilisés par l’IAEA.
En eﬀet, cette dernière préconise un facteur de conversion de
1 μSv/(Gy cm2) dans une situation similaire à cette étude (avec
écran latéral et sans lunettes plombées). Sans moyen de pro-
tection, l’IAEA préconise un facteur de 10 μSv/(Gy cm2), ce
qui démontre l’importance de l’utilisation de l’ensemble des
moyens de protection.
4.2 Efficacité des lunettes plombées
Après avoir mesuré la dose au cristallin durant les inter-
ventions, il est intéressant de se pencher sur l’eﬃcacité des lu-
nettes plombées. L’étude ORAMED souligne que seuls 31 %
des opérateurs en radiologie interventionnelle portent systéma-
tiquement des lunettes de protection. De ce fait, il est important
de pouvoir quantifier leur eﬃcacité. Un équivalent de dose au
cristallin de 4 mSv an−1 est certes faible, mais elle ne résulte
que des examens pédiatriques, qui représentent seulement une
faible proportion de l’activité habituelle d’un clinicien.
Dans les chapitres précédents, une variabilité de dose rela-
tivement importante est constatée entre les deux yeux. Notons
ici que, pour l’évaluation de l’eﬃcacité des lunettes plombées,
le détecteur a été placé sur l’œil du fantôme anthropomorphe
côté tube. Les conclusions développées dans les chapitres sui-
vants sont donc conservatives et valables uniquement pour
l’œil côté tube. Il est toutefois probable que l’eﬃcacité des
lunettes plombées ne sera pas identique entre l’œil côté tube
et l’œil opposé. Afin de diminuer le temps d’exposition néces-
saire pour les mesures, l’écran de protection latéral n’a pas été
utilisé.
4.2.1 Contribution de l’épaisseur d’équivalent de plomb
Afin d’évaluer la contribution de l’épaisseur d’équivalent
de plomb, la comparaison de l’eﬃcacité a été eﬀectuée avec
les lunettes n◦ 2, modèle sport possédant 0,75 mmEqPb et
n◦ 3, modèle classique possédant 0,5 mmEqPb. Les résultats
démontrent que la paire de lunettes n◦ 3 (modèle classique)
est plus eﬃcace que la n◦ 2 (modèle sport), alors qu’elle pos-
sède une plus faible épaisseur d’équivalent de plomb. En eﬀet,
pour le tube frontal, la paire n◦ 3 atténue le rayonnement in-
cident de 39,8 ± 2 % (tête à 90◦ ) contre 4,0 ± 2,9 %. Pour
le tube latéral et les deux tubes en simultané, c’est respective-
ment 69,0 ± 0.1 % (contre 31,9 ± 0,5 % pour la paire n◦ 2)
et 52,2 ± 0,5 % (contre 13,9 ± 0,9 %) de réduction en dose.
La tendance est similaire, quoique moins marquée, pour la tête
orientée à 45◦. Ceci confirme l’hypothèse stipulant que l’épais-
seur d’équivalent de plomb n’est pas considérée comme un bon
indicateur en vue de déterminer l’eﬃcacité d’un modèle de lu-
nettes plombées (Figure 3).
Dès lors, il s’avérait intéressant de savoir si augmenter
l’épaisseur d’équivalent de plomb dans un même modèle de
lunettes augmenterait leur eﬃcacité. Pour ce faire, une com-
paraison a été faite avec les lunettes n◦ 3 et 4, toutes deux
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Figure 3. Influence de la diﬀérence des épaisseurs d’équivalent de plomb.
Influence of the diﬀerent lead equivalent thicknesses.
du modèle classique mais possédant respectivement 0,5 et
0,75 mmEqPb. Les résultats démontrent que les lunettes pos-
sédant 0,75 mmEqPb protègent davantage le cristallin lorsque
la tête de l’opérateur est positionnée à 90◦ , orientation pré-
pondérante pour les interventions pédiatriques, notamment à
cause de la proximité de l’opérateur avec le patient. En eﬀet,
pour les tubes frontal, latéral et pour les deux tubes combinés,
la protection oﬀerte par la paire n◦ 4 est de respectivement 53,6
± 0,7 % (contre 39,8 ± 0,2 % pour la paire n◦ 3), 74,9 ± 0,1 %
(contre 69,0 ± 0,1 %) et 63,1 ± 0,1 % (contre 52,2 ± 0,5 %).
À 45◦, l’épaisseur d’équivalent de plomb n’a par contre pas
d’influence majeure sur l’eﬃcacité des lunettes.
4.2.2 Contribution de la protection latérale
Les deux paires de lunettes du modèle sport (lunettes n◦ 1
et 2) ont été testées, mais une seule possédait une protection la-
térale (lunettes n◦ 1). La contribution de cette dernière est clai-
rement démontrée. En eﬀet, la protection oﬀerte pour la tête
à 90◦ et les tube frontal, latéral et les deux tubes combinées,
est de respectivement 8,5 ± 0,5 % pour la paire n◦ 1 (contre
4,0 ± 2,9 % pour la paire n◦ 2), 43,4 ± 0,1 % (contre 31,9 ±
0,5 %) et 23,5 ± 0,2 % (contre 13,9 ± 0,9 %). Lorsque le tube
frontal est utilisé, la diﬀérence d’eﬃcacité est plus marquée à
90◦ qu’à 45◦ . La lunette munie d’une protection latérale est
ainsi plus eﬃcace dans toutes les situations. Ces résultats dé-
montrent que l’ajout d’une protection latérale sur la monture
est bénéfique. En eﬀet, le gain d’atténuation peut aller jusqu’à
13 % pour le modèle possédant une protection latérale.
4.2.3 Contribution de la surface couverte
Formellement, c’est davantage l’angle solide couvert entre
le centre du cristallin et les bords du verre qui joue un grand
rôle dans la radioprotection. Nous ferons cependant l’hypo-
thèse que la distance entre les verres et le cristallin est iden-
tique entre les diﬀérents modèles. C’est donc la surface du
verre qui sera déterminante pour la suite de l’évaluation. Les
deux modèles qui ont été testés présentent une légère diﬀé-
rence au niveau de la surface maximale du verre. En eﬀet, le
modèle sport possède des verres de 18 cm2 alors que ceux du
modèle classique sont de 21 cm2. Notons tout de même que
ces valeurs sont approximatives les verres ayant été considé-
rés comme rectangulaires pour simplifier l’estimation de leur
surface. Par conséquent, le modèle « classique » (lunettes n◦ 3
et 4) couvre d’avantage l’œil que le modèle « sport » (lunettes
n◦ 1 et 2). L’importance de la surface couverte est bien dé-
montrée. Les lunettes les plus couvrantes sont plus eﬃcaces
dans toutes les situations. La Figure 4 compare le modèle
sans protection latérale avec le modèle plus couvrant possé-
dant la même épaisseur d’équivalent de plomb. Il est possible
de constater que la diﬀérence d’eﬃcacité est beaucoup plus
marquée à 90◦ (54 % contre 4 %, 75 % contre 32 % et 63 %
contre 14 % de réduction de dose pour les tubes frontal, latéral
et la combinaison des deux tubes) qu’à 45◦ (28 % contre 11 %,
67 % contre 52 % et 44 % contre 23 % pour ces mêmes tubes).
Ceci est probablement dû au fait qu’à 90◦, l’irradiation du cris-
tallin par la partie latérale de l’œil est majorée, le plan d’inci-
dence des rayons X diﬀusés étant quasiment tangent au verre
principal. Il est donc extrêmement important d’opter pour une
paire de lunettes minimisant au maximum l’espace « libre »
entre l’opérateur et la lunette, et particulièrement lorsque ce
dernier est amené à détourner la tête (tête à 90◦).
Sturchio et al. (2013) ont eux aussi comparé un modèle
« sport » avec un modèle « classique » plus couvrant, et dé-
montrent également qu’une paire de lunettes plus couvrante
possède une meilleure eﬃcacité. Ceci permet non seulement
de soutenir l’hypothèse de cette étude, mais aussi de penser
que ces résultats sont transposables à des modèles diﬀérents
de ceux que testé dans cette étude (Sturchio et al., 2013).
5 Conclusion
La radiologie interventionnelle pédiatrique est un domaine
particulièrement irradiant pour l’opérateur, avec un ratio dose
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Figure 4. Influence de la surface couverte.
Influence of the covered area.
au cristallin / PDS 5 fois plus élevé que lors d’interventions
réalisées chez des patients adultes (McVey et al., 2013). Bien
que la pédiatrie représente généralement une faible partie de
la charge de travail globale des neuroradiologues intervention-
nistes, cette dernière nécessite néanmoins d’être prise sérieu-
sement en compte, compte tenu de son caractère particulière-
ment irradiant.
Un moyen eﬃcace pour réduire la dose au cristallin ré-
side dans l’utilisation adéquate de moyens de radioprotection.
Parmi ceux-ci, les lunettes plombées permettent d’atténuer jus-
qu’à 75 % de la dose au cristallin. Il a été mis en évidence que
l’eﬃcacité de ces dernières était grandement tributaire de cer-
tains paramètres, le plus important étant la surface couvrante,
dont l’eﬀet est plus marqué que la simple équivalence d’épais-
seur de plomb dans le verre à géométrie égale. De plus, l’ajout
d’une protection latérale sur la monture des lunettes est bé-
néfique pour réduire l’irradiation du cristallin en augmentant
simultanément la surface couvrante ainsi qu’en réduisant le
rayonnement avec un grand angle d’incidence.
Le positionnement des écrans de visualisation joue éga-
lement un rôle important dans la protection du cristallin. En
eﬀet, l’angle entre la tête de l’opérateur et la source de rayon-
nement diﬀusé influence grandement la dose au cristallin, prin-
cipalement celle de l’œil côté tube.
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Table 3. Moyenne des équivalents de dose individuel Hp(0,07) au niveau des yeux en fonction de la localisation des TLD, ainsi que les facteurs
d’exposition du cristallin obtenus en divisant le cumul de dose TLD par le cumul de PDS des trois groupes d’interventions tels que listés dans
le Tableau 2. L’incertitude élargie (k = 2) liée au TLD s’élève à 11 %.
Average individual dose equivalents Hp(0.07) of the eyes as a function of the location of the TLDs, and the eye lens exposure factors obtained
by dividing the cumulative TLD doses by the respective cumulative DAP of the three groups of procedures, as listed in Table 2. The expanded
uncertainty (k = 2) related to the TLD is 11%.
Emplacement Mesure Moyenne Hp(0,07) Facteur d’exposition
des TLD n◦ [µSv] (CI 95 %) [μSv] Sv/(Gy cm2)]
Gauche
1 141 ± 7 (136, 146) 1,2
2 134 ± 8 (129, 139) 1,2
3 218 ± 10 (212, 224 1,9
1 127 ± 7 (123, 131) 0,8
Centre 2 115 ± 9 (109, 121) 0,7
3 178 ± 12 (171, 185 1,1
Droite
1 51 ± 16 (41, 61) 0,3
2 28 ± 9 (22, 34 0,2
3 37 ± 8 (32, 42 0,2
Moy. gauche 457 ± 27 1,2
Moy. droite 268 ± 30 0,6
Table 4. Atténuation des lunettes plombées en fonction de l’orientation de l’opérateur et du tube utilisé.
Attenuation of the leaded glasses as a function of the operator’s orientation and the tube used.
Atténuation en fonction
de l’orientation de la tête
de l’opérateur
Tube utilisé Lunettes n◦ Moyenne [%] Écart type [%]90◦ 45◦ 90◦ 45◦
Frontal
1 8,5 11,8 0,8 0,4
2 4,0 10,7 2,9 0,6
3 39,8 23,7 0,2 1,9
4 53,6 28,4 0,7 1,2
1 43,4 61,8 0,1 0,2
2 31,9 52,1 0,5 0,1
Latéral 3 69,0 66,9 0,1 0,3
4 74,9 67,4 0,1 0,1
Biplan
1 23,5 34,6 0,2 0,6
2 13,9 23,4 0,9 0,3
3 52,2 44,8 0,5 0,5
4 63,1 43,6 0,1 0,6
 regis.lecoultre@hesav.ch
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i.org/1access (RFA), right radial access (RRA), and left radial access (LRA) during coronary
angiography (CA) and percutaneous coronary intervention (PCI). Because of an increased
incidence of long-term malignancy in interventional cardiologists, operator radiation
exposure is of rising concern. This prospective study included all consecutive patients who
underwent elective or emergency CA – PCI from September 2014 to March 2015. The
primary end point was operator radiation exposure, quantiﬁed as the ratio of operator
cumulative dose (CD) and patient radiation reported as dose-area product (DAP)
(CD/DAP). Secondary end points included CD, DAP, and ﬂuoroscopy time (FT). Overall
830 procedures (457 CA [55%] and 373 PCI [45%]) were performed, 455 (55%) through
RFA, 272 (33%) through RRA, and 103 (12%) through LRA. The CD/DAP was lower in
RFA (0.09 mSv/Gycm2 [0.02 to 0.20]) compared with RRA (0.47 mSv/Gycm2 [0.25 to 0.75],
p <0.001). The LRA showed lower CD/DAP compared with RRA (p <0.001). CD was
signiﬁcantly lower in RFA (3 mSv [1 to 7]) compared with RRA (12 mSv [6 to 29], p <0.001).
The LRA showed lower CD compared with RRA (p <0.001). There were no signiﬁcant
differences in DAP among the 3 access sites. FT was similar for the 3 groups (RFA 7 – 7,
RRA 5 – 5, LRA 6 – 5 minutes, RFA vs RRA: p[ 1, RFA vs LRA: p[ 0.16, RRA vs LRA:
p [ 0.52). In conclusion, the use of RFA during CA – PCI is associated with signiﬁcantly
lower operator radiation exposure compared with RRA. LRA is associated with signiﬁ-
cantly lower operator radiation exposure compared with RRA.  2016 Elsevier Inc. All
rights reserved. (Am J Cardiol 2016;-:-e-)Because of a presumably increased stochastic risk of
cancer induction among interventional cardiologists, espe-
cially neoplasms of the unprotected brain, nasopharyngeal
tract, and upper extremities, operator radiation exposure
during coronary angiography (CA) and/or percutaneous
coronary intervention (PCI) is of rising concern.1,2 There-
fore, we undertook a comparison of operator radiation
exposure during right femoral access (RFA), left radial ac-
cess (LRA), and right radial access (RRA) during CA and
CA followed by ad hoc PCI in a real-world population.Methods
From September 2014 to March 2015 at the University
and Hospital Fribourg, all consecutive procedures of elec-
tive or emergency CA and CA followed by ad hoc PCI were
prospectively considered for operator radiation exposure
measurements. Procedures were performed by 5 seniorf Cardiology, Hospital and University of Fribourg, Fri-
d; and bDepartment of Radiology, Institute of Radio-
ospitalier Universitaire Vaudois, Lausanne, Switzerland.
ed January 5, 2016; revised manuscript received and
, 2016.
disclosure information.
g author: Tel: (þ41) 26 426 7285; fax: (þ41) 26
s: jjgoy@goyman.com (J.-J. Goy).
see front matter  2016 Elsevier Inc. All rights reserved.
0.1016/j.amjcard.2016.04.045interventional cardiologists with signiﬁcant experience
(>3,000 PCI each) in both femoral and radial access routes.
Selection of the percutaneous access site was left to the
discretion of the operator. Crossover access site procedures
were excluded. This study was part of the Catheterization
Registry Fribourg (CardioFR), which was approved by the
Ethics Committee of Canton Vaud (protocol no: 339/14).
The primary end point of the study was operator radiation
exposure, expressed as the cumulative equivalent dose (in
mSv) over the lead apron at chest level, normalized for the
patient radiation exposure (dose-area product [DAP] in
Gycm2). Secondary end points included cumulative dose
(CD), DAP, and ﬂuoroscopy time (FT).
Procedures were performed on a digital single-plane
cineangiography unit (Allura FD10; Philips Medical Sys-
tems, Hamburg, Germany) with an undertable x-ray tube
MRC20025 with a magniﬁcation factor leading to a ﬁeld of
view of 21 cm and an acquisition frequency of 15 frames/s.
All procedures were performed with respect to current
guidelines using either 5Fr or 6Fr hydrophilic sheaths.
Conventional diagnostic and guiding catheters were used.
The femoral access was achieved, under local anesthesia
with 2% rapidocain, through the anterior wall puncture of
the artery; 5Fr or 6Fr Terumo (Pinnacle; Terumo Medical,
Tokyo, Japan) introducer was placed in the femoral artery.
CA and PCI were performed according to standard practice
using catheter and drugs left to the discretion of the oper-
ator. Hemostasis was achieved using closure deviceswww.ajconline.org
Figure 1. (A) Radioprotection equipment and materials. Image acquisition during a right radial case. (B) Although the shields are approximated as closely as
possible to minimize operator irradiation, there is still a radioprotection gap (yellow box), which is inevitably more important during right radial procedures.
Table 1
Baseline patient and procedural characteristics
RFA (N¼455) LRA (N¼103) RRA (N¼272) p-values
RFA vs. LRA RFA vs. RRA LRA vs. RRA
Patients
Age (yearsSD) 6812 6910 6512 1.00 0.02 0.05
Male 310 (68%) 71 (69%) 181 (67%) 1.00 1.00 1.00
Weight (kgSD) 8016 8018 8116 1.00 1.00 1.00
Height (mSD) 1.700.09 1.700.09 1.700.09 1.00 1.00 1.00
BMI (kg/m2SD) 275 275 285 1.00 1.00 1.00
Procedure
CA 216 (47%) 65 (63%) 176 (65%) 0.01 <0.01 1.00
CA followed by ad hoc PCI 239 (53%) 38 (37%) 96 (35%) 0.01 <0.01 1.00
Procedural time (minSD) 2019 1511 1812 0.05 1.00 0.08
Fluroscopy time (minSD) 77 55 65 0.16 1.00 0.52
Nb of cine-angiograms (nSD) 954520 659351 727300 <0.001 <0.01 <0.001
Variables are reported in numbers (%) or mean  SD.
BMI ¼ body mass index; CA ¼ coronary angiography; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
2 The American Journal of Cardiology (www.ajconline.org)(Femoseal; St. Jude Medical, St. Paul, Minnesota) or
external mechanical compression (Femostop; St. Jude
Medical).
After sterile preparation and anesthesia with 2% rap-
idocain inﬁltration, radial artery was punctured with a 20-
gauge needle. A 0.021 Teﬂon-sheathed short guidewire
was inserted in the needle. A 3.2-section BD Venﬂon was
then inserted in the artery. A Terumo (Pinnacle; Terumo
Medical) 0.021 hydrophilic guidewire was advanced
through the radial and brachial artery. A 5Fr introducer wasthen inserted in the radial artery. Vasodilator cocktail con-
sisting of verapamil 3 mg and enoxaparin 3,400 units was
administered after sheath insertion. Speciﬁc catheters were
used for CA and PCI. Exchange to a 6Fr sheath was possible
when technically necessary. At the end of the procedure, the
sheath was removed and an inﬂatable pressure band placed
to the access site. All radial accesses were performed at the
right side of the patient.
Operator protection was ensured with the same equip-
ment for all procedures. A leaded glass mobile panel with a
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Coronary Artery Disease/RADIO Study 3patient contour cutout (0.5 lead equivalent; MAVIG,
Munich, Germany) was positioned at the left side of the
operator. An undertable pivot-leaded side shield (0.5-mm
lead equivalent) was mounted to the side of the table. An
additional soft lead shield was adjusted in the contour cut of
the leaded glass mobile panel to minimize radiation expo-
sure. The 37  42 cm upper-shield ﬂap (RADPAD,
Worldwide Innovations & Technologies, Inc, Kansas City,
USA) was placed over the access site in each procedure to
reduce scatter radiation (Figure 1). Additional radiation
protection materials were standardized for all operators and
included a lead apron, thyroid lead collar, and leaded
glasses. All procedures were performed from the patients’
anatomical right side.
Operator radiation was measured using individual
electronic dosimeters (DoseAware; Philips Healthcare,
Best, The Netherlands) positioned on the sternum, outside
the lead apron. The dosimeters are silicon-based semi-
conductor detectors with a dose-response between 1 mSv
and 10 Sv, in steps of 1 mSv (calibrated in ambient
equivalent dose Hp(10)) and a temporal resolution of 1
second. The following parameters were recorded for each
procedure: (1) operator CD through the use of dedicated
readout software (DoseView), measured by the individual
dosimeters; (2) FT; (3) number of cine angiograms (NC);
and (4) the DAP-normalized CD deﬁned as the dose (mSv)
received by the operator with each Gycm2 applied to the
patient (known as the exposure factor) has been advo-
cated3 and applied to our study as it isolates differences in
patient radiation among the 3 vascular access sites. Patient
radiation dose was expressed as DAP. Furthermore, radi-
ation exposure of the assistant nurse, the ﬁrst nurse on the
operator’s right side, was assessed using similar dosime-
ters, in a subgroup of consecutive procedures, with the aim
to compare radiation exposure of the operator versus
assistant nurse.
All statistical analyses were performed using dedicated
software (Stata, version 13; StataCorp LP, College Station,
Texas) at a 2-tailed signiﬁcance level of alpha <0.05.
Baseline patient and procedural characteristics, and vari-
ables assessing radiation exposure of the operator, were
compared among the 3 vascular access sites. Categorical
variables are reported as counts and percentages; continuous
variables are reported as mean and SD or as median with
25% to 75% interquartile range according to their distribu-
tion. Normality was assessed by visual inspection of histo-
grams, the computation of Q-Q plots and the Shapiro-Wilk
test. Categorical variables were compared using the
chi-square or Fisher’s exact test as appropriate. Continuous
variables were analyzed using the 1-way ANOVA or the
Wilcoxon rank-sum test according to their distribution. To
account for differences of the individual operators on radi-
ation exposure according to access site, we computed a
generalized linear model including the individual operators
as potential confounders of the overall treatment effect. To
account for multiple comparisons, p values are Bonferroni
adjusted, that is, multiplied by the number of comparisons.
Comparison of radiation exposure between the operator and
the ﬁrst assistant was assessed using the paired student’s t
test or the signed-rank Wilcoxon test according to
distribution.
Figure 2. Operator CD, patient radiation dose (DAP), operator radiation exposure (CD/DAP), and FT for all procedures: CA and CA followed by ad hoc PCI.
Columns: 3 vascular access sites in percentiles (colors): black: 0 to 25th, blue: 26 to 50th, red: 51 to 75th, and beige: 76 to 100th, median values on the board of
blue and red columns.
4 The American Journal of Cardiology (www.ajconline.org)Results
During September 2014 and March 2015, 849 consecu-
tive procedures for elective or emergency CA and CA
followed by ad hoc PCI were performed in our catheteri-
zation laboratory with a dedicated dosimeter for radiation
evaluation. Nineteen procedures (1.8%) were excluded
because of a crossover in access sites. No patient was
excluded because of lesion or procedural complexity.
Finally, 830 consecutive procedures were included in the
trial, 457 CA alone (55%) and 373 CA followed by ad hoc
PCI (45%). With regard to vascular site, 455 procedures
(55%) were carried out using the RFA, 103 (12%) using the
LRA, and 272 (33%) using the RRA. Baseline patient
characteristics were generally well balanced and depicted in
Table 1. Analysis of procedural characteristics as listed in
Table 1 revealed no difference in FT among the groups and
showed a signiﬁcantly greater NC in RFA compared with
LRA and RRA group and in RRA compared with the LRA
group, probably reﬂecting higher procedural complexity.
The radiation exposure of the assistant nurse standing at
the operator’s right side was also assessed in a subgroup of
ﬁrst 293 consecutive procedures, 152 CA alone (52%) and
141 CA followed by ad hoc PCI (48%), 164 (56%)
through RFA, 49 (17%) through LRA, and 80 (27%)
through RRA.Table 2 and Figure 2 list patient and operator radiation
exposure. Adjusted CD was signiﬁcantly lower in RFA
compared with RRA but not to LRA. CD was lower for
procedures using LRA than RRA. Patient radiation dose
expressed by DAP did not signiﬁcantly vary among the 3
access sites. Operator radiation dose reported as the DAP-
normalized CD was signiﬁcantly higher in the RRA
compared with the RFA and LRA group for all pro-
cedures, procedures with CA alone, and procedures with
CA followed by ad hoc PCI. There were no signiﬁcant
differences between the RFA and the LRA for any kind of
procedure. Table 3 indicates DAP, CD, and DAP-
normalized CD for the individual operators. A signiﬁ-
cantly higher radiation exposure comparing the RRA with
the RFA was consistently found for all operators. Signif-
icant differences in radiation exposure between RFA and
LRA and RRA and LRA were found only for 2 of the 5
operators. Radiation exposure for elective and urgent
procedures is provided in Table 4. During elective pro-
cedures, radiation exposure was lower for RFA compared
with RRA, but not to LRA. However, LRA showed a
lower DAP-normalized CD compared with RRA
(p <0.001). In addition to the aforementioned differences,
LRA was associated with a higher radiation exposure
than RFA, when only urgent procedures were considered
Table 3
Radiation exposure according to the individual operator
RFA LRA RRA p-values
RFA vs. LRA RFA vs. RRA LRA vs. RRA
CA andCA followed by ad hoc PCI
Operator 1 N¼39 N¼77 N¼88
DAP (Gycm2) 31 (20-59) 28 (17-41) 32 (19-55) 0.28 1.00 0.16
CD (mSv) 9 (4-15) 6 (4-11) 15.5 (8-33) 0.08 <0.01 <0.001
CD/DAP (mSv/Gycm2) 0.28 (0.16-0.44) 0.23 (0.14-0.35) 0.51 (0.37-0.84) 0.33 <0.001 <0.001
Operator 2 N¼132 N¼3 N¼28
DAP (Gycm2) 44 (31-90) 67 (37-90) 36 (18-56) 1.00 0.07 0.20
CD (mSv) 1 (0-2) 1 (0-3) 1 (0.5-7.5) 1.00 <0.01 1.00
CD/DAP (mSv/Gycm2) 0.01 (0-0.04) 0.01 (0.00-0.04) 0.05 (0.00-0.17) 1.00 <0.01 0.53
Operator 3 N¼98 N¼1 N¼3
DAP (Gycm2) 36 (21-67) 73 135 (14-166) 0.73 0.60 1.00
CD (mSv) 4 (2-10) 7 87 (25-484) 1.00 <0.01 0.02
CD/DAP (mSv/Gycm2) 0.10 (0.05-0.19) 0.09 1.78 (0.64-2.90) 1.00 <0.01 0.36
Operator 4 N¼139 N¼12 N¼69
DAP (Gycm2) 30 (17-54) 36 (24-128) 33 (22-50) 0.23 0.49 0.82
CD (mSv) 4 (1-6) 1.5 (1-3.5) 12 (7-36) 0.16 <0.001 <0.001
CD/DAP (mSv/Gycm2) 0.10 (0.05-0.18) 0.05 (0.01-0.08) 0.45 (0.24-0.78) <0.01 <0.001 <0.001
Operator 5 N¼47 N¼10 N¼84
DAP (Gycm2) 35 (21-51) 27 (14-49) 30 (17-47) 0.92 0.40 1.00
CD (mSv) 7 (4-13) 12 (11-37) 12 (8-28) 0.04 <0.001 0.81
CD/DAP (mSv/Gycm2) 0.21 (0.12-0.35) 0.59 (0.44-1.43) 0.48 (0.32-0.72) <0.01 <0.001 0.55
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
Table 4
Radiation exposure of the operator and patient stratiﬁed by operator
RFA LRA RRA Crude p-values Adjusted p-values
RFA vs.
LRA
RFA vs.
RRA
LRA vs.
RRA
RFA vs.
LRA
RFA vs.
RRA
LRA vs. RRA
CA and CA followed by ad hoc PCI
Elective N¼285 N¼90 N¼206
DAP (Gycm2) 34 (21-57) 32 (19-48) 31 (19-50) 0.37 0.41 1.00 0.77 0.35 0.72
CD (mSv) 3 (1-6) 6 (3-12) 11 (6-25) <0.001 <0.001 <0.001 0.36 <0.001 <0.01
CD/DAP (mSv/Gycm2) 0.09 (0.03-0.20) 0.22 (0.12-0.35) 0.43 (0.23-0.72) <0.001 <0.001 <0.001 0.13 <0.001 <0.001
Urgent N¼170 N¼13 N¼66
DAP (Gycm2) 41 (25-84) 25 (12-44) 38 (21-57) 0.02 0.11 0.29 0.69 0.62 0.16
CD (mSv) 3 (1-10) 4 (1-6) 17.5 (8-41) 1.00 <0.001 <0.001 <0.01 <0.001 0.001
CD/DAP (mSv/Gycm2) 0.08 (0.02-0.19) 0.15 (0.10-0.21) 0.55 (0.37-0.85) 0.16 <0.001 <0.001 <0.01 <0.001 <0.001
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area product; LRA ¼ left radial access; PCI ¼ percutaneous coronary intervention;
RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼ standard deviation.
Coronary Artery Disease/RADIO Study 5(p <0.01). In the subgroup of the ﬁrst consecutive 293
procedures, operator exposure was signiﬁcantly higher
compared with the assistant nurse’s as listed in Table 5 for
all procedures and by access site.
Discussion
The main ﬁndings of the current prospective trial are the
following: (1) interventional Cardiologists are exposed to a
lower degree of radiation when performing CA or CA fol-
lowed by ad hoc PCI through the RFA rather than the RRA;
(2) interventional cardiologists are exposed to a lowerdegree of radiation when performing CA or CA followed by
ad hoc PCI using the LRA rather than the RRA; and (3) the
operator is more exposed to radiation compared with the
assistant nurse standing at his right side during the
procedures.
Transradial cardiac catheterization is known to be asso-
ciated with an increased operator radiation dose even for
highly experienced interventional cardiologists and despite
the use of radioprotection optimization techniques.4e9 Data
are limited with regard to operator radiation exposure when
right and left radial accesses are compared,10e13 with most
investigators reporting lower radiation levels for LRA, alike
Table 5
Comparison of radiation exposure between operator and assistant nurse
CA and CA followed by
ad hoc PCI (N¼293)
Operator Assisstant nurse p-value
DAP (Gycm2) 32 (20-53) 32 (20-53) 1.00
CD (mSv) 5 (1-13) 2 (1-5) <0.001
CD/DAP (mSv/Gycm2) 0.16 (0.04-0.46) 0.07 (0.03-0.13) <0.001
RFA (N¼164)
CD/DAP (mSv/Gycm2) 0.06 (0.01-0.18) 0.06 (0.03-0.11) <0.05
LRA (N¼49)
CD/DAP (mSv/Gycm2) 0.23 (0.10-0.45) 0.06 (0.04-0.10) <0.001
RRA (N¼80)
CD/DAP (mSv/Gycm2) 0.51 (0.32-0.81) 0.10 (0.06-0.17) <0.001
Values are reported in medians (interquartile range: P25 to P75).
CA ¼ coronary angiography; CD ¼ cumulative dose; DAP ¼ dose area
product; LRA ¼ left radial access; PCI ¼ percutaneous coronary inter-
vention; RFA ¼ right femoral access; RRA ¼ right radial access; SD ¼
standard deviation.
6 The American Journal of Cardiology (www.ajconline.org)to initial scientiﬁc concerns and despite the operator’s
inconvenience when leaning over to reach the patient’s left
side. To our knowledge, this is the ﬁrst single-center trial to
compare operator radiation exposure among these 3 vascular
access sites for CA and CA followed by ad hoc PCI.
Recently, the Randomized Evaluation of Vascular Entry
Site and Radiation Exposure trial14 evaluated patient and
operator radiation exposure among the 3 access sites RFA,
LRA, and RRA and included only CA procedures without
CA followed by ad hoc PCI procedures. It reported higher
operator radiation for LRA using air kerma as primary end
point, which is not the ideal patient exposure metric,
although also analyzing DAP as a secondary end point and
found an FT much shorter than our study’s, presumably
because PCIs were excluded. Furthermore, the population
included in the Randomized Evaluation of Vascular Entry
Site and Radiation Exposure trial shows a median weight
and height of 64 to 65 kg and 163 to 164 cm, respectively,
resulting subsequently in lower DAP values (in the order of
26 Gycm2 per procedure).
Both procedure-related and operator-related factors
appear responsible for the differences in operator radiation
exposure per vascular access site. It has been reported that
increased operator radiation exposure during radial access,
as opposed to femoral access, is related to increase in FT,
reﬂecting technical difﬁculties and to the slightly closer
operator’s position to the x-ray tube and to the patient,
compared with femoral access.5,15,16 In contrast, decreased
operator radiation dose and shorter FT have been reported
when using LRA compared with RRA.10,11,17e20 In our
study, there are some details in radiation protection tech-
niques that should be taken into consideration: First, during
RRA procedures, the leaded glass mobile panel is positioned
less proximally to the table compared with LRA and RFA to
facilitate the right radial access. The radioprotection gap
which is inevitably created between the leaded glass mobile
panel and the patient table is more pronounced during RRA
procedures, thus creating a considerable source of radiation
exposure to the operator (Figure 1). Second, when using
RRA, the operator is positioned closer to the x-ray tube and
closer to the patient compared with both LRA and RFAprocedures, increasing the effect of the patient as the main
source of scatter radiation to the operator. Furthermore,
technical challenges in maneuvering catheters into the cor-
onary vessels can lead in longer FT. In particular, the
vascular anatomy associated with the right radial artery,
including the right subclavian artery-common brachioce-
phalic trunk bifurcation and the common brachiocephalic
trunk-aorta bifurcation, could account for tortuosity and
calciﬁcations that could impair procedural success. In
considering the left radial artery, the left subclavian artery
stems directly from the aortic arch, thus reducing the tech-
nical challenges in catheter manipulation, whereas in the
right femoral artery there is no such issue at all. Finally,
further technical difﬁculties associated with radial artery
access include spasm or tortuosity of the radial artery, which
could increase ﬂuoroscopy and procedure times. Nonethe-
less, in our study, FT did not differ signiﬁcantly among the 3
access sites, suggesting a high level of operator experience
across the 3 groups. On the contrary, the longer procedural
times and the greater NC in the femoral group reﬂect a
higher complexity of procedures being performed through
this access, while still beneﬁtting from decreased operator
radiation exposure compared with the 2 radial groups.
The present study conﬁrms the greater radiation exposure
of the operator compared with the ﬁrst assistant who is
standing at his right side, regardless of the vascular access site.
This is expected because of the nurse’s greater distance from
the source of radiation and from the patient. Most authors
studying operator radiation dose issues report results
normalized per procedure and not per-patient radiation dose
measured as DAP. This means that whether the dose is higher
for femoral or radial approach will be a result of both the
higher or lower DAP (and FT), the distance effect, and radi-
ation protection aspects. If the dose is normalized per DAP,
one can isolate, to a certain extent, the ﬁrst 2 issues, and the
results will then be mostly related to the radiation protection
level and the distance between operator and patient.21 Our
results in terms of procedure (ﬂuoroscopy and procedural
times) and radiation dose of the operator (CD) and the patient
(DAP) are in line with published data in the literature.
Although not randomized, the present study reﬂects operator
radiation exposure in a real-world population in everyday
clinical practice, despite a bias in the choice of vascular access
site by the operator. Furthermore, the 3 groups were ho-
mogenous with regard to characteristics that inﬂuence oper-
ator and patient irradiation such as patients’ body mass index
and procedural and FTs, thus reﬂecting a representative
sample of a real-world population without exclusion of
emergent or complex procedures. The greater NC in the RFA
group compared with the LRA and RRA groups and in the
RRA compared with the LRA group probably suggests
increased procedural complexity and could be reﬂected in the
higher patient irradiation (DAP) in the RFA group compared
with the 2 radial groups. The normalization, however, of the
operator irradiation for patient irradiation takes into consid-
eration such parameters as procedural complexity and patient
corpulence, thus accurately reﬂecting the actual operator ra-
diation dose, and is dependent only on the following 2 pa-
rameters: (1) the degree of radioprotection itself and (2) the
distance between patient and operator. Therefore, interpreta-
tion of results using the DAP-normalized operator radiation
Coronary Artery Disease/RADIO Study 7dose allows for isolation and meaningful evaluation of tech-
nical differences among the 3 vascular access sites based on
the positioning of radioprotection equipment, the operator’s
position, and his distance from the patient and the x-ray tube.
This was a nonrandomized, single-center study.
Therefore, these results have to be interpreted with caution
for other catheterization laboratories because of possible
differences in operator experience, training and techniques,
radioprotection materials, and devices. Furthermore,
procedures were performed by 5 different, although highly
experienced, interventional cardiologists implicating differ-
ences in catheterization techniques, procedural and FTs,
NC, and thus effecting individual radiation dose. Finally, in
our study, operator dose was measured by 1 single
dosimeter positioned externally to the sternum, with no
possibility to measure and compare radiation exposure of
other corporal areas.
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Abstract 
Percutaneous coronary interventions have become one of the leading medical techniques for 
managing acute or chronic coronary artery diseases thanks to reduced septic risks, higher rates 
of success and lower hospitalization times. This implies a higher radiation burden on patients 
undergoing such procedures. An especially sensitive subgroup of patients is pregnant women, 
because of the higher radiation sensitivity of the fetus. However, the mean prevalence of 
coronary heart disease in this population is low, so theoretical and practical skills needed to 
properly handle these cases can be challenging due to the low volume of clinical cases. 
Nevertheless, some guidelines on the management of pregnant patients have been published 
by several medical societies. In this article, we will first summarize fetal risks due to ionizing 
radiation and the injection of iodinated contrast media. Then, we will detail the management of 
patients with positive pregnancy status known before the intervention. In this part, we will focus 
on the typical fetal doses, as well as the fetal risks when exposed to alternative procedures, 
such as drug-induced thrombolysis. Finally, we will address the actions to be taken when 
discovering pregnancy after the performed procedure. Especially, the risks due to ionizing 
radiation will be weighed against the natural occurrence of peripartum child morbidities. The 
overall conclusion is that, when care is being taken by the physician, no particular increase in 
child morbidity risk is to be expected, and the lives of both the mother and child will be 
preserved when treating acute coronary syndromes properly. 
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Introduction 
Percutaneous coronary interventions (PCI) have become increasingly popular due, in part, to 
their minimally-invasive nature and reduced septic risks. Advantages of fluoroscopically-guided 
interventions include a high rate of success as well as shortened in-hospital stays when 
compared to open heart surgery. Accordingly, the proportion of ST-Elevation Myocardial 
Infarction (STEMI) patients undergoing systemic drug-induced thrombolysis went from 51% 
(male) and 39% (female) in 1997 to less than 1% for both genders in 2007, while the proportion 
of direct PCI rose from 10% to 80% [1]. However, a significant downside to this treatment 
paradigm shift is an increased exposure to ionizing radiation. Indeed, fluoroscopy times for 
these patients may range from a few seconds for simple diagnostic cases to a few hours of 
beam-on time, depending on numerous factors, such as vascular abnormalities, procedure 
complexity, procedure-related complications, patient health condition and operator experience. 
This may potentially lead to excessive skin radiation doses and high patient total radiation 
exposure. 
A subgroup of patients who are especially sensitive to ionizing radiation is pregnant patients. In 
particular, infants, neonates and fetuses are more sensitive to ionizing radiation due to their 
higher metabolism and rapidly dividing young body cells [2]. These cases are somewhat rare as 
the mean prevalence of coronary heart disease is only 0.6% for patients between the ages of 20 
and 39 years in the US [3]. Simultaneously, the pregnancy rate in the U.S. in 2010 was slightly 
under 10% (98.7 per 1000) for women between the ages of 15 and 44 years [4]. This implies a 
minimal cohort of female patients at risk of undergoing PCI during pregnancy. Consequently, 
the theoretical and practical skills needed to properly handle these cases can be challenging 
due to the low volume of clinical opportunities. However, due to significant hemodynamic 
changes in the maternal cardiovascular system (increase in circulating volume and cardiac 
output, decrease in vascular resistance and hypercoagulation), as much as 0.2 to 4.0 % of all 
pregnancies could be complicated by cardiovascular disease [3]. Also, the number of pregnant 
women with coronary disease is expected to grow due to advanced pregnancy-maternal age, 
the development of reproductive techniques and increased cardiovascular risk factors in 
women, making heart disease an increasingly important cause of maternal morbidity and 
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mortality during pregnancy [3]. Most cardiac problems arising in pregnant women with heart 
disease can be managed without interventional procedures; however, hemodynamic changes 
during pregnancy may sometimes lead to deterioration in previously stable patients. Maternal 
mortality after acute coronary syndromes (ACS) (myocardial infarction, unstable angina) is 
estimated at 5–10% and is highest during the peripartum period. Survival has improved with 
primary percutaneous coronary intervention [5-7]. 
We address here the main elements that should be considered before, during and after 
performing interventional cardiology (IC) procedures on pregnant patients. These procedures 
include cardiac catheterization, coronary angiography and/or percutaneous coronary 
interventions. First, we summarize the risks for the fetus when the mother undergoes an IC 
procedure. Next, we describe management of the patient when pregnancy status is known prior 
to intervention. And finally, we describe management of the patient after intervention or when 
pregnancy is discovered post-procedure. 
 
Fetal risk during IC procedures 
During IC procedures, the embryo or fetus is exposed to two different risk classes: Ionizing 
radiation exposure and contrast agent injection [8]. Risk to the embryo or fetus depends on the 
amount and type of radiation delivered and the gestational age at the time of irradiation. 
Concerns related to ionizing radiation include radiation-induced teratogenesis, malignancy in 
childhood and mutagenesis.  
 
Ionizing radiation exposure 
Effects of radiation on the fetus have been derived from animal studies, human exposures to 
diagnostic and therapeutic radiation, atomic bomb radiation at Hiroshima and Nagasaki in 1945, 
and to fallout of the Chernobyl nuclear power plant explosion in April 1986. The currently 
accepted maximum limit of ionizing radiation exposure to the fetus during pregnancy is a 
cumulative dose of 50 mSv (or 50 mGy) [9-12]. Importantly, no single diagnostic study typically 
approaches this cautionary dose of 50 mSv.  Cardiac catheterizations, coronary angiography, 
electrophysiology procedures, and even more complex interventions are unlikely to exceed the 
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50 mGy threshold. The amount of radiation exposure to the fetus during a fluoroscopic study is 
typically in the range of 0.01 to 0.5 mSv, depending on duration of fluoroscopic time and 
operator technique [13]. 
Teratogenesis or malformations are typically associated with central nervous system problems, 
particularly microcephaly and mental retardation, and have a threshold of 100 to 200 mGy or 
higher. Fetal doses of 100 mGy are not reached with 3 pelvic computed tomography (CT) 
scans, 20 conventional diagnostic x-ray examinations or even complex fluoroscopic cardiac 
interventions. These levels can be reached however, with fluoroscopically guided interventional 
procedures of the pelvis and with radiotherapy. After Hiroshima, many victims exposed in utero 
to doses greater than 100 to 150 mSv developed microcephaly [14]. A linear, dose-related 
association between radiation dose and severe mental retardation was also found [15, 16]. 
Exposure to as little as 10 to 20 mSv has been associated with an increase in childhood 
malignancies, especially leukemia, as a stochastic effect [17]. The general background rate of 
leukemia in children is about 3.6 per 10,000. Exposure to 10 to 20 mSv increases this rate to 5 
per 10,000 which equates to a small absolute increase of ~ 1 in 10,000 [9, 18]. 
Germ-line mutations potentially affecting future generations are another stochastic effect of 
radiation. Although radiation is commonly believed to create bizarre new mutations, data show 
that it usually increases the frequency of mutations occurring naturally in the general population 
[19]. The dosage required to double this baseline mutation rate is between 500 and 1000 mSv 
[20]. Common cardiovascular fluoroscopy studies do not reach these levels. The risks of 
ionizing radiation are more significant during organogenesis and in the early fetal period, 
somewhat less in the second trimester, and least in the third trimester. Interestingly, in most 
cases of Hiroshima victims with severe mental retardation, exposure was during weeks 8 to 15 
of gestation [15, 16]. The least harmful period to perform invasive procedures is the beginning 
of the second trimester when organogenesis is complete but the uterus is still small [8]. 
 
Contrast medium injection 
Intravenous iodinated contrast media likely cross the placenta by simple diffusion and are 
evenly distributed in fetal tissues [21]. Substances such as iohexol, iopamidol, iothalamate, 
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ioversol, ioxaglate and metrizamide have been studied in animals and do not appear to be 
associated with teratogenic effects [22]. However, iodinated contrast media can cause neonatal 
hypothyroidism [23]. Bourjeily et al. studied the effect of in utero exposure to a single high dose 
of iodinated contrast material on neonatal thyroid function and identified no serious risks [24]. 
The currently used low-osmolality iodinated contrast agents are classified in pregnancy 
category B [25]. 
 
Patient management when pregnancy status is known prior to intervention 
The most frequently performed cardiac percutaneous interventions during pregnancy are mitral 
balloon valvuloplasty, coronary angiography and coronary angioplasty. Radiation doses to the 
mother for such procedures are usually lower than 20 mSv and even lower for the fetus 
because it is outside the primary field during cardiac procedures. 
In emergency cases of ACS, coronary angiography with the possibility of PCI is preferred to 
thrombolysis as it will also diagnose coronary artery dissection. Although recombinant tissue 
plasminogen activator does not cross the placenta, it may induce bleeding complications (sub 
placental bleeding); therefore, thrombolytic therapy should be reserved for life-threatening ACS 
when there is no access to PCI [26]. All reported stenting to manage ST-elevation myocardial 
infarction during pregnancy utilized bare metal stents. The safety of drug-eluting stents in 
pregnant woman is therefore still unknown; furthermore, these require prolonged dual 
antiplatelet therapy and should thus be avoided [8]. In women with intermediate or high risk non 
ST-elevation myocardial infarction, an invasive approach is indicated. In stable conditions with 
exertional symptoms, watchful waiting and conservative medical therapy is the treatment of 
choice [27]. In the case of recurrent coronary dissections, pre-term delivery may be considered 
according to fetal viability. Data on emergency coronary artery bypass graft surgery during 
pregnancy is rare, with a potentially high mortality rate [5, 6]. 
Radiation protection optimization methods for the management of the pregnant patient during 
invasive cardiology procedures include thoughtful operator technique, as well as radioprotective 
aprons. However, efficiency of the latter is not well established. In addition, there is a risk that 
part of the apron is in the primary X-ray field of view, thus triggering the automatic exposure 
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control (AEC) system of the radioscopy unit to increase radiation dose, as is also the case when 
using leaded gloves in the primary beam [29]. 
Radiation exposure to the fetus predominantly arises from scattered radiation within the patient 
[9, 30]. Procedures should be performed by well experienced invasive cardiologists for 
attainment of the lowest radiation rates by minimizing radiation time.  
A vascular access choice via the upper extremities could avoid direct fetal irradiation during 
catheter passage in many cases. Use of a lead apron on the table to shield the primary X-ray 
beam from reaching the fetus may be an option, as well as external shielding of the maternal 
pelvis; although radiation dose absorbed by the fetus without shielding was found to be only 3% 
higher than that with external shielding for all periods of gestation [30]. As mentioned previously, 
lead shielding in the primary field can potentially lead to a large increase in primary beam dose 
rate due to the response of the AEC system. 
Consideration of the following additional radioprotection measures may further significantly 
reduce radiation exposure of the patient and fetus: i) Minimization of fluoroscopy time and the 
number of fluorographic images; ii) avoiding direct radiation of the abdominal region; iii) using 
available patient dose reduction technologies such as low-fluoroscopy-dose-rate settings, low-
frame-rate pulsed fluoroscopy, removal of the anti-scatter grid, spectral beam filtration and use 
of increased X-ray beam energy; iv) positioning the patient as far distant from the X-ray tube as 
possible, placing the image receptor as close as possible to the patient and directing the 
primary beam as far away from the fetus as possible; v) adjusting collimator blades tightly to the 
area of interest, thus reducing patient dose and improving image quality by reducing scatter; vi) 
calculating the dose in concert with a knowledgeable medical physicist, if necessary; and vii) 
minimization of total administered contrast agent volume. Finally, medical physicists and 
radiologists may be consulted to evaluate such cases and consult with pregnant patients before 
or after a planned or unplanned examination with radiation. 
 
Patient management when pregnancy status is determined after the intervention. 
Cardiac diagnostic and therapeutic fluoroscopy procedures may be performed inadvertently on 
patients with unsuspected pregnancies. This would most often occur early in pregnancy, 
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perhaps after only a few weeks of gestation, when results of routine urine pregnancy tests are 
less reliable. Occasionally, human error or miscommunication is responsible for such events. 
 As previously mentioned, even the most complicated cardiac interventions are unlikely to 
exceed the fetal radiation dose cautionary threshold of 50 mGy. To our knowledge, there are no 
case data directly linking diagnostic imaging to fetal harm. In 1999, Brent et al. projected a 
general population total risk of spontaneous abortion, major malformations, mental retardation 
and childhood malignancy of approximately 286 per 1000 deliveries (28.6%). Exposing the fetus 
to 5 mSv may add approximately 0.17 cases per 1000 deliveries to this baseline rate, or about 
one additional case in 6000 [31]. It is generally not possible to convincingly differentiate 
between radiation-induced or spontaneous adverse fetal consequences. In cases where a 
positive pregnancy status is discovered after the IC procedure, proper interdisciplinary 
consultation and advising the patient regarding fetal risks associated with radiation exposure 
are important. In general, termination of pregnancy is not recommended unless there is 
reasonable documentation that an estimated fetal dose greater than 150 mGy has occurred. If 
doses between 100 and 150 mGy are suspected, individual circumstances should be 
considered to determine an appropriate course. Termination of gestation is generally not 
justified when fetal doses are below 100 mGy [11, 32-34]. 
 
 Conclusion 
The number of percutaneous cardiac interventions performed on pregnant women, although 
relatively low, is likely to increase due to rising maternal age and other factors. A main fetal 
concern when performing PCI during patient pregnancy is managing the volume of iodinated 
contrast medium, which can cause neonatal hypothyroidism.  Fetal exposure to ionizing 
radiation is a second, but lesser risk. For pregnant patients with ACS, percutaneous coronary 
intervention is preferable to drug-induced thrombolysis due to a decreased risk of mortality. 
Further, the risk of sub placental bleeding associated with thrombolysis is increased and is life 
threatening to the conceptus. For women in stable condition with exertional symptoms, watchful 
waiting and conservative medical therapy is the preferred treatment. In the case of recurrent 
coronary dissections, pre-term delivery may be considered after assessing fetal viability. 
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Abstract
Those working in interventional cardiology and related medical procedures 
are potentially subject to considerable exposure to x-rays. Two types of 
tissue of particular concern that may receive considerable doses during such 
procedures are the lens of the eye and the brain. Ocular radiation exposure 
results in lens changes that, with time, may progress to partial or total lens 
opacification (cataracts). In the early stages, such opacities do not result in 
visual disability; the severity of such changes tends to increase progressively 
with dose and time until vision is impaired and cataract surgery is required. 
Scattered radiation doses to the eye lens of an interventional cardiologist in 
typical working conditions can exceed 34 μGy min−1 in high-dose fluoroscopy 
modes and 3 μGy per image during image acquisition (instantaneous rate 
values) when radiation protection tools are not used. A causal relation 
between exposure to ionising radiation and increased risk of brain and central 
nervous system tumours has been shown in a number of studies. Although 
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absorbed doses to the brain in interventional cardiology procedures are lower 
than those to the eye lens by a factor between 3.40 and 8.08 according to 
our simulations, doses to both tissues are among the highest occupational 
radiation doses documented for medical staff whose work involves exposures 
to x-rays. We present InterCardioRisk, a tool featuring an easy-to-use web 
interface that provides a general estimation of both cumulated absorbed 
doses experienced by medical staff exposed in the interventional cardiology 
setting and their estimated associated health risks. The tool is available at 
http://intercardiorisk.creal.cat.
Keywords: fluoroscopy, dosimetry, brain tumour risk, cataracts risk, 
occupational exposure
S  Online supplementary data available from stacks.iop.org/JRP/36/561/
mmedia
(Some figures may appear in colour only in the online journal)
1. Introduction
Interventional cardiology (IC) comprises a variety of minimally-invasive procedures used in 
the diagnosis and treatment of cardiovascular disease. In fluoroscopy, a key technology used 
in this work, hard x-rays (photon energies typically above 5–10 keV) are passed through a 
patient onto a detector; catheters and contrast agents are used thereby allowing real-time visu-
alisation of internal structures, processes and activities [1]. Since interventional cardiologists 
and electrophysiologists carry out their work in close proximity to the patient on whom the 
imaging is being carried out, they are exposed occupationally to ionising radiation (IR) under 
normal working conditions.
Used appropriately to support a variety of procedures, IC provides enormous clinical ben-
efits over other surgical procedures, including minimal invasiveness, reduced pain and risk 
of complications, shorter hospital stays, and lower costs [2, 3]. The benefits of catheterisa-
tion over open surgery have resulted in a considerable increase in workloads for IC staff 
over the past two decades and, although concomitant improvements in technology and radia-
tion protection (RP) measures have reduced doses per procedure, there is concern that higher 
cumulated doses result in increased risks to IC staff (particularly surgeons) of cataracts and 
may increase the risk of brain tumours [4]. Effective use of RP measures can reduce doses to 
exposed organs and thereby lower the magnitude of associated health risks. Doses to both the 
patient and IC staff can be lowered via configuration of the fluoroscope. Doses to IC staff are 
typically reduced through personal use of lead (or lead equivalent) aprons and thyroid shields. 
International best practice recommendations state that physicians involved in interventional 
procedures should wear such an apron, a thyroid shield and leaded eyewear as a minimum set 
of RP measures [5], and these are currently used routinely in most IC procedures. A number of 
additional protection measures may, however, be employed to further reduce operator doses. 
As well as personal protective equipment such as lead caps, several radiation shielding devices 
may be employed, including flexible blanket-type shields laid over the patient during inter-
ventions to reduce operator exposure to scattered radiation, table skirts (screens suspended 
between the operating table  and the floor), RP cabins (several screens assembled so as to 
surround the operator, with apertures for the hands), and ceiling-suspended screens (manoeu-
verable screens that can be pulled down in front of the operator’s face) [6]. The degree to 
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which such measures are employed vary by procedure, specialisation, experience, individual, 
hospital and country. There are differences in their availability as well: while table skirts and 
ceiling-suspended screens are available in most IC environments, flexible blanket-type shields 
are not commonly available and RP cabins are very seldom installed. It has been suggested 
that such measures are not employed in all catheterisation laboratories, possibly due, in part, 
to the lack of available information and training in RP [7]. This is especially true for those pro-
tection measures that are widely available such as table skirts and ceiling-suspended screens. 
The latter is probably the most important item of protection for the head. In some cases, 
impracticability, discomfort and occupational back pain may also play a role in IC staff not 
employing certain measures. Recent substitution of lightweight high atomic number mat erials 
for the heavier lead used in protective clothing has reduced discomfort for personnel and 
increased compliance [8]. Given typical RP practices at the present time, the organs of opera-
tors that remain chiefly exposed are those in the head, including the eyes and the brain. This 
gives cause for concern, since IR is known to have the potential for causing damage to these 
tissues.
Scattered radiation doses to the eye lens of an interventional cardiologist in typical working 
conditions can exceed 34  μGy min−1 in high-dose fluoroscopy modes and 3 μGy per image dur-
ing image acquisition (instantaneous rate values) when radiation protection tools are not used 
[9]. Radiation-induced cataract has been recognised as a highly relevant non-cancer endpoint 
among those exposed to IR since the 1930s [10]. Radiation-induced cataracts typically develop 
as central opacities in the subcapsular posterior region of the lens, and consist of small granules 
and vacuoles that form a roughly circular opacity. Defects in lens transparency cause little or no 
visual impairment in the early stages of the disease, but eventually cause distortion and clouding. 
The reaction of the lens to radiation is partly attributable to lifelong continued differentiation of 
the epithelial cells that make up the lens (fibrogenesis); aberrant differentiation of cells due to 
exposure to radiation results in their accretion to the superficial posterior cortex [11].
Primary tumours of the central nervous system (CNS) include tumours, both malignant 
and benign, of the brain, brain stem and spinal cord. The epidemiological literature provides 
clear evidence for a causal association between brain tumours and exposures to IR [12, 13]. 
Although some of the available literature supporting this association relate to childhood 
exposures to low linear energy transfer (LET) radiation (such as x-rays) [14], studies of the 
Japanese atomic bomb survivors indicate increased risks of various CNS tumours (mainly 
brain tumours) characterised by linear dose-response in adults [15].
Accurate estimation of health impacts to medical staff from IR under a variety of opera-
tional and RP scenarios is increasingly important as use of IC procedures continues to grow. 
Of the existing online radiation risk assessment tools, the majority are focused on radiation 
exposures to the general population or to medical patients undergoing specific diagnostic or 
radiotherapeutic procedures, and tend to provide estimates of cancer risk only [16, 17]. Our 
primary objective was to produce a tool that estimates the most relevant organ doses in IC 
staff occupationally exposed to radiation, and to estimate the associated health impacts due to 
these exposures taking into account all sources of uncertainty, specifically in terms of the risk 
of cataracts and brain tumours. All the abbreviations used throughout the paper are available 
as supplementary material (stacks.iop.org/JRP/36/561/mmedia).
2. Methods
We designed a tool that produces distributions of annual and total cumulated absorbed doses to 
the brain and eye lens by employing robust estimators of parameters [18] based on a multiple 
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linear regression of predictors of dose, and subsequently estimates risk based on published 
epidemiological data.
We developed the tool in R [19] using the shiny package [20], which allows construc-
tion of interactive web applications from R and provides an easy-to-use web front-end. The 
user interface (figure 1) comprises two panels, positioned side by side. In the left-hand ‘input’ 
panel, the users can introduce specific data concerning their career (profession, work period 
and annual numbers of procedures), the target organ of interest (brain or eye lens), and the 
required output in terms of either absorbed dose (in mGy) or associated health risk. Results 
are automatically generated and presented in the right-hand ‘output’ panel.
The output panel is further divided into five tabs, the first three presenting the user with 
organ-specific absorbed doses to the eye lens or brain (in mGy), and the associated risk 
of cataracts and CNS tumours, respectively. These tabs correspond to dose and risk esti-
mates under different RP scenarios, namely (a) ‘typical working practices’; (b) ‘no radiation 
protection measures used’; and (c) ‘protective equipment fully employed’—a career during 
which all RP measures typically available throughout that time period were used. Absorbed 
doses are presented both annually and cumulated across the whole career, together with 95% 
credibility intervals. The fourth tab presents the cumulated doses and risk estimates for each 
of the three scenarios side by side, thereby facilitating comparison of the potential impacts on 
dose and risk of employing RP measures. The last tab presents a summary of the underlying 
assumptions employed by the tool in its calculations. In addition to the web version of the 
results, the user can download a summary report in PDF format that includes all input data 
and results.
An eye lens dose prediction model was built using data collected in the ORAMED 
(Optimization of RAdiation protection for MEDical staff) project—described in 
 section 2.1—and from the literature, together with the user-defined occupational history. 
The potential predictors of absorbed dose to the eye lens included the usage of RP measures, 
catheterisation access route, tube configuration and operator experience. It was considered 
Figure 1. Screenshot of the web-based tool, showing the estimated absorbed dose 
(in mGy) to the eye lens for an interventional cardiologist, under the ‘typical working 
practices’ scenario.
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unduly cumbersome to input precise details of every cardiological procedure carried out over 
a career. Instead, the tool was designed so that the user is required to specify only annual 
numbers of interventions carried out during their career (via a graphical interface), and an 
occupational history is reconstructed using the proportion of procedures reported as typi-
cal for France across each decade between 1970 and 2010 [21], in the absence of country-
specific data. For the ‘typical working practices’ career scenario, the occupational history 
is reconstructed also assuming the RP practices typical amongst French cardiologists over 
the same time period. For the other two scenarios, the amount of RP practices incorporated 
into dose calculations is altered accordingly. Changes in dose area product (DAP) typically 
available to interventional cardiologists over the past four decades were taken into account 
by fitting a metaregression model using results from the literature [22–34], and subsequently 
adjusting the computed doses using these values. Probability distributions of measures of 
risk under each scenario are calculated on the basis of the resulting cumulated absorbed 
doses, using estimates of dose-response and related uncertainties derived from the epide-
miological literature (described in section 2.3). Various sources of uncertainty are taken into 
account by means of Monte Carlo simulation, which allows uncertainties in several model 
inputs to be propagated through to results, and thereby expressed as 95% credibility intervals 
on estimates of dose and risk.
2.1. Data
The data used for fitting the dose prediction model were collected previously within the frame-
work of the ORAMED project, a collaborative project funded in 2008 by the European Union 
under its 7th Framework Programme. Its remit included the development of methodologies for 
better assessing and reducing exposures to medical staff from procedures that potentially result 
in large radiation doses or are associated with complex radiation fields, such as those used in 
fluoroscopically guided procedures and nuclear medicine. The project collected information on 
the doses incurred to the eyes and the extremities of operators during IC and electrophysiology 
procedures in seven European countries (Belgium, Greece, France, Italy, Poland, Slovakia and 
Switzerland) through a measurement campaign. In total, 381 such procedures were monitored, 
including coronary angiography (CA) and percutaneous transluminal coronary angioplasty 
(PTCA), radiofrequency (RF) ablations and pacemakers and cardiac defibrillator implantations 
(PM/ICD). For each type of procedure, detailed data were collected on the configuration of 
the x-ray tube employed, the degree of usage of RP measures, and operator experience. These 
data are the most extensive data (in terms of number of monitored procedures and countries 
included) so far collected through measurements following a common protocol [35].
2.2. Dose estimation
Doses to the eye lens were estimated by means of a robust linear regression model on the basis 
of ORAMED data (dose per unit DAP considering the most exposed eye), including usage of 
table skirt, cabin and ceiling screen, on the type of procedure, on tube configuration, and on 
operator experience (defined as high after 4 years of working in IC or electrophysiology) as 
predictors of the absorbed dose. The obtained estimates are shown in table 1.
For instance, the dose estimated by the model for an interventionalist with relatively 
 little work experience, using a biplane tube configuration and conducting a CA interven-
tion, protected only by screen and table  is + − − − =exp 1.031 0.057 1.183 0.486 0.011( )   
0.55 μSv Gy · cm−2. The corresponding average dose in the ORAMED database is 
0.52 μSv Gy · cm−2.
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In theory, dose to the eye lens is typically reduced by a factor of around 30 when 0.5 mm 
lead-equivalent eyewear are used, but this degree of attenuation is only achieved under fron-
tal exposure to non-scattered radiation. In reality, interventionalists tend to position them-
selves sideways to the primary beam, are also subjected to scattered radiation emitted from the 
patient, and coverage of the eye may be reduced due to poor eyewear fit [36]. The reduction 
factor of absorbed dose to the eye lens due to the usage of protective eyewear was therefore 
assumed to follow a project evaluation and review techniques (PERT) distribution [37] with 
minimal, modal and maximal values of 1, 3 and 10 respectively, based on expert opinion and 
a review of the literature [8, 38–40]. The PERT distribution is a particular case of the Beta 
distribution, characterized by the density function
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Sampling from the beta distribution requires minimum and maximum values (scale) and 
two shape parameters, α and β. The PERT distribution uses the mode or most likely parameter 
to generate the shape parameters α and β. An additional scale parameter λ scales the height of 
the distribution; the default value for this parameter is 4. In the PERT distribution, the mean 
μ is calculated as
µ
λ
λ
=
+ + ⋅
+
min max mode
2
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And it can be used to compute the Beta distribution parameters α and β:
Table 1. Parameter estimates and confidence intervals.
βˆ0 (95% CI)
Intercept 1.031 (0.56; 1.51)
Protection method βˆ (95% CI)
Table −0.011 (−0.369; 0.346)
Screen −0.486 (−0.788;  −0.184)
Cabin −0.648 (−1.118;  −0.177)
Procedure βˆ (95% CI)
CA PTCA Reference
PM/ICD 0.610 (0.225; 0.995)
RF ablation −0.025 (−0.355; 0.305)
Tube configuration βˆ (95% CI)
Above Reference
Below −0.869 (−1.249;  −0.489)
Biplane −1.183 (−1.681;  −0.684)
Experience βˆ (95% CI)
High Reference
Low 0.057 (-0.178; 0.293)
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The PERT distribution was preferred over the triangular distribution, which is commonly 
used to model data elicited from experts or assembled from a variety of published courses, 
as it does not suffer the same potential for systematic bias [37]. Like the triangular distribu-
tion, the PERT distribution emphasizes the ‘most likely’ value over the minimum and maxi-
mum estimates. However, unlike the triangular distribution the PERT distribution constructs 
a smooth curve which places progressively more emphasis on values around (near) the most 
likely value, rather than on values around the edges.
The considered PERT distribution profile is shown in figure 2.
The metaregression model fitted to incorporate the changes in DAP over time was 
893.34– ⋅0.43  year. Therefore, the estimated dose in μSv Gy · cm−2 is multiplied by the 
corresp onding factor taking into account the year to obtain an estimated dose per procedure 
(in μSv). This dose is finally multiplied by the number of procedures carried out that year by 
the user and converted into mGy to be reported by the tool.
Doses to the brain were estimated as a function of modelled eye lens dose assuming a 
linear relationship. This function was estimated by way of carrying out measurements in a 
typical angiography room. Doses were measured using thermoluminescent dosimeters (TLD) 
in a CIRS 702-D anthropomorphic female phantom, which was draped with a lead apron and 
a thyroid shield, and positioned laterally to a single flat panel detector (Philips Allura XPer 
Figure 2. Profile of a PERT distribution with minimum 1, maximum 10 and mode 3.
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FD10) (figure 3). The patient was simulated with polymethyl methacrylate (PMMA) slabs 
assembled as a rectangular cuboid of dimensions    × ×25.2 cm 20 cm 40.5 cm. Eleven TLDs 
were used for brain dosimetry (distributed across four 2.5 cm slabs), and 2 TLDs were used to 
measure doses to the eye lens. Absorbed doses were measured for the eyes and for the brain 
(those parts considered most relevant in terms of tumours). The ratios between each measured 
eye dose and a brain dose weighted on the volumes of individual anatomical regions in which 
the TLDs were placed, were calculated for use as a conversion factor from eye dose to brain 
dose. This conversion factor was found to be between 3.40 (eye furthest from fluoroscope) and 
8.08 (eye closest to fluoroscope). Operators increasingly work from both sides of the patient 
during procedures [1]. In order to account for uncertainties due to positioning of the inter-
ventionalist in our estimation of brain dose, the conversion factor was defined as a uniform 
distribution between 3.40 and 8.08.
2.3. Risk estimation
In addition to providing estimates of dose to the eye lens and to the brain, the tool also provides 
the user with estimates of the magnitude of health impacts associated with cumulated doses of 
IR, specifically in terms of the relative risk (RR) of radiation-related cataracts and the lifetime 
fractional risk (LFR) of CNS tumours, a measure that scales the lifetime attributable risk (LAR) 
to the lifetime spontaneous cancer incidence or mortality [41]. For the sake of internal consis-
tency and to ease comparisons to other studies, RR of CNS tumours are also shown.
In the case of the eye lens, we calculated a dose-response coefficient for stage 1 to 5 cataracts, 
by scaling summary risk estimates at 1 Gy derived from the epidemiological literature [11] (Odds 
Ratio: 1.70; 95% confidence intervals: 1.22, 1.38). Using the published 95% confidence intervals 
for the summary risk estimates it was possible to calculate the standard error (SE) and thereby 
define the dose-response function probabilistically. Although the risk estimates at 1 Gy proposed 
in [11] were obtained through a log-linear model, the excess relative risk model was preferred in 
InterCardioRisk tool in order to ensure reasonable risk estimates at the highest doses.
Figure 3. Set-up of anthropomorphic phantom in angiography room.
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The time between irradiation and the appearance of lens opacities is still uncertain but nev-
ertheless, early work on radiation-induced cataract among the atomic bomb survivors showed 
an approximate average latency period for development of lens opacities of 2–3 years [42, 43]. 
As we are quantifying risks of cataracts of a range of severities, starting from stage 1, which 
are just minor changes in the lens, lower severity than those studied in atomic bomb survivors, 
we considered a lag of 5 years.
By way of Monte Carlo simulation, the tool uses the dose-response function and the sce-
nario-specific distributions of cumulated absorbed dose to the eye lens to calculate a distribu-
tion of RR under each scenario.
The LFR of CNS tumours was estimated using the methods developed by the BEIR VII com-
mittee [44] and data from the 1958–98 Life Span Study data [45], as was carried out in devel-
oping the NCI RadRAT tool [16]. This is computed as LFR  =   
B
LAR, where ∫=B m a S a0
110 ( ) ( ) 
is the baseline risk for a general population (m(a) is the background cancer incidence in the 
European population) and LAR is the lifetime attributable risk, computed as suggested by the 
BEIR VII committee:
( ) ( )( )∫ β= γ
ν
+
∗
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where e is the age at exposure, =∗ −e e 30
10
 if e  <  30 or e*  =  0 otherwise, a is the attained age 
and according to the BEIR VII committee and [16], β = 0.71, 0.24s  for males and females 
respectively, γ = −0.3 and ν = −1.4. L is the latency period, considered to be of 5 years 
for all solid cancer by BEIR VII committee. ( )( )
S a
S e
 is the probability of being alive at age a, 
given that an individual is alive at age e, and D is the estimated dose. The approach used here 
for dose and dose-rate effectiveness factor (DDREF) is the same that was used in [16], i.e. 
described by a lognormal distribution with a geometric mean of 1.5 and a geometric standard 
deviation of 1.35. LAR can be understood as an approximation to the premature probability of 
developing a cancer that can be attributed to radiation exposure, while LFR is useful because 
it is a relative number. Uncertainty in the LAR definition parameters (4) have been taken into 
account by means of Monte Carlo simulation.
The RR of CNS tumours are calculated according the values reported in [12].
3. Results
The tool provides us with a means to estimate the cumulated absorbed doses to the eye lens 
and brain (in mGy)—and associated health risks—under the three scenarios, and easily make 
comparisons between them. As an example, we can estimate the doses and health risks for a 
‘typical’ male interventional cardiologist born in 1960, who worked from 1985 to 2014, car-
rying out 300 procedures per year between 1985 and 2000, and then 350 per year until 2014. 
Distributions of cumulated absorbed doses to eye lens and brain under the three RP scenarios 
(‘typical working practices’, ‘no radiation protection measures used’, and ‘protective equip-
ment fully employed’) are presented as histograms (figure 4).
Median annual absorbed doses for each scenario (figure 5) are also presented by the tool in 
tabulated form, along with 95% credibility intervals (CI). The figure illustrates an increase in 
dose of about 15%–20% (depending on the scenario) after 2000 due to increased workload (from 
300 annual procedures to 350). It also reflects the impact of the introduction of new radiation 
protection measures, for instance a large reduction in annual absorbed doses can be seen in 1990, 
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when an increase of 25% in the usage of lead glasses is assumed. In this example, the estimated 
total cumulated absorbed lens dose is about 200 mGy (95% CI: 40, 645) under the ‘typical 
working practices’ scenario. If no protection methods are used, these values are increased to 380 
mGy (95% CI: 200, 800). In the scenario under the usage of all available protection methods, 
the estimated dose is 40 mGy (95% CI: 10, 140). The R code to generate figure 4 and figure 5 is 
provided as supplementary material (stacks.iop.org/JRP/36/561/mmedia). All the assumptions 
on changes in RP measures usage are based on the results of the O’CLOC study (Occupational 
Cataracts and Lens Opacities in Interventional Cardiology, [21]). The O’CLOC study included 
about 40 French centers ([46]), with a balanced distribution of the centres across France and a 
balanced distribution of public and private hospitals ([46, 47]). The resulting differences in esti-
mated health risks calculated for the three scenarios are shown in table 2.
It is clear that the use of protection methods has a great impact on reducing cumulated 
absorbed doses to the eye lens and, subsequently, on reducing the risk of cataracts. If we compare 
the doses to the eye lens incurred under a scenario in which no protection methods are used at 
all, these impacts become all the more apparent. The user can also see the difference between the 
different protection methods usage scenarios on the cataract risk. For example, figure 6 shows 
the difference in the distribution of RR and LFR of CNS tumours and RR of stage 1–5 cataracts.
4. Discussion
We developed a novel tool, InterCardioRisk, that allows IC personnel to estimate their annual 
and cumulated doses to the eye lens and brain, and associated potential health impacts in terms 
Figure 4. Estimated probability density function of distributions of cumulated 
absorbed doses (mGy) to the eye lens (upper panel) and brain (lower panel), for a 
typical cardiologist working between 1985 and 2014.
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Figure 5. Annual absorbed doses (mGy) to eye lens (upper panel) and brain (lower 
panel), for a typical cardiologist working between 1985 and 2014.
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Table 2. Estimates of potential health risks for the three different RP scenarios, in terms 
of relative risks of cataracts for doses to the eye lens and RR and lifetime fractional risk 
(LFR) for CNS tumours, for a typical cardiologist working between 1985 and 2014.
Outcome Scenario
Measure  
of risk Estimate (95% CI)
Stage 1–5 
cataracts
Typical working practices RR 1.11 (1.02, 1.51)
Protective equipment fully 
employed
1.02 (1.01, 1.10)
No radiation protection 
measures used
1.22 (1.09, 1.58)
CNS tumours Typical working practices RR 1.05 (1.01, 1.30)
Protective equipment fully 
employed
1.01 (1.00, 1.06)
No radiation protection 
measures used
1.10 (1.02, 1.44)
CNS tumours Typical working practices LFR 1.00 (1.00, 1.01)
Protective equipment fully 
employed
1.00 (1.00, 1.00)
No radiation protection 
measures used
1.01 (1.00, 1.02)
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of risk of cataracts and CNS tumours. Specifically, the tool allows the user to compare esti-
mated doses to a worker with a typical career and typical use of RP measures, and the associ-
ated estimated risks of cataract and CNS tumour, with the reductions in dose expected where 
protective equipment is employed to the maximum possible extent. By extension, the output 
of the tool allows for estimation of the expected health benefits for that population associated 
with increased use of available RP measures. The InterCardioRisk tool directly supports the 
aims of RP, and would make a useful addition to the RP training of those working in IC. In 
particular, the use of LFR as the risk metric facilitates direct comparison with the lifetime 
cancer risk of a person of the same age and sex in the general population. For those already 
employing RP practices effectively in their work, the small magnitude of increased risks 
serves as a reassurance that they are successfully minimising their occupational exposure. By 
the same token, those not following RP guidelines may be motivated towards employing RP 
measures to reduce their cumulated doses and attendant health risks.
Cumulative eye lens doses estimated by the InterCardioRisk tool are consistent with the 
results of the French O’CLOC study [21, 46, 47]. This study presented a retrospective assess-
ment of cumulative eye lens doses for interventional cardiologists and electrophisiologists 
using dose data from the ORAMED project, as well as information on the workload, radia-
tion protection equipment and dose reduction factors. The authors reported a median cumu-
lative eye lens dose of 309 mSv, ranging from 25 mSv to more than 1600 mSv, for 129 
interventional cardiologists at an average age of 51 who had worked for an average period 
of 22 years, similar to the estimates provided by the InterCardioRisk tool using Jacob’s data 
under the typical working practices scenario (median of 314 mSv, with a credibility interval 
of (61 mSv–1142 mSv)). In contrast with these dose levels, other studies report cumulative 
Figure 6. Estimated probability density function of distributions of stage 1–5 cataracts 
RR (upper panel) and CNS tumours RR and LFR (lower panel) for a typical cardiologist 
working between 1985 and 2014.
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eye lens doses significantly higher. These studies are based on a different, common methodol-
ogy [48–51], using experimental data of scattered dose factors per unit DAP measured with 
electronic dosemeters, corrected by the operator position and the use of protective devices, 
and reported workload. Cumulative eye lens doses reported in these works are of 6 Sv 
(100 mSv–27 Sv) (median value, average age of 46, average working period of 14 years) [48], 
3.7 Gy (20 mGy–43 Gy) (mean value, average age of 42, average working period of 9.2 years) 
[50] and 420 mSv (46 mSv–7.3 Sv) (median, average age of 43, average working period of 
8 years) [51]. These values lead to average annual doses ranging from 53 mSv to 429 mSv, in 
contrast with an annual dose of 14 mSv issued from InterCardioRisk and Jacob’s paper. The 
different doses estimated by each methodology fall within the large ranges of dose reported in 
the literature. The variation in reported doses is associated with the high degree of uncertainty 
in measurements of lens dose, with different methodologies used, and the assumptions used 
to extrapolate eye doses from other dose measures [52]. However, we consider that estimates 
based on ORAMED measurement campaign are likely to provide more realistic outcomes 
because doses were measured under real conditions.
There have been several reports made regarding radiation-induced cataract in ICs who have 
performed procedures for a number of years, and of equivalent doses to the lens approaching 
the annual limit of 150 mSv during angiographic procedures [48, 53–55]. Recent studies have 
shown that under typical workloads of an IC, the radiation dose to the lens may exceed the cur-
rent threshold for tissue reactions after several years of work if radiological protection devices 
are not used and radiological protection principles are not followed [6, 53]. Several surveys 
of cardiologists and support staff working in catheterisation laboratories, conducted with co-
ordination provided by the International Atomic Energy Agency (IAEA) in Latin America and 
Asia, have found a high prevalence of lens opacities of the type associated with occupational 
radiation exposure [50, 53]. These recent data and the mechanistic uncertainties regarding cata-
ract development highlighted the need for a detailed re-appraisal of the radiosensitivity of the 
lens of the eye. This issue is addressed in Publication 118 of the ICRP and in the Commission’s 
statement on tissue reactions [56, 57]. The previous Commission recommendation [58] of an 
equivalent dose limit of 150 mSv y−1 for occupational exposure in a planned exposure situa-
tion (e.g. occupational exposure of interventionalists) has been changed. The Commission now 
recommends that the lens-equivalent dose limit for chronic occupational exposure should be 
20 mSv y−1, averaged over a defined 5-year period, with no single year exceeding 50 mSv 
(i. e. the same as the annual whole-body limit for workers) [56, 57]. Note that a study  performed 
with data from 1984 through 1988, when both cardiac interventions and fluoroscopic equip-
ment were less sophisticated than they are now, determined that the annual equivalent dose 
to cardiologists’ heads was approximately 20–30 mSv [59]. The Commission considers the 
threshold for absorbed dose to the lens of the eye to be 0.5 Gy [56]. The Commission judges, 
based on existing evidence, that an acute dose of up to around 0.1 Gy (100 mGy) produces no 
functional impairment of tissues, including the lens of the eye with respect to cataract, although 
the use of a threshold model remains uncertain for this tissue [56].
As the degree of usage of available RP measures determines an operator’s absorbed dose 
to a great extent, our tool provides an invaluable means for an individual to quantify the effi-
cacy of using those measures in their daily practice. Some RP measures like cabins are not 
generally available or usable.However, very appreciable reductions in absorbed doses can 
be attained through using the most common protection measures properly, in particular lead 
glasses and ceiling-suspended screens. The presentation of the estimates of absorbed dose in 
the various scenarios side by side exemplifies the very real importance of making use of the 
measures available to reduce dose, further supported by estimation of the associated health 
risks. The most important sources of uncertainty are taken into account through Monte Carlo 
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simulation, thereby showing these outputs as ranges. Upon identifying a high rate of radia-
tion lens injuries in a population of Colombian interventional cardiologists [48], the authors 
highlight the urgent need to take appropriate action to increase the use protective measures 
and strengthen training programmes in RP. Tools such as the one presented in this work can be 
useful for this purpose, as the difference in absorbed dose and associated health risks between 
the distinct scenarios of use of protective measures is easily quantified. Although treatment 
of cataracts is a relatively straightforward procedure nowadays, this should not encourage 
interventional cardiologists to take an increased risk of cataracts lightly: not all operations to 
remove cataracts are successful, and complications may result in irreversible opacities which 
could diminish a surgeon’s ability to continue with their work.
5. Limitations
We consider that the outputs of InterCardioRisk tool are of potentially great usefulness to the IC 
and RP communities, but with some limitations. Relatively sparse historical data were available 
on working practices—both in terms of IC procedures and RP measures taken—so estimates 
of dose made by the tool may be inaccurate when used in those working environments where 
practices over the past 40 decades have differed greatly to those common in France. Also, 
it is conceivable that as cardiologists progress through their careers, they may increasingly 
focus on a particular type of intervention. This may also result in divergence between their true 
cumulated dose and those estimated by the tool. For example, those working in paediatric IC 
may be required to work much closer to the x-ray beam due to the size of the patient, and as a 
result have higher doses. Similarly, those working predominantly in emergency interventional 
treatment of heart attacks have less time to configure radiation shields prior to catheterisation.
The tool predicts various kind of cataracts at all stages of development from stage 
1—defined as discrete posterior subcapsular cataract (PSC) or cortical opacity in a small area 
of the lens—to stage 5—defined as a mature cataract with complete lens opacification. This is 
a broad definition, and includes a variety of different kinds of cataract, each of which has a dif-
ferent pathogenesis and prognosis. IR has been found to be most strongly associated with PSC 
formation [10, 60]. Unlike age-related cortical or nuclear cataracts, which primarily cause a 
change in visual acuity, a PSC cataract is more likely to result in changes in both visual acuity 
and contrast sensitivity [61]. The RR of radiation-induced PSC cataracts is somewhat higher 
than that of other kinds of cataract, hence the tool may be slightly underestimating the risk of 
cataract specifically related to radiation dose.
Evidently, the validity of our assumption that OR is a good estimate of the RR is depend-
ent on the incidence of the health outcome of interest in the unexposed population (i.e. the 
baseline rate). Although such an assumption is reasonable for rare outcomes such as cancers, 
the high incidence of cataracts in the unexposed population results in a slight overestimation 
of the risk of cataracts when using OR to estimate measures of risk and health impact. It was 
not possible to adjust the ORs using baseline rates as reliable baseline rates of the specific 
cataract types of interest were not available for European populations. We simulated the effect 
of using the OR in place of the RR on our estimates of health impact for a number of base-
line rate scenarios. If baseline rates of stage 1–5 cataracts were 25%, we estimated that our 
risk estimate might be overestimated by less than 10%. The OR reported in [11] are obtained 
from Chernobyl clean-up workers, and although these are the most comprehensive estimates 
to date, and are compatible with those obtained from studies of surgically removed cataracts 
in the atomic bomb survivors study [45], there are issues concerning the adequacy of current 
dosimetric estimates.
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In order to calculate a dose conversion factor between absorbed dose to the eye lens and 
absorbed dose to the brain, it was necessary to make a number of relatively crude simplifica-
tions. TLDs were positioned only in some of the anatomical regions of the brain, and dose was 
averaged over those regions using their approximate sizes as weights. When combining the 
brain dose data with dose-response and population data on cancer incidence in the calculation 
of LFR, it was necessary to assume that the brain and the whole CNS could be considered as 
‘equivalent’, in the sense that dose-response and incidence data were only available for brain/
CNS tumours combined. Any dose estimate to the brain is therefore considered to be valid 
for the CNS; when considering the CNS as a whole, it is therefore possible that dose has been 
overestimated. Since the majority of CNS tumours occur in the brain, however, and that the 
brain makes up the greater part of the CNS, we do not imagine that this overestimation has a 
large impact on the estimates of CNS tumour risk generated by the tool.
6. Recommendations for further work
Following discussions with cardiologists and RP staff, a number of improvements and 
extensions are planned for the tool. In particular, we would like to include the estimation of 
absorbed doses for other organs and calculation of risks for other endpoints. Extension of the 
tool to include other measures of health impact would be merited as a means of maximising 
the population for which the tool provides useful information. For example, it would be pos-
sible to estimate the total disability-adjusted life years (DALYs) for the health outcomes con-
sidered. Although not without its drawbacks, the use of DALYs allows for the synthesis and 
compariso n of health impacts due to multiple diseases within a single framework. Currently, it 
is far from clear which metric might best communicate the gravity of potential health impacts 
to the target populations of interest i.e. interventional cardiologists, electrophysiologists and 
RP staff in hospitals. Further work on quantifying the efficacy of the tool to communicate 
health impacts to IC staff is necessary in order to refine it. A pilot version of the tool was sent 
to a group of over 100 experts in RP, medical radiation dosimetry and IC together with an 
online questionnaire designed to gauge their opinions on the user-friendliness of the tool, their 
perceptions of the magnitude of estimated doses, and the tool’s usefulness in terms of improv-
ing compliance with RP guidelines and, ultimately, in reducing potential health impacts, and 
as a perspective to this work, with the aim of keeping the tool updated with the current stan-
dard procedures and RP methods usage in IC, a survey will be prepared including questions 
regarding the protection methods the IC use and their reasons for not following all guidelines.
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The goal of the present work was to report and investigate the performances of a new iterative reconstruction algorithm, using a
model observer. For that, a dedicated low-contrast phantom containing different targets was scanned at four volume computed tom-
ography dose index (CTDIvol) levels on a Siemens SOMATOM Force computed tomography (CT). The acquired images were
reconstructed using the ADMIRE algorithm and were then assessed by three human observers who performed alternative forced
choice experiments. Next, a channelised hotelling observer model was applied on the same set of images. The comparison between
the two was performed using the percentage correct as a figure of merit. The results indicated a strong agreement between human
and model observer as well as an improvement in the low-contrast detection when switching from an ADMIRE strength of 1–3.
Good results were also observed even in situations where the target was hard to detect, suggesting that patient dose could be further
reduced and optimised.
INTRODUCTION
Over the past decade, the radiation dose delivered to
patients via diagnostic X-ray imaging has continuous-
ly increased until today, where it reaches 25 % of the
accumulated man-made and natural radiation contri-
butions. Among that 25 %, computed tomography
(CT) raises a particular concern, since this imaging mo-
dality represents in Switzerland for example 68 % of
the collective dose, yet only 8 % of the number of exam-
inations(1). In this context, CT manufacturers have
developed new strategies like iterative reconstruction
(IR) algorithms in order to ensure that the benefits–
risk ratio remains in favour of the patient. This new
technology certainly improved the clinical practice(2),
but it has also led to drastic changes in image percep-
tion. Thus, ensuring an adequate level of image quality
while keeping patient’s exposure as low as reasonably
achievable constitutes a new challenge to be addressed.
The use of task-based image quality assessment method
could represent an efficient way to perform this opti-
misation scheme(3, 4). Therefore, the goal of this study
was to report and investigate the performances of a
new IR technique using a model observer that mimics
human detection of low-contrast targets: the channe-
lised Hotelling observer (CHO) model.
MATERIALS AND METHODS
Data acquisition
A dedicated low-contrast phantom (QRM, Moehrendorf,
Germany), mimicking the attenuation produced by a
patient’s chest, was used. The phantom could embed
two different custom-made modules in its middle: a
homogeneous modulus and another containing low-
contrast spherical targets of 6 and 8 mm in diameter
with contrast levels of 10 and 20 HU at 120 kVp.
Data acquisition was performed at the University
Hospital Zurich on a third-generation dual-source
192-slice CT scanner (SOMATOM Force, Siemens
Healthcare, Erlangen, Germany). A tube voltage
of 120 kVp, a 300 mm display field of view (DFOV),
a 512 ` 512 matrix size and 2.0-mm-thick slices,
which were reconstructed every 1.0 mm, were used.
Acquisitions were performed in the helical mode with
a pitch of 0.98. Four dose levels [1.0, 3.5, 8.0 and 15.0
mGy expressed in a volume computed tomography
dose index (CTDIvol) phantom of 32 cm in diameter]
were investigated, using the procedure described in
the IEC 60601-2-44(5) to measure the CTDIvol. The
phantom was scanned 20 times for each condition.
Reconstructions were performed using the Siemens
advanced model iterative reconstruction (ADMIRE)
with strength levels 1 and 3. On the machine, users
can choose ADMIRE levels ranging from 1 to 5, with
level 1 being closest to the image impression of trad-
itional, filtered back-projection, and level 5 showing
the strongest noise reduction. In the end, 32 different
categories were obtained (four dose levels, two
ADMIRE levels, two contrast levels and two target
sizes). From these sets of acquisitions, regions of
interest (ROIs) of 41`  41 pixels (0.59 mm pixel size)
containing the centred targets were extracted. For
each category, 100 images containing a signal
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(20 scans` 5 targets with identical size and contrast
in the phantom) and 1000 images with only noise
were extracted. The ROIs that contained noise only
were extracted from the homogeneous modulus,
whereas the ROIs containing the signals came from
the low-contrast modulus. This methodology enabled
holding the same position on the (x,y) plane for both
signal and noise ROIs, in turn enabling solving the
noise stationarity problem.
Human observer
In the human observer experiment, three medical
physicists took part in four alternative forced choice
(4-AFC) experiments in order to yield a percentage of
correct responses (PC) indicating how well they
managed to detect the signals. The 4-AFC experiment
consisted in selecting the signal-present image in a
batch of three signal-absent images and one signal-
present image, which were presented together in a
randomised order. All observers were blinded to the
CT acquisition and reconstruction conditions and
began their test with a training session that was made
of images acquired at high dose level. They were then
asked to make decisions for all 32 categories acquired.
The previously made acquisitions provided 100
signal-present ROIs and 1000 signal-absent ROIs for
each category. ROIs among those data were selected
randomly and used for the 4-AFC tests. For each ob-
server and category, every answer to the 100 trials was
stored and compared with the correct response, allow-
ing the computation of the PC.
CHOmodel observer
A model observer enables to predict the detection of
low-contrast signals by calculating a scalar response
called the decision variable and denoted by li. This
parameter is given by
li ¼ wT  gi ; ð1Þ
where w is the template of the model observer, and gi
is the analysed ROI (i ¼ n or i ¼ s represents signal-
absent or signal-present hypothesis, respectively).
The CHO model used in this study is an anthropo-
morphic model observer also including preprocessing
of the image by a set of channels that enhance some
spatial frequencies(6, 7). The template wCHO of this
model is obtained as explained in the following part
(extensive details can be found elsewhere(8 – 11)):
wCHO ¼ 12 ðKcs þ KcnÞ
 1
ðgcs  gcnÞ; ð2Þ
where
Kcn ¼ UTKnU and Kcs ¼ UTKsU : ð3Þ
In this equation, Kn and Ks are the covariance matrix
calculated, respectively, from the signal-absent and
signal-present data, and U is the matrix representa-
tion of the channel filters described more extensively
below.
In Equation 2, gcs and gcn are the means of the
channel outputs under a signal-present and signal-
absent hypothesis and can be estimated according to
gcs ¼ UTgs and gcn ¼ UTgn: ð4Þ
The employed set of channels is called dense dif-
ference of Gaussian (DDoG) channels and was
described by Abbey and Barrett in 2001(12). It in-
cludes 10 channels for which the radial frequency
profile of the jth channel is given by
UjðrÞ ¼ exp  12
r
Wsj
 2" #
 exp  1
2
r
sj
 2" #
; ð5Þ
where r is the spatial frequency, W ¼ 1.67 defines the
bandwidth of the channel, and sj is the standard devi-
ation of the jth channel. Each sj value is defined by the
equation sj ¼ soaj with so ¼ 0.005 and a ¼ 1.4(12).
The decision variable can then be calculated by
injecting the channel output of the ROI (denoted
by gci) and the template wCHO in Equation 1:
li ¼ wTCHO  gci: ð6Þ
The PC was obtained using the CHO model to
perform 4-AFC tests on the acquired images. The
value of the decision variable was used to determine
which of the four images contained the signal (the
highest value of l is supposed to be the signal-present
image). Then, the results of the model observers were
compared with the truth in order to enabling the com-
putation of PCs.
Uncertainty estimation
The uncertainties of the models’ results were esti-
mated by performing bootstrap(13). According to the
bootstrap method and the set of 100 signal-present
ROIs, the 4-AFC test was performed 150 times for
each category, leading to 150 values of PC. Then, the
mean and standard deviation of the 150 values
obtained were computed in order to determine the
final mean PC value as well as its standard deviation
for each acquisition condition. This allowed to esti-
mate a 95 % confidence interval. The uncertainties
for the human observers were calculated using the
results of the three different observers. For each cat-
egory, the mean PC value of the observers and its
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standard error were calculated in order to display a
95 % confidence interval.
RESULTS
In this section, the qualities of the images obtained
using the ADMIRE algorithm with strength levels 1
and 3 are assessed through the performances of
model (Figure 1) and human observers (Figure 2).
Results of the CHO model with the DDoG channels
suggest that both strength levels exhibited PCs in the
same range with an increase of a few per cent in the
results when switching from strength level 1 to 3. This
trend was, however, only observed for certain signals
and dose range, namely the lowest contrast (10 HU)
associated to low dose levels (1.0 and 3.5 mGy).
Human observers exhibited results very similar to
the ones obtained with the CHO model in terms of
PC values. The results also suggest that the use of
higher ADMIRE strength level is useful to improve
the detection of small-size and low-contrast signal
under low CTDIvol. On top of that, it was observed
that the largest signal size (8 mm) with the highest
contrast (20 HU) corresponded to a trivially easy task
Figure 1. Results of the CHO model observer (in PC,
obtained by performing 4-AFC tests).
Figure 2. Results of the three human observers (in PC,
obtained by performing 4-AFC tests).
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with PC always equal to 100 % no matter which dose
and ADMIRE level was employed. Those results re-
mained true for both human and model observers
and are therefore not presented in Figures 1 and 2.
Model and human observers exhibited a great ad-
equacy in their results, both of them indicating that the
use of a higher ADMIRE level enhances the detection
when working under conditions where the signal is hard
to detect. It was also witnessed that the PC increases
with the given dose until it reaches an asymptote and
that this asymptote is reached faster when using higher
ADMIRE strength level. Furthermore, the results en-
lighten that no more dose increase is needed once an
amount of 4 mGy is reached because the perform-
ance of the human observer is already almost maximal
at this point.
DISCUSSION
The goal of the present investigation was to determine
if the use of the ADMIRE algorithm at different
strength could lead to a high detection performance,
therefore allowing a further dose reduction in the clin-
ical practice. The results showed that the CHO model
with DDoG channels gave coherent results since it
reproduced the behaviour of humans very well and
under a wide range of conditions and signal contrasts.
The model seems to be very efficient in low-contrast
detection and even sometimes overestimates human
results for low contrast and low doses. These results
are coherent with recent studies from Leng and Yu(14)
which showed the efficiency of the CHO model for
the low-contrast detection. Also, both model and
human observers reported a visible improvement in
the low-contrast detection when increasing the
ADMIRE strength. This trend was observed when
working at low dose levels (,4 mGy) for all signal
types. Indeed, when working at higher dose levels, the
PCs always reached 100 %, letting no room for im-
provement. In the end, the use of ADMIRE makes it
possible to diminish the dose without losing informa-
tion in the image. Indeed, the PC results obtained in
the study reach very high or perfect values for almost
every acquisition condition and signal, indicating that
a dose reduction without impacting the detection per-
formance would be possible.
However, some limitations of the present study
have to be underlined. First among them, the number
of images acquired may be considered as low since
not enough ROIs were disposed to separate them in
two exploitable data sets. Usually, a first set is used for
the computation of the covariance matrix in the deter-
mination of the template of the CHO model, while
the second data set is used for the computation of
the PCs. However, it is worth to underline that Barrett
and Myers(15) who studied this problem concluded
that using one single set of data remained a reliable way
to proceed. Moreover, performing a limited number of
acquisitions (20 scans for each acquisition condition in
the present case) allowed to reduce the operating time
of the device, which is appreciable when working in a
clinical environment. The second limitation faced is
that the paradigm worked with (when the signal, loca-
tion and background are exactly known) was simplified
and therefore different from real anatomical conditions.
The results could nevertheless be used in order to as-
sess the performances of the tested IR algorithms, but
it is worth to mention that there is room for a more
complex study on the subject.
CONCLUSION
Nowadays, assessing CT image quality cannot be
done with image space metrics anymore. Moreover,
evidence indicates that frequency metrics should not
be used either when working with IR. However,
the task-based tool used in this investigation (CHO
model observer associated to the DDoG channels)
successfully demonstrated its ability to reproduce the
human’s response in a low-contrast detection task,
thus establishing its reliability for image quality
assessment.
The results obtained with this tool revealed that
the ADMIRE algorithm led to high PCs even in
situations where the target was harder to detect (i.e.
low CTDIvol and contrast level). Also, using higher
ADMIRE strength led to PC improvement, particu-
larly in the low CTDIvol range. Therefore, using those
benefits to keep the image quality equivalent to what
was previously obtained would enable to spare some
delivered dose.
All those elements suggest that the patient dose
could be further optimised and reduced thanks to the
use of the ADMIRE algorithm and this new CT unit.
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BENCHMARKING OF CT FOR PATIENT EXPOSURE
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Patient dose optimisation in computed tomography (CT) should be done using clinically relevant tasks when dealing with image
quality assessments. In the present work, low-contrast detectability for an average patient morphology was assessed on 56 CT
units, using a model observer applied on images acquired with two specific protocols of an anthropomorphic phantom containing
spheres. Images were assessed using the channelised Hotelling observer (CHO) with dense difference of Gaussian channels. The
results were computed by performing receiver operating characteristics analysis (ROC) and using the area under the ROC curve
(AUC) as a figure of merit. The results showed a small disparity at a volume computed tomography dose index (CTDIvol) of
15 mGy depending on the CT units for the chosen image quality criterion. For 8-mm targets, AUCs were 0.999 + 0.018 at 20
Hounsfield units (HU) and 0.927 + 0.054 at 10 HU. For 5-mm targets, AUCs were 0.947 + 0.059 and 0.702 + 0.068 at 20
and 10 HU, respectively. The robustness of the CHO opens the way for CT protocol benchmarking and optimisation processes.
INTRODUCTION
In 1997, the European Council Directive 97/43/
EURATOM(1) required that medical physics experts
(MPEs) be involved in the optimisation process of
radiological diagnostic procedures. That recommen-
dation has been translated into the Swiss Radiological
Protection Ordinance and was officially applied in
2008(2): ‘For nuclear medicine applications and for
fluoroscopy-guided interventional radiology and com-
puter tomography, the licence holder must periodically
enlist the services of a medical physicist’.
The objective is to involve the medical physicist in
the optimisation process of medical devices, especially
in CT, which is one of the most commonly used tools
in the medical imaging field and which is responsible
for the highest dose delivered to the population from
diagnostic radiology. Evaluating image quality is
crucial when optimising or comparing CT devices, re-
construction algorithms and clinical protocols in
order to respect the as low as reasonably achievable
(ALARA) principle, especially with the introduction
of iterative reconstruction into CT because the stand-
ard Fourier metrics are no longer applicable(3, 4). The
aim of this study was to provide an objective tool to
compare CT protocols and to develop methods to
then use the devices at their full potential, i.e. using
the minimum dose while maintaining image quality
for diagnosis. This optimisation scheme relied on the
use of task-based metrics that approximate the clinic-
al task in order to qualify the image quality and facili-
tate the cooperation between medical physicists,
radiographers and radiologists.
Clinical diagnosis is composed of three tasks: the
detection task, the localisation task and the character-
isation task. In the present case, the detection task
performance was evaluated with a mathematical ob-
server model, which is used to substitute the human
observer. The use of these tools provides an objective
metric to evaluate image quality. The advantage of
this approach is that it takes into account the entire
imaging chain at the same time as it remains as close
as possible to a simplified diagnostic task.
During the authors’ visits to the various centres,
image acquisitions were performed together with the
verification of the indicated volume computed tomog-
raphy dose index (CTDIvol) and the assessment of
other parameters such as X-ray beam efficiency and
the Hounsfield unit (HU) calibration in water at the
available X-ray tube voltages(5). This contribution
will focus on a CT benchmarking based on a model
observer. The first aim was the assessment of image
quality on several CT units at a given dose level. The
second aim was the assessment of image quality while
using different acquisition parameters.
MATERIALS AND METHODS
Model observer: channelised Hotelling observer
Anthropomorphic model observers are mathematical
models based on the statistical decision theory to esti-
mate the detection performance of human observers.
In this study, a linear anthropomorphic model was
chosen, namely the channelised Hotelling observer
(CHO)(6, 7), which is usually used to evaluate the
image quality. As Ott et al.(8) demonstrated, the CHO
can mimic the human observer performance for a de-
tection task. In this case, the methodology used for
the CHO is directly inspired by the methodology used
by Ott et al., and extensive details can be found in the
chapter on the CHO model observer(8).
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Performance measurement of the model observer
All decision variables provide a distribution depend-
ing on the presence or absence of a signal. In the
receiver operating characteristics (ROC) analysis, if
the decision variable calculated using an image con-
taining the signal is above the threshold, then the
response is considered true positive. If this variable is
calculated with the image containing only noise is
above the threshold, then the response is considered
false positive. For a given threshold, a true positive
fraction (TPF) and a false positive fraction (FPF) are
obtained, and the ROC curve is then constructed
from pairs of TPF and FPF.
The ROC curve can give a complete description of
the performance of an observer. To summarise the
performance of an observer, the area under the curve
(AUC) can be calculated(9). It ranges from 0 to 1,
with a value of 0.5 meaning that the test is not better
than tossing a coin to give a positive or negative
answer, and was estimated using the trapezoidal
method with 100 points.
Description of phantom and CT units
An abdominal anthropomorphic phantom (Figure 1)
(QRM, Moehrendorf, Germany) was scanned in 56
CT units (20 % of all CT units in the country). This
phantom is composed of an external shell intended to
closely mimic the X-ray attenuation of an abdomen
during a CT examination, and of two embeddable
modules. The materials used represent three densities
and anatomical shapes of the human body:
- Liver (55 HU at 120 kV),
- Spleen (55 HU at 120 kV),
- Vertebra (cortical and cancellous bone).
The uniform phantom background is equivalent to
the soft tissue of the abdomen (35 HU at 120 kV).
Two modules can be inserted into this external
shell: a homogeneous module identical to the back-
ground phantom and a module containing low-con-
trast signals. These signals are spheres of different
sizes (8, 6, 5, 4 and 3 mm) with contrasts of 220 and
210 HU at 120 kV with respect to the background.
In 2014, the equipment from four CT manufac-
turers in Western Switzerland was investigated with
the range of the detector coverage represented in
Table 1 (in detail 20 devices for Philips, 18 for GE, 12
for Toshiba and 6 for Siemens).
Acquisition protocols
The acquisitions were performed following two
protocols:
† One protocol called ‘Reference’ with the same
parameters for all radiological services. Acquisitions
were performed at 120 kV, and the tube current was
adapted to get indicated CTDIvol values of 15 mGy
[the diagnostic reference level (DRL) for the abdom-
inal region in Switzerland]. During the visit, the
CTDIvol values were measured on each CT unit
using a CTDIvol phantom of 32 cm in diameter and
a 100 mm pencil ionisation chamber as described in
the IEC 60601-2-44(10). The X-ray tube rotation
time was 1 s, and the pitch was close to one. The
display field of view (DFOV) was 320` 320 mm
for a 512`  512 matrix size, in order to have a con-
stant spatial resolution. Slices were reconstructed
with a nominal thickness of 2.5 or 2.0 mm asso-
ciated to an interval of 2.5 or 2.0 mm (depending
on the possibilities offered by the different manufac-
turers), respectively. Images were reconstructed only
with the filtered back-projection (FBP) in the
axial plane with a standard convolution kernel
used locally for abdominal acquisitions.
† The other protocol called ‘Local’ where the acqui-
sition parameters were those usually employed by
the centre for the detection of focal liver lesion
(i.e. FBP or iterative reconstruction algorithm was
used). The DFOV was then adjusted to 320`  320
mm for all centres in order to obtain comparable
pixel sizes. Since the spread in slice thicknesses
Figure 1. QRM phantom image from an acquisition at a
high dose level (CTDIvol 20 mGy). The phantom contains
four 8-mm spheres and five 5-mm spheres. The signals
represented in this figure have a contrast of 20 HU.
Table 1. Number of CT units included in the study for each
detector coverage range.
Collimation (number of rows) Number of CT units
16 10
32 1
40 3
64 36
80 3
128 3
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and doses used in the local protocols was large, an
alternative metric, called ‘volumetric dose’, was
used. The volumetric dose is defined as the
product of the dose and the slice thickness, corre-
sponding to the dose length product of the recon-
structed slice.
For the two protocols, the phantom was positioned
at the isocentre of the CT unit, and the module con-
taining the low-contrast spheres was scanned 10 times
successively. Then, the homogeneous module was
scanned without changing the position of the abdomen-
like shell.
Generating signal-absent and signal-present images
For practical reasons, only two sphere sizes were
investigated, namely the 5 and 8 mm (smaller sizes
were not visible enough at the dose levels investi-
gated). For each acquisition, 4 centred regions of
interest (ROIs) (22` 22 pixels, 1 pixel ¼ 0.625 mm)
per sphere size/contrast combination were extracted
from the module containing the sphere, and 8 ROIs
per slice were extracted from images of the homoge-
neous module at the same location (x,y) as the ROI
containing the signal. Hereafter, for convenience,
ROIs will be called signal-present images if the signal
is present in the ROIs and signal-absent images if the
signal is absent.
RESULTS
‘Reference’ protocol
Using a CTDIvol of 15 mGy on all systems, the detec-
tion performance for a given contrast/diameter com-
bination was globally comparable with a few outliers
(Figure 2). Centres 41 and 48 in Figure 2a and
Centres 43, 45, 46 and 47 in Figure 2c provided a
lower-level image quality when compared with the
other centres. For 8-mm targets, the averaged AUCs
were 0.999 + 0.018 at 20 HU and 0.927 + 0.054 at
10 HU. For 5-mm targets, the averaged AUCs were
0.947 + 0.059 and 0.702 + 0.068 at 20 and 10 HU,
respectively (the error represents one standard devi-
ation). Thus, the relative standard deviation was in the
range of 1–10 %, indicating, for that specific image
quality criterion and this specific acquisition protocol,
that the CT units in Western Switzerland are relatively
homogeneous at the quite high dose level investigated.
As expected, the detection was greatly enhanced when
the diameter increased (5 vs. 8 mm) as well as when the
contrast became higher (10 vs. 20 HU).
‘Local’ protocol
When using the local protocol instead of the reference
protocol, as expected, it was noticed that the detect-
ability still increased with the contrast and the
diameter of the spheres. However, it was also discov-
ered that the mean AUC did slightly change depend-
ing on the reconstruction algorithms (AUC was lower
in iterative than in FBP), but the mean delivered dose
was also much lower for the iterative algorithms
(no distinction was made between the level of com-
plexity of the iterative algorithms available) compared
with FBP. These measurements clearly highlighted
the contribution of the iterative algorithm on dose re-
duction (almost a factor of two) associated to a slight
reduction in low-contrast detectability.
Figure 3 illustrates the detection performance for
combinations 8 mm/10 HU and 5 mm/20 HU when
switching from the reference to the locally implemen-
ted protocols. Varying the parameters used [nominal
slice thicknesses (ranging from 0.5 to 7 mm), dose levels,
algorithm reconstruction and convolution kernels used
for standard abdominal protocols] in each centre slightly
increased the variability. Moreover, some centres work
with unexpected parameters, which deteriorate image
quality and increase the image quality variability. In
some cases, the CTDIvol was quite low (3.3 mGy) with
very thin slice reconstruction thickness (0.5 mm) or the
dose was quite high (12.3 mGy) with the reconstruction
of thick slices (7 mm), see three red circles in Figure 3.
In the first case, even if the image was reconstructed
with an iterative algorithm, the low-contrast detectabil-
ity could not be recovered. In the second case, the
partial volume effect was responsible for the poor score
obtained.
DISCUSSION
In this study, an objective task-based image quality
assessment was performed using a model observer
on an anthropomorphic phantom to assess image
quality. The CT units in use in the Western part of
Switzerland are relatively recent and homogeneous,
but the image quality with the ‘Reference’ protocol
was explored at a high dose level. In this case, the dis-
crimination between the CT units is limited, but this
benchmark has, however, demonstrated that several
units led, for the chosen image quality criterion, to
a lower performance. One limit of this ‘Reference’
protocol is that it investigates the image quality at one
dose level and only with the FBP algorithm. The
benefits of introducing the iterative algorithm, espe-
cially the model-based iterative algorithm, were not
explored(11). In future work, the performance of CT
units will be investigated in a range of dose and algo-
rithms in order to be able to qualify image quality in-
cluding high- and low-contrast performances.
When switching to the ‘Local’ protocol, the dose
and slice thickness varied in a wide range between the
centres and noticeable image quality variations were
observed. Based on this metric, it will be possible to
optimise and standardise the clinical practice to
D. RACINE ETAL.
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converge towards a given level of image quality for a
particular clinical examination. The main limit of the
use of the volumetric dose parameter for that part of
the study is the range of slice thickness investigated,
since partial volume effects could be very different
from one protocol to another. This could be certainly
improved by a closer collaboration between the
medical physicists and the radiologists when selecting
acquisition parameters and the range of reconstructed
slice thickness.
Figure 2. Results of a comparison of the image quality for CT units in Western Switzerland when dealing with the
‘Reference’ protocol for spheres of 8 mm/10 HU at 2.0 mm slice thickness (a), 5 mm/20 HU at 2.5 mm slice thickness (b)
and 5 mm/10 HU at 2.5 mm slice thickness (c). The red line represents the median value.
BENCHMARKOF CT
81
 at U
niversite and EPFL Lausanne on June 16, 2016
http://rpd.oxfordjournals.org/
D
ow
nloaded from
 
Thus, the proposed method seems suitable for bench-
marking the CT unit as well as the clinical protocols. The
method could be improved by adding high Z materials
targets, making it possible to optimise the choice of X-ray
tube high voltage when dealing with injected protocols.
CONCLUSION
A method for benchmarking CT units has been
applied to different CT units in Western Switzerland
for a specific task (i.e. detection of low-contrast spher-
ical targets); it appears that the image quality was
relatively homogeneous. The results also show that
the methodology could be used to assess clinically
relevant image acquisition protocols to optimise the
process of patient exposure. It was observed that the
use of iterative reconstruction allowed a significant
dose reduction (almost a factor of two) associated,
however, with a slight reduction in low-contrast
detectability.
Figure 3. Results of a comparison of image quality for 5 mm/20 HU (a) and 8 mm/10 HU (b) as a function of the
volumetric dose (CTDIvol multiplied by the reconstructed slice thickness for taking into account the various slice thicknesses
produced) regarding the practice in Western Switzerland when dealing with the protocol used for the detection of hepatic
metastasis. The red circles represent the poor image quality obtained with unexpected parameters (slice thickness
inappropriate for the lesion size).
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Evaluating image quality by using receiver operating characteristic studies is time consuming and difficult to implement. This
work assesses a new iterative algorithm using a channelised Hotelling observer (CHO). For this purpose, an anthropomorphic
abdomen phantom with spheres of various sizes and contrasts was scanned at 3 volume computed tomography dose index
(CTDIvol) levels on a GE Revolution CT. Images were reconstructed using the iterative reconstruction method adaptive statistical
iterative reconstruction-V (ASIR-V) at ASIR-V 0, 50 and 70 % and assessed by applying a CHO with dense difference of
Gaussian and internal noise. Both CHO and human observers (HO) were compared based on a four-alternative forced-choice
experiment, using the percentage correct as a figure of merit. The results showed accordance between CHO and HO. Moreover,
an improvement in the low-contrast detection was observed when switching from ASIR-V 0 to 50 %. The results underpin the
finding that ASIR-Vallows dose reduction.
INTRODUCTION
Image quality in computed tomography (CT), and hence
clinical protocol optimisation, is a challenge because
CT delivers the highest dose to the population in
Switzerland, as in most Western countries(1). To over-
come this problem, manufacturers developed new
technologies (e.g. iterative reconstruction) to minim-
ise the amount of dose delivered. However, those new
technologies must be evaluated and optimised(2, 3). To
optimise protocols, it is possible to evaluate simple
binary tasks, such as the discrimination between the
presence and absence of a pathology, which can be char-
acterised by the use of receiver operating characteris-
tic (ROC) studies(4). These methods can be used to
assess image quality especially when new reconstruc-
tion algorithms are implemented(5). Unfortunately,
these studies are time consuming and difficult to im-
plement. Developing a tool based on mathematical
model observers like the channelised Hotelling obser-
ver (CHO) to optimise clinical protocols and ensure
that dose reductions do not affect the detection of
low-contrast structures (using a similar paradigm as
ROC studies) is an effective way to perform CT image
quality—dose optimisation(6). Nowadays, a new algo-
rithm is often assessed by model observer studies
in the image domain because the new iterative
algorithms do not respect the shift-invariance and
cyclostationarity assumptions necessary to use Fourier-
based metrics(7 – 9). In this study, the CHO model that
mimics the human observer performance was used to
assess the dose reduction potential of a new iterative
reconstruction algorithm while keeping the image
quality constant.
MATERIALS AND METHODS
Data acquisition
An anthropomorphic abdomen phantom (QRM 401,
Moehrendorf, Germany) simulating the attenuation
produced by a thin patient (equivalent diameter 24 cm)
was scanned on a new Revolution CT (GE Healthcare,
USA). Two modules can be inserted in the middle: a
homogeneous module similar to the phantom’s back-
ground and a low-contrast module that contains 6 and
8 mm spherical targets with contrast levels of 10 and
20 HU at 120 kV.
The phantom was scanned using the helical mode
with a pitch of 0.984 at 120 kVp. The tube current was
adapted for three dose levels [5, 10 and 15 mGy, volume
computed tomography dose index (CTDIvol) values
were calculated as described in the IEC 60601-2-44(10)
in a 32-cm CTDIvol abdomen phantom]. However, the
CTDIvol indicated was overestimated, because it was
calculated for a 32-cm CTDI phantom, whereas the
phantom measured only 24 cm.
Fifty acquisitions per condition were made, and
images were reconstructed using a 320-mm display
field of view (DFOV), a 512`  512 matrix size and a
reconstructed slice thickness of 2.5 mm associated
to a reconstruction interval of 2 mm. A new iterative
algorithm, adaptive statistical iterative reconstruc-
tion (ASIR-V) at different levels (0, 50 and 70 %),
was used to reconstruct the images(11). This algo-
rithm is a mixture between ASIR and MBIR, but to
decrease the time reconstruction, ASIR-V does not
model system optics(12 – 15). The ASIR-V level repre-
sents the noise reduction rate.
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A total of 36 different categories were obtained
(three dose levels, two ASIR-V levels, two contrast
levels and two target sizes), and 200 regions of interest
(ROIs) of 28` 28 pixels containing centred signals
were extracted for each category. The ROIs containing
the noise were extracted from the homogeneous
modulus at the same (x,y) location as the signals in
order to avoid the problem of non-stationary noise.
Model observer: channelised Hotelling observer
In this work, three human observers (medical physi-
cists) and the CHO model performed a four-alterna-
tive forced-choice (4-AFC) experiment in which a
series of four images were displayed but only one con-
tained a signal. The CHO is a linear and anthropo-
morphic model that can be used to evaluate the image
quality(2, 3). The methodology used in this paper for
the CHO is directly inspired by the methodology used
by Ott et al.(16). (The reader interested in all the math-
ematical details of the process will find extensive
details in the chapter on the CHO model observer in
Ott et al.).
For each trial of four images, the observer had to
identify the image that was the most likely to contain
the signal. The model observer compared the decision
variable of the four displayed images and chose the
one with the highest value as a signal-present image.
In the end, a percentage correct (PC) was calculated
and used as a figure of merit.
The average and standard deviation of the model
observer’s PC were estimated by performing a boot-
strap method(17). In practice, 1000 4-AFC experiments
were performed for each category, and each 4-AFC ex-
periment was created from 100 trials (1 image contain-
ing the signal and 3 signal-absent images per trial).
Then, the mean and standard deviation of the 1000 PC
values were computed. For human observers, the mean
value and its standard deviation were calculated using
the PC of the three observers. Error bars represent plus
or minus one standard deviation.
Internal noise
To adjust the model’s response to human observers’
responses, it was necessary to reduce the model’s perfor-
mances with an internal noise e because the CHO
model with DDoG channels overestimates the perform-
ance of human observers in some conditions(18). First,
the decision variable l was calculated as described in
the methodology presented by Ott et al.(16), but at the
end a random variable was added to obtain a noisy de-
cision variable(8, 16):
lnoisy ¼ lþ 1: ð1Þ
Internal noise e was added to the decision variable
l with probability proportional to the standard
deviation of the distribution of the decision variable
amplitude images when the signal was absent:
1 ¼ a sbg  j; ð2Þ
where a is the weighting factor, j is a random number
generated between 21 and 1, and sbg is the standard
deviation of the distribution of the decision variable
of signal absent.
The a value was obtained by a calibration using
images containing the signal 6 mm/20 HU at 10 mGy
reconstructed with ASIR-V 50 %. The a value that
minimised the difference between the model observers
and the human observer was selected.
RESULTS
Figure 1 shows the humans’ performances and Figure 2
the model observer’s performances using ASIR-V algo-
rithm at different levels. The category 8 mm/20 HU
was too trivial (PC always equal to 1 in every con-
ditions), and it was used as a training test for each
dose and algorithm level.
For human observers, the results suggest that the
detectability slightly increases with the level of ASIR-V
(Figure 1). Thus, when the dose increases, PC tends to
reach a plateau. This phenomenon was similar when
the size or the contrast levels increased. In some con-
ditions, using a higher ASIR-V level slightly improved
the detectability, especially at low contrast.
As can be seen in Figure 2, the trends obtained from
the CHO with DDoG and without adding internal noise
were very similar to those obtained with human obser-
vers, even if the model overestimates the human perform-
ance and clears the difference between ASIR-V levels. In
the high dose range, no significant difference appeared
when using ASIR-V 70 % instead of ASIR-V 50 %.
Figure 3 shows the variation of PC as a function of
A at a dose level of 10 mGy for the sphere 6 mm/20
HU reconstructed with ASIR-V 0 %. As expected,
the higher the A, the lower the PC. The A value that
provided the best match between the CHO perform-
ance and the human observers’ performance for this
category was chosen for other categories. The Avalue
that provided the best match was equal to 4.0.
Adding internal noise within the CHO decreased its
performance in order to match the human observers.
This match was quantified with the root-mean-square
error (RMSE). The value of the RMSE for all categories
decreased from 0.62 to 0.178 when internal noise was
added. Like the human performance, the PC increases
with the dose when an internal noise is added. The
human’s performance is linked with the ASIR-V levels.
However, for the model observer, the hierarchy between
different ASIR-V levels is not very clear. For example,
the PC for the category 8 mm/10 HU became unexpect-
edly worse at 15 mGy. Thus, the image quality tends to
a plateau between 10 and 15 mGy with ASIR-V 70 %
D. RACINE ETAL.
74
 at U
niversite and EPFL Lausanne on June 16, 2016
http://rpd.oxfordjournals.org/
D
ow
nloaded from
 
for the sphere at 6 mm and 10 and 20 HU (Figure 4a
and b). For the other levels, the image quality increased
by 10 %, whereas the dose was increased by 50 %.
DISCUSSION
In recent years, the introduction of iterative algo-
rithms has led the way to optimising clinical protocols
and possibly decreasing the collective effective dose,
especially in CT. The aim of this study was to evaluate
the impact of the new ASIR-V algorithm on image
quality in order to optimise the patient’s exposure
using a model observer. The results show that the
image quality increased with the level of ASIR-V, but
Figure 2. Results of the CHO model observer performing
without internal noise and DDoG channel in PC for category:
(a) 6 mm/10 HU, (b) 6 mm/20 HU and (c) 8 mm/10 HU.
Figure 1. Results of the human observers who performed a
4-AFC test: (a) 6 mm/10 HU, (b) 6 mm/20 HU and (c) 8
mm/10 HU.
LOW-CONTRAST DETECTABILITYWITH ASIR-V
75
 at U
niversite and EPFL Lausanne on June 16, 2016
http://rpd.oxfordjournals.org/
D
ow
nloaded from
 
only for the human observer. The human observer
seemed more efficient at detecting a signal in a less
noisy image, but the results were not statistically sig-
nificant ( p ¼ 0.26). The model observer with internal
noise function selected allowed to get a better match
with human detection performance. Nevertheless, the
results could be improved by using more functions
since the type of image texture varied in a wide range
(new algorithm allowing various strength levels). In
spite of this, the authors preferred to use a unique
noise function since only one iterative algorithm was
used. Thus, the RMSE was just minimised until re-
aching a plateau, and note that the RMSE was very
dependent on an outlier (Figure 4c point at 15 mGy
and ASIR-V 70 %). The PC tends to plateau when
the dose, the contrast or size increases, and no differ-
ence was seen between levels of ASIR-V 50 and 70 %,
because this study only focussed on the low-contrast
detectability and high-contrast performances were
not evaluated. To evaluate the interest of the ASIR-V
70 % or higher, the spatial resolution could be evalu-
ated with the target transfer function(19).
One limitation of this study is the use of a simplistic
anthropomorphic phantom. Even if it mimics human
body attenuations, it does not contain any texture.
Furthermore, only two sizes and two contrasts were
investigated. Another limitation is that the paradigm
used (signal, location and background are known
exactly) was simple and therefore different from actual
clinical conditions.
CONCLUSION
Evaluating image quality with frequency metrics is
far away from the clinical task. To be close to the con-
cerns of radiologists, task-based tools (e.g. CHO
model) must be used to objectively evaluate the image
quality. The CHO model with DDoG filter used in
this study successfully demonstrated its capacity to
mimic the human’s performance. Thus, the ASIR-V
algorithm evaluated with this tool shows that the
image quality on the low-contrast detectability stays
high even with the small sphere of low contrast. These
findings suggest that patient dose could be reduced
using the ASIR-V algorithm and the new CT unit
evaluated, without decreasing image quality.
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